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H9N2 avian influenza viruses (AIV) are widespread in poultry populations 
worldwide, causing large economic losses. Influenza viruses have an RNA 
genome which is split into 8 sections called segments. Different strains of virus 
can swap segments to produce new strains in a process known as reassortment. 
Within H9N2 AIVs, the exchange of gene segments has led to an increased 
pathogenicity of the virus in poultry but the reasons behind this remain 
undetermined.  Previous experiments have shown that segment 3 may be 
important. This segment produces multiple proteins including PA, a subunit of 
the viral RNA polymerase, and the PA-X virulence factor. It is important to 
understand the factors responsible for enhancing pathogenicity in order to 
improve control measures and identify risk factors. This study uses H9N2 AIV as 
a model to understand how evolutionary molecular changes in segment 3 (PA 
gene) modulate virus virulence in birds.  
To investigate the molecular basis of this, reciprocal alterations were 
made to the PA genes of two pre- and post- reassortment H9N2 AIV strains, 
A/guineafowl/Hong Kong/WF10/99 (WF10) and A/chicken/Pakistan/UDL-
01/08 (UDL-01) respectively. One method used to determine the fitness of a virus 
is to see how it can spread within cell sheets to create holes termed plaques.  A 
single change next to the PA endonuclease active site (K26E) was identified to 
have the largest effect on viral phenotypes; by swapping the size of the plaque the 
virus makes within MDCK cells as well as the amount of viral output after 
infection. This change also reduced overall pathogenicity in infected chickens by 
16 
 
reducing viral replication in the birds. These experiments identified the E26K 
change as a pathogenicity determining residue.  
The E26K mutation lies within the protein domain common to PA and PA-
X. PA-X has roles in host cell protein synthesis shut off, which is a mechanism 
viruses use to avoid the host immune response. When the shut off activity of the 
WF10 and UDL-01 PA-Xs were assessed, there was a marked difference. WF10 
PA-X was unable to control host cell protein synthesis whereas UDL-01 PA-X had 
highly active host cell shut off ability. This activity could be switched with the 
introduction of the E26K PA mutation.  
Further functions of the H9N2 PA-Xs were then investigated. Removal of 
PA-X expression from UDL-01 led to the production of smaller plaques and 
reduced viral replication. Removal of PA-X from WF10 had no viral fitness 
implications. When chickens were infected with the UDL-01 strain either with or 
without PA-X expression, loss of PA-X reduced viral shedding at earlier times post 
infection.  
Overall, these studies show that a single amino acid change within the PA 
gene of H9N2 avian influenza viruses is able to reduce replication and 
pathogenicity of these viruses in poultry via impacting upon ability of the virus to 
control host cell protein synthesis. These results can potentially be exploited to 






H9N2 avian influenza viruses (AIV) are widespread in poultry populations 
worldwide, causing large economic losses. Reassortment events with other co-
circulating AIV strains has led to an increased pathogenicity of H9N2 in poultry. 
However, the molecular basis of this increased pathogenicity remains largely 
undetermined, although previous experiments have implicated exchange of 
segment 3; encoding the PA subunit of the viral RNA polymerase and the PA-X 
virulence factor. It is important to understand the factors responsible for 
enhancing pathogenicity in order to improve control measures and identify risk 
factors. This study uses H9N2 AIV as a model to understand how evolutionary 
molecular changes in segment 3 (PA gene) modulate virus virulence in birds.  
To investigate the molecular basis of this, site directed mutagenesis was 
used to introduce reciprocal alterations to the PA genes of two pre- and post- 
reassortant H9N2 AIV strains: A/guineafowl/Hong Kong/WF10/99 (WF10) and 
A/chicken/Pakistan/UDL-01/08 (UDL-01) respectively. A single polymorphism 
adjacent to the PA endonuclease active site (K26E) was identified as having the 
largest impact on viral phenotype. This change did not significantly affect the 
transcriptional activity of the viral polymerase. However, when the mutation was 
introduced into viruses, the replication phenotypes (assessed via plaque size and 
viral titre) were switched between the WF10 and UDL-01 strains. During in vivo 
pathogenicity studies within the UDL-01 virus, the introduction of the E26K 
change altered viral replication as well as reducing overall pathogenicity in 
directly inoculated and contact chickens but without affecting transmission.  In 
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contact birds, the mutant virus was less able to disseminate beyond the 
respiratory tract to the visceral organs. Thus overall, the E26K change altered 
viral replication in vitro and in vivo, identifying it as a pathogenicity-determining 
residue.  
The E26K mutation lies within the protein domain common to PA and PA-
X. PA-X has roles in host cell protein synthesis shut off and when the shut off 
activity of the WF10 and UDL-01 PA-Xs were assessed, there was a marked 
difference in their activity. WF10 PA-X was unable to control host cell protein 
synthesis whereas UDL-01 PA-X had highly active host cell shut off ability. This 
activity could be switched with the introduction of the E26K PA mutation. Further 
functions of the H9N2 PA-Xs were then investigated. Polymerase transcriptional 
activity was also similar between the virus strains. However, removal of PA-X 
expression from UDL-01 led to a reduced plaque phenotype and viral replication. 
Removal of PA-X from WF10 had no viral fitness implications. When both the 
E26K change was made and PA-X expression was removed from UDL-01 segment 
3, viral replication and plaque diameter was reduced, the reciprocal effect was 
observed with the introduction of both mutations into WF10.  During in vivo 
pathogenicity studies with the UDL-01 strain with or without PA-X expression, 
loss of PA-X reduced viral shedding at earlier times post infection.  
Overall, these studies show that a single amino acid change within the PA 
gene of H9N2 avian influenza viruses is able to reduce replication and 
pathogenicity of these viruses in poultry via impacting upon ability of the virus to 
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Chapter 1: Introduction to influenza A virus 
1.1: Influenza viruses 
Influenza viruses are members of the Orthomyxoviridae family (McGeoch 
et al., 1976). There are 4 described genera within influenza viruses, Influenzavirus 
A, B, C and D (Rota et al., 1990; Francis et al., 1950; Hause et al., 2014). However, 
this thesis will only concentrate on influenza A viruses (IAV). IAV are enveloped 
RNA viruses with a genome consisting of eight negative sense, single stranded 
segments (McGeoch et al., 1976). The natural reservoir of IAV is thought to be 
wild aquatic birds of the Anseriformes and Charadriiformes orders. IAV are 
subtyped according to the presence of two surface antigens; Hemagglutinin (HA) 
and Neuraminidase (NA). To date, 16 HA and 9 NA subtypes have been identified 
to circulate within the aquatic bird reservoir, with each virus containing a 
combination of HA and NA such as H1N1 or H7N9 (reviewed by Webster et al., 
1992). However, in recent years two further HA/NA combinations have been 
identified in bats (H17N10 and H18N11) which have not yet been found in other 
species (Tong et al., 2012; Tong et al., 2013).  
Several pandemics have resulted from IAV infection in humans in the past 
century due to the introduction of novel HA subtypes into the population (Yoon 
et al., 2014). The most severe pandemic recorded was the 1918 H1N1 Spanish 
Flu. This resulted in between 50 and 100 million deaths worldwide 
(Taubenberger et al., 2012; Johnson et al., 2002) with many deaths due to severe 
complications related to secondary bacterial pneumonia (Taubenberger and 
Morens, 2006; Morens et al., 2008). More recent pandemics including the 1957 
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Asian Flu (H2N2), 1968 Hong Kong Flu (H3N2) and 2009 Swine Flu (H1N1) have 
had lower mortality rates but still show the potential of IAV to periodically cross 
over into human populations. Once an animal strain of IAV has caused a pandemic 
within the human population, a baseline of protective immunity against the virus 
develops, so the virus then causes seasonal epidemics which peak during the 
winter period (Taubenberger and Kash, 2010). Seasonal influenza infections are 
usually transmitted by airborne droplets and fomites, usually leading to mild 
respiratory infection. Currently, only H1, H2 and H3 subtypes have been known 
to persist in human populations, although other strains such as H5, H7 and H9 
have sporadically crossed over (Schrauwen and Fouchier, 2014).  
1.2: The influenza virus genome 
IAV have a segmented, negative sense RNA genome of around 13.4 Kb in 
size. Each segment encodes at least one protein; with the genome encoding 10 
core proteins and several accessory proteins (Figure 1.1). Each segment has one 
main open reading frame (ORF) which allows for the faithful translation of a 
protein product; Polymerase Basic protein 2: PB2 (segment 1), Polymerase Basic 
protein 1: PB1 (segment 2), Polymerase Acidic protein: PA (segment 3), 
Hemagglutinin: HA (segment 4), Nucleoprotein: NP (segment 5), Neuraminidase: 
NA (segment 6), Matrix protein: M1 (segment 7) and Non-Structural protein 1: 
NS1 (segment 8). However, other mechanisms are adopted by IAV to increase the 
coding capacity of the genome including alternative splicing, frameshifting and 






















Figure 1.1: Schematic of the influenza A virus genome. The IAV genome consists of 8 
segments of ssRNA which encode for a range of proteins shown within this diagram. The RNA 
genome segments are indicated by the square ended black lines, mRNAs are shown as black 
lines with the 5’ cap structures depicted as black circles and the polyA tails as (A)n. Spliced 
regions are represented by dotted lines. Black arrows indicate initiation sites of protein 
synthesis. Proteins are shown as blue rectangles with the alternative ORFs depicted in 
different shades. FS indicates the conserved frameshift site. The hypothetical NEG8 mRNA 
and resulting protein are also shown as a dotted line at the base of the schematic.  Figure 




Segment Protein Expression mechanism Function(s) Reference 
1 PB2 Faithful translation Binds capped host non-coding RNAs within trimeric 
polymerase to prime viral mRNA transcription  
Blaas et al., 1982 
PB2-S2 Spliced mRNA Inhibitor of RIG-I signalling  Yamayoshi et al., 2016 
2 PB1 Faithful translation Contains catalytic site for RNA dependant RNA polymerase Braam et al., 1983 
PB1-N40 Alternate AUG site Unknown  Wise et al., 2012 
PB1-F2 Alternate AUG site Reduces IFN induction and roles in viral virulence  Chen et al., 2001 
3 PA Faithful translation Cleaves host mRNAs during cap-snatching via endonuclease 
activity to prime viral mRNA transcription  
Dias et al., 2009 
PA-X Ribosomal frameshifting Host cell shut off  Jagger et al., 2012 
PA-N182 Alternate AUG site Unknown Muramoto et al., 2013 
PA-N155 Alternate AUG site Unknown Muramoto et al., 2013 
4 HA Faithful translation Attachment to cell surface via receptor binding, fusion of 
endosomal membranes and budding  
Johnson et al., 1964; Connor 
et al., 1994; Skehel and Wiley, 
2000 
5 NP Faithful translation Coats viral genome, required for polymerase activity  Baudin et al., 1994; Huang et 
al., 1990; Ortega et al., 2000 
6 NA Faithful translation Virus release from cell surface, membrane scission during 
budding  
Hirst et al., 1941; Kobasa et 
al., 1999; Palese et al., 1974 
7 M1 Faithful translation Roles in virion structure, associated with recruitment of 
vRNPs during viral budding  
Gomez-Puertas et al., 2000 
M2 Spliced mRNA Forms a proton channel within endosomal membranes, 
required for virion budding  
Lamb and Choppin, 1981; 
Pinto et al., 1992 
M42 Spliced mRNA Modified version of M2 Shih et al., 1995 
8 NS1 Faithful translation Interferon antagonist Hale et al., 2008 
NEP Spliced mRNA Nuclear export of vRNPs, regulates switch between viral 
transcription and translation 
Inglis et al., 1980; O’Neill et 
al., 1998; Paterson and Fodor, 
2012;  
NS3 Spliced mRNA Unknown  Selman et al., 2012 
NEG8 Unknown Protein expression not detected  Clifford et al., 2009 
Table 1.1: Gene products encoded by IAV 
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Genomic viral RNA segments (vRNA) are encapsidated in multiple copies 
of the nucleoprotein (NP). Influenza viruses encode a heterotrimeric RNA 
dependant RNA polymerase (PB2, PB1 and PA) which is responsible for the 
transcription of viral mRNA and also for replication of the viral genome (Fodor, 
2013) (Figure 1.2A, B). One copy of each subunit of the polymerase complex is 
bound to the promoter region of the vRNA which leads to the formation of viral 
ribonucleoproteins (vRNP), the minimal unit required for transcription and 
replication (Huang et al., 1990). Each genome segment is flanked by conserved 
sequences at each end which have some complementarity, termed untranslated 
regions (UTRs). The polymerase sits on the panhandle structure formed via this 
terminal complementarity and the vRNPs take on the form of a helical filament, 
seen in Figure 1.2B (Hsu et al., 1987; Baudin et al., 1994; Klumpp et al., 1997; 
Compans et al., 1972).  
1.3: Influenza virion structure 
IAV particles are pleomorphic in shape producing filamentous or spherical 
morphologies (Mosley and Wyckoff, 1946). Lab adapted strains tend to have 
more spherical phenotypes, with particles of 100nm in diameter whereas clinical 
isolates tend to adopt filamentous phenotypes of up to 20µm in length and 100nm 
in diameter (Mosley and Wycoff, 1946; Harris et al., 2006; Cox et al., 1980). M1 
plays a vital role in virion structure and is important for overall morphology 
(Roberts et al., 1998; Bourmakina and Garcia-Sastre, 2003; Elleman and Barclay, 
2004). However, the function of IAV particle morphology remains unclear 





















Figure 1.2: Diagrams of the structure of the polymerase heterotrimer and vRNP 
organisation. Structure of the polymerase heterotrimer (A) front and (B) back. PB2 shown 
in blue, PB1 shown in red, PA in green, 3’ vRNA in yellow and 5’ vRNA in pink. Polymerase 
structure adapted from Reich et al., 2014 PDB = 4WSB, provided by Tom Peacock. (C) vRNP 
structure cartoon with the polymerase complex depicted at the panhandle terminus and NP 






A schematic of a spherical IAV particle is shown in Figure 1.3. IAV are 
enveloped viruses whose membrane is derived from the host phospholipid bi-
layer. Three transmembrane proteins are present: HA, NA and the M2 proton 
channel (Laver and Valentine, 1969; Zebedee and Lamb, 1988). HA and NA are 
surface glycoproteins which protrude from the virion, acting as antigenic 
determinants, usually present in a ratio of 4:1 (Webster et al., 1968). The M1 
protein is the most abundant protein in the virion and forms a ‘shell’ underlying 
the viral envelope, giving the virus structure (Richardson and Akkina, 1991; 
Hutchinson et al., 2014). The 8 vRNPs are packaged into the space inside the 
virion along with NS1, NEP and other cellular factors which vary depending on 
the originating host species (Hutchinson et al., 2014; Shaw et al., 2008). M1 
interacts with the lipid bilayer and the vRNPs (Ruigrok et al., 2000, Noton et al., 
2007; Noton et al., 2009). A 7+1 ‘core-bundle’ arrangement has been suggested 
for the structure of vRNPs within the virion with the presence of one central 
segment surrounded by the other 7 was detected via transmission electron 
microscopy (Noda et al., 2012).  
1.4: Virus life cycle 
Unlike most other non-retroviral RNA viruses, IAV completes RNA 
synthesis within the host nucleus, allowing easier access to host mRNA 
transcription and processing machinery. This may also reduce the likelihood of 
activating host cytoplasmic sensors for vRNA and thereby triggering an innate 























Figure 1.3: Schematic of IAV spherical virion structure. IAV have two surface 
glycoproteins, HA and NA, which are embedded in the host derived lipid bilayer envelope of 
the virion along with the M2 proton channel. Oligomers of viral M1 protein provide the 
structural shell of the virion. The ssRNA of the genome is split into 8 segments each 
encapsidated with multiple copies of NP.  The trimeric polymerase sits on the panhandle at 



































Figure 1.4: Schematic of the IAV lifecycle. IAVs enter the host cell via attachment of HA to 
sialic acid on the cell surface followed by endocytosis. As the endosome acidifies, membrane 
fusion is triggered, mediated by HA, which allows for release of vRNPs into the cytoplasm. 
vRNPs enter the nucleus using importins and genome replication and transcription take 
place. Newly synthesised copies of the genome and translated viral proteins assemble to form 
progeny vRNPs which are exported from the nucleus via Crm1 mediated export and 
trafficked to the cell surface. Virus assembly and budding takes places and infectious particles 




1.4.1: Virus entry 
IAV infection starts with binding of virus to the host cell surface, a 
processes mediated via the influenza HA protein attaching to N-acetylneuraminic 
(sialic) acids covalently linked to oligosaccharides on glycoproteins or 
glycolipids, via its receptor binding site (Johnson et al., 1964). Avian- and human- 
IAVs have been shown to preferentially recognise different terminal sialic acid 
linkages; with avian influenza viruses (AIVs) recognising sialic acids attached to 
galactose in α-2,3 linkage, and human IAVs recognising sialic acids attached to 
galactose in α-2,6 linkage (Connor et al., 1994). This receptor binding preference 
correlates to the abundance of cellular receptors in sites of replication within the 
host. Human upper respiratory tracts have an abundance of α-2, 6 linked sialic 
acids whereas the avian enteric and respiratory tracts have an abundance of α-2, 
3 linked sialic acids (Matrosovich et al., 2004). 
Upon binding, virions are internalised via methods dependent on virion 
morphology. Spherical virions are internalised via clathrin-mediated endocytosis 
(Eierhoff et al., 2010), whereas filamentous virions enter via macropinocytosis 
(Rossman et al., 2012). To enter the cell cytoplasm, the virus must fuse its 
membrane with that of the endosome to allow release of vRNPs, a process 
mediated by HA (Jardetzky and Lamb, 2004). HA contains a fusion peptide, which 
is a hydrophobic stretch of amino acids at the N-terminus of the HA2 subunit.  On 
the virion at neutral pH, HA is present in a state whereby the fusion peptide is 
hidden at the base of the molecule (Chen et al., 1998a+b). As the endosome 
containing the virion acidifies, cleaved HA (in multiple trimers) undergoes a 
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conformational change at between pH 5-6, enabling the fusion peptide to insert 
into the endosomal membrane (Huang et al., 1981; Maeda et al., 1980; White et 
al., 1981). This is followed by further protein re-folding to bring the fusion 
protein into close proximity with the HA C-terminal transmembrane domain, 
bringing the endosomal and viral envelope membranes together (Sauter et al., 
1989; Bizebard et al., 1995; Skehel et al., 1982). The energy released from this 
conformational change permits the fusion of the two membranes. Simultaneously 
within the endosome, the M2 proton channel is activated allowing H+ ions to be 
transferred into the virion interior. This allows for dissociation of M1 from the 
vRNPs, enabling them to enter into the host cytoplasm and complete virus entry 
(Bui et al., 1996; Ciampor et al., 1992) 
1.4.2: Nuclear import of vRNPs and transcription and replication machinery 
Transport of vRNPs from the endosome to the nuclear membrane is rapid, 
although the exact mechanism is undetermined. vRNPs must enter the nucleus 
for vRNA synthesis to occur. Due to the large size of the vRNPs, an active transport 
mechanism is required, as any molecules larger than 2.6nm cannot pass passively 
through the nuclear pore complexes (NPC) (Eibauer et al., 2015). Several 
influenza proteins have been identified to contain nuclear localisation signals 
(NLSs) including all three of the polymerase components and NP (O’Neill et al., 
1995).  NLSs consist of a series of basic residues forming a single cluster or 
bipartite motif (Cingolani et al., 2002) and allow for the transport of the vRNPs 
into the nucleus by mediating binding to host importins in the cytoplasm. Binding 
of importins to Ran-GTP releases vRNPs into the cell nucleus. Once within the 
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nucleus the viral polymerase can carry out a primary round of transcription and 
the viral mRNAs can be exported into the cytoplasm for translation via host 
machinery.  
Viral RNP components that have been translated within the cytoplasm are 
required to be imported back into the nucleus to further aid in transcription and 
replication of the genome, a process mediated by NLSs. PB2 contains two NLS 
regions (residues 449-495 and a bipartite NLS within the C-terminal domain) 
allowing import of PB2 via the classical pathway (Tarendeau et al., 2007). A PB1 
and PA heterodimer is required for efficient nuclear import of these proteins via 
a non-classical pathway interacting with RanBP5, however, the full import 
mechanism remains undetermined (Fodor and Smith, 2004; Deng et al., 2006; 
Hutchinson et al., 2010). NP contains an unconventional NLS in the N-terminal 13 
residues (Wang et al., 1997) allowing it to utilise the classical import pathway via 
interaction with various isoforms of importin-α (O’Neill et al., 1995; Gabriel et al., 
2008). These processes allow for all of the required components to be present 
within the nucleus for further RNA synthesis to be completed.  
1.4.3: Transcription and replication of the IAV genome 
The hetero-trimeric viral RNA-dependent RNA polymerase, consisting of 
PB2, PB1 and PA subunits, is responsible for the transcription and replication of 
the vRNA genome segments (Arranz et al., 2012; Coloma et al., 2009; Moeller et 
al., 2012). All eight vRNPs serve as separate transcription units. Synthesis of viral 
mRNA is initiated via a cis-acting viral RNA polymerase which is part of the vRNP 
structure bound to the 5’ and 3’ UTRs (Fodor et al., 1994; Tiley et al., 1994; Luytjes 
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et al., 1989). Viral mRNA synthesis is dependent on cellular RNA polymerase II 
activity, as this allows for access to a pool of host pre-mRNAs (Engelhardt et al., 
2005). Transcription is primed via a ‘cap-snatching’ mechanism, involving the 
cleavage of 10-13 nucleotide RNA fragments from host precursor mRNAs 
(particularly small non-coding RNAs) containing 5’ 7-methylguanosine caps 
which act as primers for viral transcription (Plotch et al., 1981; Gu et al., 2015). 
The influenza PB2 subunit is involved in binding to the 5’cap of the host pre-
mRNAs (Blaas et al., 1982) and the endonuclease within the PA subunit is 
responsible for mRNA cleavage. These caps are used for viral mRNA initiation 
within the polymerase active site (Hara et al., 2006; Yuan et al., 2009; Dias et al., 
2009). The PB1 subunit contains the main catalytic site for the RNA dependant 
RNA polymerase, allowing for RNA elongation in the 3’ to 5’ direction (Braam et 
al., 1983). Transcription is terminated at a sequence of 5-7 U residues which leads 
to stuttering of the polymerase and the addition of a poly (A) tail (Robertson et 
al., 1981; Moeller et al., 2012; Poon et al., 1998; Te Velthuis et al., 2016). 
Therefore, the nascent viral mRNAs contain both a 5’ 7-methylguansine cap and 
a 3’poly (A) tail and resemble mature host mRNAs.  
Once viral mRNAs have been transcribed they are processed similarly to 
host mature mRNAs and can take advantage of host splicing machinery to 
increase coding capacity (Amorim et al., 2007; Read and Digard, 2010; Bier et al., 
2011; York and Fodor, 2013). Viral mRNAs from segment 7 and 8 are spliced 
within nuclear speckles in a NS1-dependent manner (Robb and Fodor, 2012; Mor 
et al., 2016). Viral mRNAs are exported from the nucleus via interaction with 
numerous host proteins including the cap binding complex (CBC) and the 
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transcription export complex (TREX) and the nuclear export factor 1 (NXF1) 
pathway for export via the NPC is utilised. Once in the cytoplasm host translation 
machinery is accessed for protein expression (Wang et al., 2008; Hao et al., 2008; 
Read and Digard, 2010; Bier et al., 2011).  
Replication of the viral RNA genome consists of two stages: i) synthesis of 
a positive sense copy of vRNA termed complementary RNA (cRNA) using vRNA 
as a template and ii) synthesis of vRNA using the cRNA as a template. Replication 
does not require a primer for initiation leading to the presence of a 5’ 
triphosphate moiety within both the cRNA and vRNA (Hay et al., 1982). However, 
the precise mechanism of initiation is not fully understood. Vreede et al. (2008), 
suggested that the polymerase binds to GTP, followed by phosphodiester bond 
formation with ATP directed by template position 1, which gives rise to the 
pppApG dinucleotide needed for elongation via the polymerase. Newly generated 
RNAs synthesised during replication are encapsidated by free NP and polymerase 
subunits within the nucleus to form vRNPs which are exported from the nucleus 
prior to viral assembly (Shapiro et al., 1987; Tchatalbachev et al., 2001). The 
mechanisms by which the viral polymerase is able to switch from transcription 
of viral mRNAs to replication of the viral genome are unclear. It has been 
suggested that accumulation of NEP is involved in this regulation while others 
have suggested  small vRNAs (22-27 nucleotides in length) play a role (Robb et 





1.4.4: Nuclear export and trafficking of vRNPs 
vRNPs are exported from the nucleus via the chromosome region 
maintenance 1 (Crm1) pathway (Elton et al., 2001; Watanabe et al., 2001; 
Neumann et al., 2000). The viral protein NEP mediates this nuclear export by 
direct interaction with Crm1 through the presence of nuclear export signals 
(NES) and binding to the M1 protein, which is then believed to bind NP on the 
vRNP (O’Neill et al., 1998; Akarsu et al., 2003; Wakefield and Brownlee, 1989; 
reviewed by Paterson and Fodor, 2012). However, interactions between NEP and 
the polymerase have also been more recently identified (Manz et al., 2012). Prior 
to export, vRNPs have been shown to be tethered to chromatin, which is thought 
to improve efficiency of binding to Ran-GTP via association with Rcc-1 (Chase et 
al., 2011). Crm1 is activated for nuclear export by binding to Ran-GTP, and 
crosses the NPC via interaction with nucleoporins. This allows for nuclear vRNPs 
to be transported across the NPC into the cytoplasm where they can be assembled 
into virions. Once transported into the cytoplasm the vRNPs are dissociated from 
Crm1 via conversion of Ran-GTP to Ran-GDP via Ran-GAP (Eisfeld et al., 2015). 
Once within the cytoplasm, vRNPs need to be trafficked towards the 
cellular membrane for virus assembly and budding. vRNPs accumulate at the 
perinuclear cytoplasm in regions containing the microtubule organising centre 
(MTOC), where they interact with Y-box binding protein-1 (YB-1) allowing 
association with microtubules (Kawaguchi et al., 2012; Amorim et al., 2011; 
Momose et al., 2007). Transport through the cell requires interaction of the 
vRNPs with recycling endosomes through Rab11’s interaction with PB2 which 
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mediates vesicular transport via microtubules to the apical plasma membrane 
(Momose et al., 2007; Amorim et al., 2011; Eisfeld et al., 2011; Bruce et al., 2012).  
1.4.5: Virus assembly and budding 
For an influenza particle to be infectious all eight gene segments must be 
packaged into the virion and studies have shown this occurs through segment-
specific packaging mechanisms (reviewed in Hutchinson et al., 2010). Virions do 
not typically package more than eight segments and each segment usually only 
occurs once per virion. This is known to be mediated by the presence of RNA 
packaging signals at the termini of each segment (Inagaki et al., 2012; Chou et al., 
2012; Duhaut and McCauley, 1996; Fujii et al., 2003; Gog et al., 2007). At the point 
of packaging, complexes of eight parallel and closely packed vRNPs can be 
observed by electron tomography. These segments appear to be of distinctive 
lengths and only a small number of segment orders are observed. The RNP 
complexes are specifically packaged in a 7+1 arrangement where one central RNP 
is surrounded by the seven others (Noda et al., 2018; Nakatsu et al., 2016; Noda 
et al., 2006; Harris et al., 2006; Noda et al., 2012; Fournier et al., 2012). These 
interactions appear to be hierarchical, with certain segments (1 and 7) being 
shown to have importance in co-ordinating the interactions of the RNPs. The 
mechanism of how influenza viruses make use of these packaging signals is still 
debated although there is increasing evidence to suggest that RNA-RNA 




Virion assembly and budding takes place at lipid raft domains within the 
plasma membrane of infected cells. These are regions rich in cholesterol and 
sphingolipids (Brown and London, 1998). IAV HA and NA are intrinsically linked 
with these regions whereas M2 is excluded (Chen et al., 2007; Leser and Lamb, 
2005; Rossman et al., 2010; Takeda et al., 2003). The concentration of HA within 
lipid raft domains allows for initiation of virus budding although the exact 
mechanism is unknown. However within virus-like particle (VLP) studies, HA 
alone appears to possess the ability to alter membrane curvature leading to 
initiation of budding (Chen et al., 2007). Other studies have shown that co-
expression of HA, NA, M2 and M1 enhances VLP release, suggesting all four 
components are required for the most efficient budding process (Chen et al., 
2007; Lai et al., 2010). M1 mediates recruitment of the viral proteins necessary 
to complete budding by crosslinking the cytoplasmic tails of HA and NA to 
facilitate their incorporation into the budding virion (Gomez- Puertas et al., 2000; 
Ruigrok et al., 2000; reviewed by Schmitt and Lamb, 2005). Within the virion M1 
interacts with both the plasma membrane and NP (within the vRNPs) (Bui et al., 
1996; Noton et al., 2007; Zhang and Lamb, 1996). M1 polymerises at the sites of 
viral budding which can lead to the elongation of the budding virion and therefore 
production of a filamentous virus. Membrane bound M1 can also mediate 
additional alterations in membrane curvature, further progressing the budding 
process (Chen et al., 2007). M2 appears to stabilise the site of budding and aid 
with proper virion assembly before budding occurs. It also alters the membrane 
curvature to provide the final force required to mediate membrane scission 
(Rossman et al., 2010). Some host factors such as G-protein, F1Fo-ATP activity 
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and Rab11 are also required for virus budding (Gorai et al., 2012; reviewed by 
Ludwig et al., 1999; Bruce et al., 2010). Following membrane scission, the virion 
may still be attached to the cellular membrane via interaction of HA with sialic 
acid moieties. NA can then cleave the sialic acid, allowing the virion to be released 
(Palese et al., 1974).  
1.5: Influenza A virus evolution 
There are two main mechanisms by which IAVs can evolve:  
i) Antigenic drift:  
The error rate within the IAV RNA polymerase is high due to a lack of 
proof-reading ability which leads to the gradual addition of mutations within the 
genome. Drake et al. (1993) estimated that every time the IAV polymerase 
replicates its genome around one error is made. Antigenic drift describes the 
introduction of mutations into viral surface glycoproteins which can result in 
alterations to antigenic regions leading to immune escape from neutralising 
antibodies (reviewed by Scholtissek, 1995). Antigenic drift can occur under the 
selection pressure of the natural immune response or from vaccines. Lauring and 
Andino (2010), described the theory that a viral ‘quasi-species’ exists during each 
round of infection where a swarm of viruses, inherently linked via mutation, are 
produced. The highest frequency mutations within the population depends on 
the ability of individual members of the virus population to survive within the 
environment they find themselves in. Many of the mutants created during 
antigenic drift will be detrimental to viral fitness and will not persist.  
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ii) Antigenic shift: 
Antigenic shift refers to the introduction of a new IAV subtype into the 
human population, either via direct introduction or as a result of reassortment 
(Schrauwen et al., 2014). This latter event occurs when two or more viruses infect 
the same cell, allowing for the exchange of gene segments between the viruses, 
potentially leading to the emergence of a new viral subtype to which the 
population may have no prior immunogenicity. If the combination of segments is 
advantageous to viral fitness and the virus can successfully replicate, a 
‘reassortant’ strain can emerge. This has occurred numerous times within the 
human population, for example, in 1957 when the H2N2 subtype replaced the 
H1N1 subtype. The appearance of this novel H2N2 strain was the result of natural 
reassortment between the prevailing human H1N1 strain and an avian H2N2 
virus which donated its HA, NA and PB1 genes (Scholtissek et al., 1978).  
1.6: Avian influenza viruses (AIVs) 
It is believed that all IAV originate in aquatic birds such as ducks and sea 
birds as the majority of HA and NA subtype combinations have been isolated from 
them (Fouchier et al., 2005; Webster et al., 1992; Alexander., 2000). Within the 
natural host species IAV replicates within the gastrointestinal tract and are 
usually asymptomatic (Webster et al., 1992). AIVs are spread via the faecal-oral 
route and can remain infectious for weeks within lake water, facilitating efficient 
spread within the aquatic bird reservoir (Webster et al., 1978). IAV also have 
lower rates of nucleotide substitution within their natural reservoirs compared 
to those viruses which infect humans and poultry (Webster et al., 1992). AIVs can 
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cause infection within domestic poultry, with numerous subtypes jumping from 
the natural aquatic bird reservoir, including H5Nx, H6N1, H7Nx and H9N2 
subtypes. Within poultry species such as chickens, clinical disease signs can be 
severe, and mortality can result from infection, leading to large economic losses 
for the poultry industry (Swayne and Pantin-Jackwood, 2006).  
IAV are often categorised based on the severity of the disease they cause 
within a galliform host (Capua and Alexander, 2004). Low pathogenicity avian 
influenza viruses (LPAIV), generally cause little morbidity; characterised by mild 
respiratory signs, depression and egg production problems in layers (reviewed 
by Yoon et al., 2014). However, co-infections or other environmental factors have 
been shown to exacerbate disease signs and lead to high mortality rates in the 
field (Kishida et al., 2004; Pan et al., 2012; Seifi et al., 2010). Within poultry, LPAIV 
are mainly restricted to replication within the respiratory and gastrointestinal 
tracts and transmit via the faecal-oral route, although some airborne 
transmission has been observed (Claes et al., 2013; Pantin-Jackwood et al., 2013; 
Zhou et al., 2016; Lv et al., 2015).  
On the other hand, high pathogenicity avian influenza viruses (HPAIV) can 
cause up to 100% mortality in chicken flocks within several days, transmitting 
via a combination of airborne and faecal-oral routes (Shortridge et al., 1998; Pu 
et al., 2015; Spekreijse et al., 2011; Zhou et al., 2016). At the current time, HPAIVs 
have only been regularly derived from viruses of H5 and H7 subtypes and are 
defined as having an intravenous pathogenicity index (IVPI) of 1.2 or above in 6-
week old chickens. Within these studies chickens are inoculated intravenously 
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with a high viral dose and monitored for clinical disease over a period of 10 days. 
A score of 0 indicate no birds died whereas a score of 3 indicates all birds died 
within 24 hours of infection (OIE, 2017). HPAIVs replicate systemically within the 
galliform host as they can utilise endogenous subtilisin-like proteases, such as 
furin to cleave HA0, due to the presence of a poly-basic cleavage site (PBCS) (e.g. 
PQRERRRKKR/GLF) within HA (Vey et al., 1992; Wood et al., 1993; Senne et al., 
1996). The acquisition of a PBCS in HPAIV has been proposed to be the result of 
the error prone polymerase, where polymerase slippage would result in 
accidental repetition of nucleotides (Perdue et al., 1997). Monne et al. (2014), 
showed that HPAIVs emerged from low-pathogenic precursor viruses in the 
absence of reassortment. However, the presence of a PBCS does not automatically 
determine viral pathogenicity. For example, a H4N2 AIV isolated from quail in the 
USA had a naturally occurring PBCS, but this virus had an IPVI of 0 retaining a 
LPAIV phenotype (Wong et al., 2014). Conversely, an H10 AIV isolated from ducks 
in Singapore had an IVPI indicative of a HPAIV despite not having a PBSC (Wood 
et al., 1996). This indicates that other viral factors play a role in overall 
determination of pathogenicity. Some well characterised markers of 
pathogenicity include NA stalk deletions which increase AIV pathogenicity 
(Matsuoka et al., 2009; Sun et al., 2013b), polymerase polymorphisms (Suzuki et 
al., 2014), the presence or absence of accessory proteins such as PB1-F2 and PA-
X (James et al., 2016; Gao et al., 2015c) and polymorphisms in NS1 (Kong et al., 




1.6.1: Host species determinants in IAV 
It is important to understand the factors responsible for the ability of AIVs 
to infect and become transmissible within mammals to be able to better 
implement control measures, therefore a large body of work has been completed 
to identify factors responsible for this host switch.  
One of the main determinants is the ability of the HA to bind to α-2, 3 
(generally avian) or α-2, 6 (generally mammalian) linked sialic acid on the cell 
surface (Connor et al., 1994). Multiple HA residues have been deemed important 
for enabling viruses to switch receptor binding preference, including mutations 
within the 220-loop and 190-helix. However, many studies have shown that an 
amino acid change from Q to L at position 226 (H3 numbering) within HA is 
sufficient to alter receptor binding preference from avian- to human-like, 
enabling viruses to transmit between ferrets. This has been seen within H2, H3, 
H5, H7 and H9 AIVs (Rogers et al., 1983; Wan et al., 2007; Imai et al., 2012; 
Schrawen et al., 2016; Matrosovich et al., 2000). Other residues including G228S 
have also been shown to influence receptor binding preference of H2, H3, H5 and 
H7 viruses (Schrawen et al., 2016; Gambaryan et al., 1997; Teng et al., 2016).  
Another determinant of host range is the pH stability of cleaved HA. AIVs, 
along with swine influenza viruses, have a higher pH of fusion than that of human 
viruses. Human HAs usually fuse at a pH of 5.4-5.6 where avian and swine HAs 
fuse at a pH of 5.6-6.0 (Galloway et al., 2013; Russier et al., 2016; Costello et al., 
2015). This alteration in fusion pH can be seen when AIVs are experimentally 
passaged in ferrets (Linster et al., 2014; Herfst et al., 2014). It has been 
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hypothesised that the different fusion pHs allow for airborne transmission within 
humans (and ferrets) and persistence of viruses on fomites rather than in 
waterborne systems as with AIVs (Krenn et al., 2011). On the other hand, the 
mammalian respiratory tract is also mildly acidic and the lower pH of fusion may 
aid with stability in this environment (Washington et al., 2000). A high pH of 
fusion has been shown to increase pathogenicity in avian species but reduce 
pathogenicity in mammals (Reed et al., 2010; Zaraket et al., 2013).  
The avian viral polymerase has been demonstrated to be a limiting factor 
in transmission and viral fitness within mammalian hosts, with avian polymerase 
complexes often displaying inefficient replicative abilities within mammalian 
cells. The most extensively characterised change to counteract this restriction is 
a lysine to glutamic acid substitution at position 627 of PB2 (Subbarao et al., 
1993; Chen et al., 2006). It has been hypothesised that this substitution facilitates 
adaptation to physiological constraints of the species such as differences in body 
temperature (Hatta et al., 2007; Massin et al., 2001). Long et al. (2016), 
characterised the role of PB2 E627K as being involved in interactions with the 
host protein ANP32A, which varies in structure between avian and mammalian 
hosts. The presence of 627E mediates interaction with the avian but not human 
variant of the protein. However, the molecular mechanism behind ANP32A’s 
interaction with PB2 remains unclear. Several other polymerase adaptive 
mutations have been identified, including PB2 D701N, which can partially 
compensate for AIV PB2 627E in mammalian cells by increasing binding to 
importin-α isotypes (Steel et al., 2009; Tarendeau et al., 2007 and Gabriel et al., 
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2008). Several mutations in PA have also been investigated to impact upon host 
adaptation (see section 1.8.1.1 for details).  
Adaptive mutations within NP have been described which alter replication 
of AIVs in mammalian cells including N319K which affects NP interactions with 
host importin-α isoforms (Gabriel et al., 2005; 2007; 2008 and 2011). Other NP 
mutations can overcome the restriction of AIVs by human MxA (Manz et al., 
2013a). Finally, within H5N1 AIVs, particularly those which lack the PB2 E627K 
mutation, mutations within NEP (M16I, Y41C and E75G) have been shown to 
enhance viral RNA synthesis by avian polymerases in human cells (Manz et al., 
2012).  
1.6.2: Zoonotic potential of AIVs 
Several of the human influenza pandemics over the last century were 
derived from viruses of avian origin. This includes the 1968 Hong Kong flu, which 
was the result of reassortment between the seasonal H2N2 strain and an avian 
H3Nx strain which donated its HA and PB1 segments (Kawaoka et al., 1989). 
There is also some evidence to suggest the 1918 H1N1 pandemic was of avian 
origin (Taubenberger et al., 2012).  
As well as their pandemic potential and infection in poultry, AIVs have led 
to sporadic zoonotic infection in humans. HPAIV H5N1 first caused an outbreak 
in humans in Hong Kong in 1997, after direct transmission from poultry, causing 
fatality in 6 out of 18 cases (Yuen et al., 1998). Since this outbreak, HPAIV H5N1 
spread to poultry populations in Asia, Europe and Africa, causing severe disease 
outbreaks. This has corresponded with increased cases within humans; as of July 
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2018, there have been 860 confirmed human cases of H5N1 with 454 deaths; a 
case fatality rate of 53%. Most of the human cases have been within Egypt, 
Indonesia and Vietnam (WHO, 2018a). The majority of human H5N1 infections 
have been the result of direct transmission from poultry in areas such as live bird 
markets and there is little evidence of human-human transmission. In 2013, a 
new AIV zoonotic incursion occurred in China with a novel reassortant H7N9 
virus. This LPAIV causes little disease signs in poultry, however, in humans it 
leads to severe and often fatal respiratory disease (Kalthoff et al., 2014). As of July 
2018, there have been 1625 laboratory confirmed cases resulting in 623 deaths; 
a case fatality rate of 38% (WHO, 2018b). Again human-human transmission is 
limited but, studies have shown transmission can occur via direct contact within 
ferret models (Zhang et al., 2013). Several mammalian adaptation markers have 
been identified within these H7N9 strains, including HA 226L and PB2 627K 
changes (Zhang et al., 2014a; Watanabe et al., 2014). In 2017, a H7N9 virus was 
isolated from a human infection which contained the HPAIV signature PBCS 
(Yang et al., 2017). Other viral subtypes including H5N6, H6N1, H7N2, H7N3, 
H7N7, H9N2, H10N7 and H10N8 have also caused a limited number of human 
infections (see Table 1.2 for details). All of these data suggest that it is important 


























Years Countries Reference 





Yuen et al., 
1998 
H7N9 1625 623 38% 2013-
present 
China Kalthoff et al., 
2014 




Peiris et al., 
1999 
H5N6 19 6 43% 2014-
present 
China Shen et al., 
2016 
H10N8 2 2 100% 2014 China Chen et al., 
2014 
H6N1 1 0 0% 2013 Taiwan Shi et al., 
2013 
H7N3 2 0 0% 2012 Mexico CDC., 2012 
H10N7 2 0 0% 2010 Australia Arzey et al., 
2012 
H7N2 1 0 0% 2004 USA CDC., 2004 
H7N7 78 1 1% 2003 Netherlands Fouchier et 
al., 2004  
H7N4 1 0 0% 2017 China Tong et al., 
2018  
Table 1.2: Total human infections with different AIV subtypes. Data collected from WHO, 
July 2018.  
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1.6.3: Avian influenza virus control 
Once an HPAIV outbreak has been confirmed within a poultry flock, the 
preferred method of control is quarantine and ‘stamping out’. This involves 
culling all birds in an infected farm as well as those within a 10km perimeter. 
Movement restrictions are also placed upon birds and their products to prevent 
further spread to other surrounding farms (OIE, 2017). However, in many 
countries AIV has become enzootic and therefore it is not practical to cull the 
entire poultry populations, so vaccination has become the main method for 
control (Swayne, 2012). For example, vaccination has been used against H5N2 
viruses in Mexico, H7N3 in Pakistan and H5N1 in China (Capua and Alexander, 
2004). Vaccination has been shown to protect against clinical signs and mortality, 
reduce shedding and increase resistance to infection. However, viral replication 
is not always fully ablated, allowing the viruses to spread without the presence of 
clinical signs (Capua and Marangon, 2004). Currently, the majority of vaccines 
used within the field are inactivated vaccines; where viruses are grown in eggs 
and then inactivated using formalin (Swayne, 2012; Rahn et al., 2015). However, 
in recent years, research has been focused on developing recombinant vectored 
vaccines for AIV, using either avian herpesviruses, Newcastle disease virus or 
fowlpox virus backbones expressing the IAV HA (Rahn et al., 2015). A 
combination of monitoring systems, strict biosecurity and depopulation is 





1.7: H9N2 AIVs 
H9N2 AIVs have become endemic in poultry populations throughout 
much of Asia and North Africa. H9N2 are LPAIV which do not usually induce 
obvious clinical signs in chickens, with birds typically only showing signs 
including depression and ruffled feathers (Sun et al., 2010). Despite this, infection 
with H9N2 has led to cases with high morbidity, mortality and reduced egg 
production in layers (Bano et al., 2003; Kishida et al., 2004), although this is 
usually linked with secondary co-infections, poor housing or nutrition. In one 
case, an H9N2 AIV was isolated that caused lethal infection in chickens, where 8 
out of 10 6-week old SPF chickens died after infection (Zhang et al., 2014b). 
1.7.1: Epidemiology, ecology and evolution 
As stated above, throughout much of Asia, the Middle East and North 
Africa, H9N2 AIVs have become endemic in poultry populations and although the 
virus has not yet crossed into poultry flocks in Europe, recent incursions into 
Morocco and Turkey in 2016 suggest that the threat is increasing (Figure 1.5). 
H9N2 AIVs can be grouped phylogenetically via their HA gene which splits them 
into two main branches; Eurasian and America. The American branch of H9N2 
are mainly responsible for historical infections in turkey farms (Homme et al., 
1970). Within the Eurasian branch, there are 3 distinct lineages of virus. These 
are named after the prototypic virus in each group: A/chicken/Beijing/1/94-like 
(BJ/94-like), A/quail/Hong Kong/G1/97-like (G1-like) and A/duck/Hong Kong/ 
Y439/97 (Y439-like). The G1 lineage is the most widespread in the regions 






































Figure 1.5: Enzootic spread of H9N2 viruses in poultry in Asia, Middle East and North 
Africa. H9N2 enzootic countries represented in blue. Dates show the first isolation in 
chickens within the given country. Map made using mapchart.net 
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lineages based on geographical location: G1-Western (Bangladesh to Morocco) 
and G1-Eastern (South China, Vietnam and Hong Kong). The BJ/94 lineage mainly 
affects poultry in China but is also found in Vietnam and Cambodia. The Y439 
lineage is mainly isolated in wild birds throughout Eurasia and occasionally 
causes disease in poultry. In addition, a BJ/94 sub-lineage 
(A/chicken/Shanghai/F/98 – F/98-like), has persisted in poultry in Eastern 
China since 1998 (Lu et al., 2005, Zhang et al., 2009 and Zhang et al., 2008). 
However, since 2010 a novel genotype (G57 or genotype S) has become 
predominant in vaccinated poultry flocks in China and Vietnam (Gu et al., 2014; 
Liu et al., 2016). This genotype has been shown to have greater infectivity and is 
the predominant strain to donate internal gene segments to highly zoonotic AIVs 
(Pu et al., 2015; Gao et al., 2013). 
H9N2 infections occur throughout the year within poultry flocks and are 
frequently isolated from live bird markets in apparently healthy chickens, ducks 
and other poultry species (Xu et al., 2007b). Between 2008 and 2010, 2.6% of 
birds tested in live bird markets in Shanghai were positive for H9N2 AIV (Wang 
et al., 2014). These viruses are transmitted between birds via air droplet, dust, 
feed or water (Liu, 2012).  
1.7.2: Pathogenicity in different hosts  
The first outbreak of H9N2 in China was characterised by a mortality rate 
of 10-40% in broiler birds and reduced laying rates by 14-17% (Chen et al., 1994; 
Zhang et al., 1994). However, when introduced into SPF chickens, no mortality 
was observed. Since this time, H9N2 AIVs have been shown to display an 
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enhanced clinical presentation within poultry as well as increased transmission 
(Gao et al., 2016; Iqbal et al., 2013; Zhong et al., 2014; Seiler et al., 2018). Along 
with chickens, H9N2 AIVs have also become established in other poultry species 
such as quail, guinea fowl, partridge and pheasants (Zhou et al., 2016; Xu et al., 
2007a). Quail have been shown to be more susceptible to H9N2 infection than 
other species; they also possess more ‘human-like’ receptors than chickens 
suggesting they could play a role in the zoonotic potential of H9N2 AIVs (Perez et 
al., 2003; Wan and Perez, 2006; Costa et al., 2012).  
There have also been several isolations of H9N2 in swine, mainly in China. 
Mammalian adaptation markers including full length NA stalks and a high affinity 
for binding human-like α-2,6 sialic acids via an HA Q226L mutation have been 
identified in some of these viruses (Xu et al., 2004; Cong et al., 2007; Cong et al., 
2008; Yu et al., 2008). H9N2 infection in swine is of particular interest because of 
the propensity for pigs to be ‘mixing vessels’ for infection between mammalian 
and avian influenza viruses due to the presence of both human- and avian- like 
receptors in their respiratory tracts (Ito et al., 1998). Pigs with H9N2 AIV 
infection display symptoms such as high fever, coughing and tearing (Xu et al., 
2004). However, in experimental infections, H9N2 AIV show little replicative 
ability and limited transmission between pigs, although this was viral strain-
dependent (Obadan et al., 2015; Wang et al., 2016a). The lack of transmission 
between pigs suggests outbreaks are the result of repeated reintroduction from 
avian species.  
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Within canine and equine hosts there have been a handful of isolations of 
H9N2 AIVs. In China, BJ/94-like H9N2 AIVs were identified in dogs displaying 
classical signs of influenza infection (Sun et al., 2013a) and several studies have 
shown seroconversion in stray dogs present at live poultry markets in China to 
H9N2 (Zhou et al., 2015; Su et al., 2014). There has been a single case of H9N2 
equine influenza, which was again a BJ/94 lineage virus from China (He, 2012).  
Within ferret models, H9N2 AIVs have been shown to replicate efficiently 
although to a lesser extent than a human H3N2 virus. Direct transmission 
between experimental animals occurred with 2 strains of H9N2, deemed to be 
the result of the mammalian adaptation marker HA Q226L (Wan et al., 2008; Gao 
et al., 2016). In addition, several of the G57 genotype H9N2 AIVs have been 
shown, within ferret models, to transmit via respiratory droplet (Li et al., 2014; 
Yuan et al., 2015). The ability of H9N2 AIV to replicate and acquire mammalian 
adaptive mutations increases their zoonotic and pandemic potential. H9N2 AIVs 
have caused sporadic infections in humans. The first recorded case was two 
children displaying cold and flu-like symptoms, from Hong Kong in 1997 (Peiris 
et al., 1999). In humans, H9N2 infections are generally mild and only one death 
has been reported; in a patient with underlying health conditions (WHO report, 
2016). H9N2 is most often reported as the result of screening for zoonotic H5N1 
and H7N9 infections in China, Egypt and Bangladesh (Zhou et al., 2016; Monne et 
al., 2013; ICDDRB, 2011). Therefore, due to the mild clinical presentation of 
human disease it is likely that many cases go unreported. Studies looking at 
seropostivity to H9N2 in poultry exposed groups show that 1.7% - 6.5% of 
individuals display α-H9 antibodies (Wang et al., 2009; Pawar et al., 2012; Ma et 
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al., 2018). Many of the cases of H9N2 can be attributed to prior contact with 
poultry and there is no evidence of human-human transmission (Uyeki et al., 
2002). However, Matrosovich et al. (2001) reported that Asian poultry H9N2 
viruses show increased binding to human-like receptors and Chrzastek et al. 
(2018) showed a heterogeneity in Q and L at HA226. Overall, this suggests that 
although H9N2 infections are usually mild or asymptomatic and do not transmit 
further that the initial zoonotic event, further adaptation could lead to viruses 
becoming a true pandemic threat.  
1.7.3: Reassortment  
H9N2 AIVs, have been recognised as viruses which readily donate and 
receive gene segments from many other viral subtypes, including highly 
pathogenic and zoonotic strains. In experimental studies, a high frequency of 
reassortment (40-64%) was seen during co-infection of H4N6 and H9N2 IAVs in 
chickens (Li et al., 2018). This is particularly notable with the donation of the 6 
internal gene cassette of G57-like H9N2 AIVs to viruses such as human infecting 
H7N9, H10N8 and H5N6 shown to have a high propensity to cause death within 
humans (Shen et al., 2015; Zhang, 2016; Lam et al., 2013; Kageyama et al., 2013). 
The donation of H9N2 internal genes has been linked back as far back as the 
HPAIV H5N1 outbreak in Hong Kong in 1997, where retrospective analysis 
showed that all internal genes were derived from co-circulating G1-like H9N2 
AIVs (Guan et al., 1999).  Live poultry markets are suggested as places where the 
H9N2 AIVs can mix and reassort with H7 and H5 subtype strains, with co-
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circulation often being reported (Yu et al., 2014; Su et al., 2015; Wu et al., 2015; 
Naguib et al., 2015; Horwood et al., 2018).  
H9N2 AIVs have also donated their internal genes to novel genotypes of 
virus emerging in poultry populations. For example, a H5N2 AIV isolated from 
apparently healthy chickens in China was found to contain 7 gene segments 
(minus HA) derived from H9N2 (Wang et al., 2016b; Zhao et al., 2012). Another 
example comes from the identification of an H5N1 virus where four of the 
internal genes (PB2, PB1, PA and M) were of H9N2 origin (Gu et al., 2010). The 
emergence of a novel H7N7 AIV in chickens in China has also been shown to be 
the result of reassortment with H9N2 viruses and the donation of the internal 
gene cassette (Lam et al., 2013). 
On the other hand, H9N2 viruses readily accept internal genes from other 
IAV subtypes. For example, the currently circulating H9N2 lineage in Pakistan 
and Bangladesh is known to have received several internal genes from HPAIV 
H7N3 and H5N1 viruses (Iqbal et al., 2009; Parvin et al., 2014). The viruses 
circulating in Bangladesh contain the NS, NP, M, PA and PB1 genes from H7N3 
originating in Pakistan (Shanmuganatham et al., 2014). These reassortant viruses 
have an enhanced replication and transmission in both quail and chickens 
compared to the predecessor strains (Seiler et al., 2018). In China, there have also 
been multiple reports of H9N2 viruses isolated with internal genes derived from 
HPAIV H5N1 strains including the entire internal gene cassette (Guan et al., 2000) 
or different combinations of genes such as PB1 alone (Dong et al., 2011b) or PB2, 
PA and NP (Choi et al., 2004).  
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These reassortment events have enabled H9N2 AIVs to drastically change 
since they were first isolated in poultry and all their internal genes clustered with 
the G1-lineage (Cameron et al., 2000). The reassortant viruses have been shown 
to have increased fitness and to cause more severe clinical signs within chickens 
and wild terrestrial species such as quails and sparrows (Iqbal et al., 2013; Aamir 
et al., 2007; Guo et al., 2000; Zhang et al., 2014b). In experimental infections, some 
H9N2 AIVs, isolated from 2000-2002, were able to replicate in mice and lead to a 
5-20% weight loss compared to the pre-2000 strains which were unable to 
replicate (Li et al., 2005). Deng et al. (2010) also showed that a H9N2 AIV from 
2008 led to up to 60% mortality in mice caused by severe respiratory distress. 
These factors demonstrate the importance of furthering our understanding of the 
molecular factors responsible for the increased pathogenicity of H9N2 AIVs in 
both avian and mammalian hosts.  
1.7.4: H9N2 segment 3 
 In Pakistan, H9N2 AIV segment 3 has been shown to be derived from 
HPAIV H7N3 viruses, which H9N2 acquired, along with the PB2, PB1 and NS gene 
segments, during its spread throughout the country (Iqbal et al., 2009). A similar 
pattern has also been seen in Bangladeshi H9N2 AIVs, where reassortment again 
with HPAIV H7N3 has resulted in novel viral genotypes emerging. The currently 
circulating H9N2 viruses possess the PA gene plus PB1, NP, M and NS derived 
from these highly pathogenic strains (Shanmuganatham et al., 2014). These 
reassortant strains, in both cases have been demonstrated to have increased 
replication and transmission in poultry compared to the parental G1-like viruses 
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(Seiler et al., 2018; Iqbal et al., 2013). Sealy et al., (2019), recently showed that 
theses internal gene reassortment events including the PA gene have remained 
prominent within the Pakistani H9N2 virus population, cementing their 
importance for viral fitness.  
1.7.5: Vaccines  
Many countries which have enzootic H9N2 infection have adopted 
vaccination as a control method, including China (Zhang et al., 2008), Morocco (El 
Houadfi et al., 2016), Pakistan (Naeem et al., 2006), Iran (Bahari et al., 2015) and 
Egypt (Kilany et al., 2016). The majority of vaccines are traditional inactivated 
vaccines which, unlike the human seasonal vaccine, are not regularly updated. 
This has led to H9N2 continuing to infect and cause disease in poultry flocks in 
many areas (Zhang et al., 2008).  
1.8: The PA segment of IAV   
The role of the PA segment (segment 3) in determining H9N2 AIV viral 
fitness and pathogenicity forms the basis of this thesis. Accordingly, this section 
gives a further introduction to the proteins encoded by segment 3 and their 
functions.  
1.8.1: PA  
The influenza Polymerase Acidic (PA) protein is translated from segment 
3 of the viral genome (Braam et al., 1983; Fodor., 2013). PA is 716 amino acids in 
length and consists of two protein domains: a 25 kDa N-terminal domain and a 
55 kDa C-terminal domain (Hara et al., 2006; Guu et al., 2008). The domains are 
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connected via a 60 amino acid linker domain, which allows for conformational 
flexibility of the protein (Guu et al., 2008), see Figure 1.6 for details.  
The N-terminal domain of PA - PAN (residues 1-197) contains the major 
functional region of the protein, the endonuclease domain, and has pleiotropic 
effects.  Crystal structures of the PAN domain show that it contains five mixed β-
strands which form a twisted plane surrounded by seven α-helices. It contains a 
strongly negative charged cavity, which houses a metal binding site, with a 
similar structure to other endonucleases. Several residues have been identified 
which are important for the enzyme’s catalytic activity including H41, E80, P107, 
D108, E119 and K134, as these residues coordinate the magnesium metal ion 
found in the active site (Yuan et al., 2009; Dias et al., 2009). The endonuclease 
activity allows PA to cleave host mRNAs 10-15 nucleotides downstream of the 
5’cap during the ‘cap snatching’ process of viral mRNA synthesis. The short host 
mRNAs are then used as primers for the initiation of transcription via the PB1 
polymerase segment. A number of important residues have been identified which 
can affect the catalytic ability of the PA endonuclease which are summarised in 
Table 1.3. There is also limited data to suggest the PAN domain plays a role in 
regulating cRNA/vRNA synthesis as when PA T157 is present an increased cRNA 
synthesis is observed (Huarte et al., 2003) and has vRNA/ cRNA promotor 
binding ability with PA more involved in cRNA promotor binding suggesting 
possible functions in the cRNA/vRNA production switch by the polymerase (Hara 
et al., 2006; Maier et al., 2008). Kashiwagi et al., (2009), showed that H5N1 PA has 
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Figure 1.6: Influenza segment 3 structure. (A) Pymol software was used to map the 
structural domains onto the crystal structure of the influenza PA protein (PDB ID: 4WSB). PA 
endonuclease- pink, linker- yellow, C-terminus- blue, arch- purple. (B)Schematic to show the 
codon positions of the breaks between regions and the domains present in the PA accessory 
proteins. Colour scheme as above, X-ORF – pale blue. 
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The PA C-terminal domain- PAC (residues 256- 713), is involved in the 
binding of PA to PB1 (Gonzalez et al., 1996). The two polymerase components 
directly interact and form a stable complex which allows for binding to vRNA 
promotors. The PAC domain consists of 13 α-helices, one short 310 helix, 9 β-
strands and several loops/turns split into two domains (He et al., 2008; Obayashi 
et al., 2008). The binding of PB1 and PA is between the PAC residues 668 and 692 
and PB1N residues 1-12 (Perez and Donis, 2001), specific resides summarised in 
Table 1.3.  This interaction is essential for viral replication and polymerase 
activity, shown by the introduction of mutations into specific residues in PB1 
(Ghanem et al., 2007) and could pose an interesting target for the development 
of novel antivirals, as the interacting residues are highly conserved across not 
only IAV but also influenza B and C strains (Liu et al., 2009; Watanabe et al., 2017; 
Muratore et al., 2012). During the late stages of influenza virus infection, several 
studies have shown PA to be important for packaging and assembly of the viral 
genome. Regan et al. (2006), showed that introduction of G507A and R508A into 
the PA gene disrupts the assembly of infectious virions. 
The PAC domain has also been shown to interact with host proteins. In a 
screen of PA interactions using liquid chromatography-tandem mass 
spectrometry, Bradel-Tretheway (2011) putatively identified interactions with 
over 300 cellular proteins of which ~20% were mitochondrial proteins. One 
interaction that has been well validated is with the host protein human 
homologue chicken CLE (hCLE) (Huarte et al., 2001). This interaction is involved 
with the active reconstitution of vRNPs and positively modulates RNA 

















H41 Endonuclease active site  Yuan et al., 2009 
E80 Endonuclease active site Yuan et al., 2009 
K102A Decreases viral transcription and 
replication. Decreases cap and vRNA 
promotor binding activity  
Hara et al., 2006  
D108 Endonuclease active site ; D108A- 
selectively inhibits transcription  
Yuan et al., 2009; Hara 
et al., 2006 
E119 Endonuclease active site Yuan et al., 2009 
K134 Endonuclease active site Yuan et al., 2009 
T157A Decreases proteolytic activity and 
synthesis of cRNA 
Perales et al., 2000 
T162A Decreases protease activity and RNP 
replication, delays nuclear import of PA 
Huarte et al., 2003 
K328 PB1 binding site He et al., 2008 
H501A Decreases transcriptional activity of the 
polymerase  
Fodor et al., 2002 
G507A, R508A Disrupt virion assembly  Regan et al., 2006 
R566 PB1 binding site He et al., 2008 
K574 PB1 binding site He et al., 2008 
K539 PB1 binding site He et al., 2008 
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identified an interaction of PA with the minichromosome maintenance complex 
(MCM), a DNA replicative helicase, which was proposed to stabilise viral 
replication elongation complexes and stimulate virus replication.  
1.8.1.1: Influenza PA, host adaptation and virulence  
There is considerable research to suggest that PA is important for AIVs to 
adapt to replication within mammalian hosts, although a sequence alignment 
between several avian and mammalian PA genes (Figure 1.7) suggests there are 
no conserved markers for host adaptation, at least within this limited number of 
strains. However, several amino acid changes have been implicated with 
increasing viral replication and pathogenicity in mice including K356R and 
E684G within H9N2 and V44I, V127A, C241Y, A343T and I573V within H5N1 (Xu 
et al., 2016a; Lee et al., 2018; Yamaji et al.,2015). Conversely, several PA codon 
alterations can also attenuate AIVs within mammalian hosts including R185K 
within H5N1 and P103H and S659L within H7N7 (Fan et al., 2014; Zhao et al., 
2016). P190S and Q400P alterations in H7N3 PA decreased viral virulence in 
mice due to a corresponding reduction in inflammation after infection 
(DesRochers et al., 2016). When the recently described H5N6 AIVs, which can 
cause severe disease and death in humans, were passaged in mice to determine 
any markers of mammalian adaptation an amino acid substitution within the PA 
gene (A343T) was identified which mildly increase polymerase activity in 
mammalian cells and contributed to increased viral virulence within mice (Peng 
et al., 2018). Several residues within H7N9 PA have also been identified to 






















Figure 1.7: Sequence alignment of avian and mammalian PA genes. Randomly selected 
avian and mammalian PA protein sequences were downloaded from the NCBI database and 
aligned using MEGA 7.0 CLUSTAL multiple alignment software.  
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mouse model (Yamayoshi et al., 2014). 
Within 2009 pH1N1, numerous studies have been completed to passage 
the virus in mice to determine key residues for adaptation. Several markers 
within PA have been identified such as F35L (Seyer et al., 2012), A36T (Zhu et al., 
2012), L259P (Ilyushina et al., 2010), M21I, and S616P (Sakabe et al., 2011). In 
addition to forcing adaptation of viruses to the mammalian host, several natural 
polymorphisms have been identified within PA which can contribute to altered 
viral replication and virulence in a mammalian host. For example, PA K142E is 
associated with high polymerase activity and replication within several human 
viruses and when introduced into an H5N1 background these viruses displayed 
increased replication and virulence within a mouse model as well as enhance 
polymerase activity in mammalian cells (Kim et al., 2010; Manz et al., 2013b). 
These studies all show that several residues within the PA gene can govern the 
pathogenicity and adaptation of IAV to mammalian hosts. 
Along with amino acid substitutions in PA influencing host adaptation, 
exchange of the entire gene has been shown to affect IAV adaptation in 
mammalian hosts (Mehle et al., 2012; Chen et al., 2008; Hara et al., 2013). Of 
particular note, is the successive passage of the PA and PB2 genes from the 
pandemic 1918 H1N1 through to the 1957 H2N2 strain and then to the 1968 
H3N2 virus, suggesting that these two gene segments are important for the 
maintenance of these viruses within the human host (Wright et al., 2007). 
 PA has also been shown to be a virulence determinant within the natural 
host in several scenarios. Studies have attributed the PA gene to the increased 
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pathogenicity of H5N1 AIVs in mallard ducks. For example, Hu et al. (2013a + b), 
demonstrated that the PA and HA genes of H5N1 AIVs contribute to high 
pathogenicity of the virus in mallard ducks and mice via the enhancement of the 
innate immune response and detection of virus within the brain. Song et al. 
(2011) also demonstrated that S224P and N383D mutations within PA of H5N1 
AIV contribute to the enhanced pathogenicity in mallard ducks due to increased 
viral replication, polymerase activity and delayed nuclear accumulation of PA and 
PB1. Kajihara et al. (2013), also identified the PA gene to be a contributing factor 
in the high virulence of a H5N1 strain in domestic ducks. Current data suggests 
that adaptive mutations within PA may enhance the ability of IAV to disseminate 
throughout the birds to organs such as the brain and therefore contribute to 
enhanced lethality (Bingham et al., 2009; Kishida et al., 2005; Londt et al., 2008).  
1.8.2: PA-X 
IAV segment 3 encodes several accessory gene products, including PA-X. 
PA-X is a +1 frameshift product of segment 3 which is accessed via a highly 
conserved frameshift site (FS). The resulting protein is a 29 kDa fusion protein 
consisting of the N-terminal 191 amino acids of PA and a (usually) 41 or 61 amino 
acid X-ORF which is viral strain-dependent (Jagger et al., 2012). The shorter 41 
amino acid X-ORF is most notably present within 2009 pH1N1 viruses as well as 
other swine viruses, equine H7N7, canine H3N8 and H3N2 as well as the bat 
influenza virus strains. However, the remaining 75% of sequences possess the 61 























Figure 1.8: Schematic for active domains of the influenza PA-X protein. Locations of 
amino acid residues previously identified to affect host cell shut off activity or 
endonuclease activity highlighted in the above diagram.  Regions identified to affect host 
cell shut off in blue, regions identified to affect endonuclease activity seen in red. Figure 
adapted from Hu et al., (2018).  
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The production of PA-X is the result of +1 ribosomal frameshifting at a 
highly conserved UCC UUU CGU C site. The conservation of amino acids at this site 
is highly unusual as both serine (UCC) and arginine (CGU) can be encoded by any 
of 5 other codons, CGU is also one of the least used codons within both 
mammalian and avian genomes. Frameshifting to the +1 ORF is promoted due the 
presence of a slow-to-decode amino acid within the A site of the ribosome. This 
results in the ribosome pausing at this site and, in this case, slippage into the +1 
frame can occur when the UUU codon is positioned in the ribosomal P site and 
the rare CGU codon in the A site. Frameshifting is further promoted as both UUU 
and UUC are translated via a single phenylalanine tRNA (GAA) which has a higher 
affinity for UUC than UUU, so therefore favours P-site re-pairing within the +1 
frame (Yewdell and Ince, 2012; Firth et al., 2012). The efficiency of frameshifting 
into the +1 X-ORF is approximately 1.3% (Jagger et al., 2012).  PA-X has been 
shown to localise equally within both the nucleus and the cytoplasm of cells 
(Hayashi et al., 2016).  
PA has been previously proposed to be a protease that degrades both viral 
and host proteins (Sanz-Ezquerro et al., 1996; Perales et al., 2000). However, 
Jagger et al. (2012) showed that this function is the result of the accessory protein 
PA-X, acting on mRNA instead of the protein products themselves. It was 
described that PA-X is involved in modulation of the host immune response 
during viral infection via selective degradation of host mRNAs, abolishing their 
translation and reducing expression of cellular proteins; a process termed host 
cell shut off. This process allows for viruses to inhibit expression of many cellular 
genes to dampen the antiviral response and also direct the ribosome towards the 
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translation of viral mRNAs (Weber and Haller, 2007). PA-Xs derived from 
multiple IAV subtypes have been shown to induce host cell shut off including 
equine and canine H3N8 viruses (Feng et al., 2016), H1N1 and pH1N1 
(Khaperskyy et al., 2016; Hayashi et al., 2015; Gao et al., 2015b; Lee et al., 2017; 
Gong et al., 2017), H5N1 (Hu et al., 2015; Gao et al., 2015b; Hu et al., 2016), H9N2 
(Gao et al., 2015c) and swine H1N2 (Xu et al., 2016b; Xu et al., 2017). Khaperskyy 
et al. (2016) reported that PA-X is able to selectively degrade host RNA 
polymerase II transcribed RNAs within the nucleus, including non-coding RNAs 
in a way that is independent of mRNA translation. Complete degradation of these 
PA-X cleaved host mRNAs is also dependent on the host 5’-3’ exonuclease Xrn1. 
The N-terminal 15 amino acids within the C-terminus of PA-X (amino acids 192-
206), particularly six basic amino acids within this area (195R, 198K, 199R, 202K, 
203K and 206K), have been shown to be important for the host shut off activity 
of PA-X (Desmet et al., 2013; Oishi et al., 2015). Hayashi et al. (2016) took this 
further and identified 195K, 198K and 199R to be the most important residues in 
determining the host cell shut off activity of PA-X. Oishi et al. (2018), also 
identified a further 22 amino acids distributed throughout the protein, which are 
important for PA-X shut off activity via alteration of the subcellular localisation 
of PA-X  (from nuclear to cytoplasmic) within mammalian cells. To identify host 
proteins that PA-X may interact with to exert its host shut off functions, Li et al. 
(2016), performed affinity purification and mass spectrometry looking at 
interactions between H5N1 PA-X and cellular proteins within chicken (DF-1) 
cells. Within this screen, 56 host proteins were shown to interact with H5N1 PA-
X. Many of the identified proteins had previously been described as pro- or 
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antiviral host factors. Several protein groups which have specific biological 
functions were identified to interact with PA-X. This included proteins involved 
in i) protein transport between the Golgi complex and endoplasm such as archain 
1 and ARF1, ii) ribosomal protein complexes such as RPLPO and RPS20, iii) ATP 
hydrolysis including myosin light chain 1 and 2. Therefore, PA-X-binding proteins 
were apparently enriched in mitochondria and lipid transport, nucleosome 
assembly and RNA processing factors. However, many of these polymorphisms 
are common contaminants in “pull down” interaction assays (Mellacheruyu et al., 
2013) and more work still needs to be completed to fully understand the 
mechanism of action of PA-X.  
PA-X has also been shown to be a virulence determinant in several IAV 
strains, although (as with so many aspects of the virus biology) this appears to be 
strain- and host-dependent. For example, within pH1N1 2009 virus the 
expression of PA-X enhances viral replication and pathogenicity in mice, which 
corresponded with a reduced host innate immune response. At early time points 
post-infection, mice lungs showed an increased viral load and histopathology 
score when PA-X was present (Lee et al., 2017). However, Gao et al. (2015b) 
showed that mice infected with pH1N1 2009 virus containing PA-X had a reduced 
mortality compared to viruses which lacked PA-X, with these viruses displaying 
a reduced pathology and viral titre in the mouse lung. Both studies used Balb/c 
mice; however, the strain of pH1N1 was different between the studies which 
potentially could have had an impact on the study outcome. Within pH1N1 1918 
IAVs, the virus which contained PA-X showed reduced weight loss and increased 
survival compared to a virus with PA-X removed (Jagger et al., 2012). The kinetics 
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and magnitude of the host immune response within the lungs of infected animals 
was altered with the presence or absence of PA-X in particular genes related to 
inflammation, apoptosis and cell differentiation and tissue remodelling.  When 
PA-X was removed, many genes were more highly induced compared to the WT 
virus, including genes involved in CCR5 signalling in macrophages and T cells, IL-
15 signalling, CD28 signalling and IFN-γ signalling (Jagger et al., 2012). Within 
classical swine H1N1 viruses, PA-X has been shown to inhibit viral replication and 
decrease virulence in a mouse model (Gao et al., 2015b) similarly to that seen for 
pH1N1 by Jagger et al. (2012). However, within swine H1N2 IAV expression of 
the PA-X protein enhances viral replication and transmissibility within pigs by 
delaying the proinflammatory response within the lungs (Xu et al., 2017).  
Again, with AIVs, the presence of PA-X has been shown to have differential 
effects on pathogenicity depending on the viral strain in question. Within H9N2 
LPAIV, PA-X has been shown to be a pro-virulence factor. Presence of PA-X 
induced a 33.3% mortality rate and corresponding 15% weight loss in infected 
mice compared to no mortality or significant weight loss in mice when PA-X was 
removed from the virus. The mice infected with virus containing PA-X showed 
enhanced vascular congestion and higher viral titres within the lungs than those 
from mice infected with virus lacking PA-X. Cytokine and chemokine protein 
levels (including IL-6, IL-1β, CCL3, IFN-γ and TNF-α) were consistently higher in 
lungs of mice infected with virus expressing PA-X at both 3 and 5 days post-
infection. Collectively these data demonstrated that within H9N2 AIVs PA-X leads 
to an increased pathogenicity and up-regulation of cytokines within a mouse 
model (Gao et al., 2015c). However, within H5N1 HPAIVs, PA-X has been shown 
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to reduce viral virulence in mice, chickens and ducks acting to inhibit viral 
replication and dampen the host immune response (Gao et al., 2015b; Hu et al., 
2015; Hu et al., 2016). Within the chicken lung, PA-X globally blunts the immune 
response, particularly by downregulating genes associated with inflammation 
and cell death. A global downregulation of the cytokine response in multiple 
organs of chickens and ducks was also observed (Hu et al., 2015).  
The effect of possessing a 41 or 61 amino acid X-ORF within PA-X has also 
been investigated. Gao et al. (2015a) showed that pH1N1, H5N1 and H9N2 
viruses which expressed PA-X with a 61 amino acid X-ORF were more virulent, 
showing increased replication in mouse lungs and causing an increased 
inflammatory response compared to the same viruses with the shorter X-ORF. 
When a comparison of swine H1N2 IAVs with a 41 or 61 amino acid X-ORF was 
conducted, the viruses containing the truncated PA-X showed increased viral 
replication, transmissibility and replication in pigs (Xu et al., 2016b), implicating 
the truncated PA-X as an adaptation marker for pigs and perhaps explaining the 
preponderance of truncated PA-Xs within swine influenza viruses (Shi et al., 
2012). A separate study has also shown that the 41 amino acid truncated PA-X 
has reduced nuclease activity compared to full length PA-X (Bavagnoli et al., 
2015), although the link between this finding and pathogenicity was not 
determined. Overall, these studies all show that PA-X is a virulence factor within 
IAV, but the outcome of infection when PA-X is removed from viruses appears to 




1.8.3: Other gene products of PA  
IAV segment 3 also encodes two further accessory proteins termed PA-
N155 and PA-N182. These two PA encoded proteins are not especially well 
characterised within the current literature. They are translated from the 11th and 
13th in-frame AUG respectively producing N-terminally truncated versions of PA 
(Muramoto et al., 2013). These AUG codons are highly conserved, suggesting that 
expression of these proteins is universal across IAVs (Gong et al., 2014). When 
the AUG codon are removed from a H1N1 virus replication is slowed and 
pathogenicity in mice is reduced (Muramoto et al., 2013). In order to further 
characterise the function of these proteins, Wang et al. (2018) investigated the 
host interactome of H5N1 derived PA-N155 and PA-N182. A total of 491 (PA-
N155) and 302 (PA-N182) interacting proteins were identified; proteins involved 
in RNA processing, viral processing and protein transport, and signalling 
pathways of the proteasome, ribosome and aminoacyl-tRNA biosynthesis were 
enriched.  
1.9: Host cell shut off  
When a virus infects a cell, it can induce an antiviral host response; many 
viruses have evolved mechanisms to avoid, overcome and counteract this 
response. One such strategy is the general inhibition of host gene expression in a 
process referred to as host cell shut off (Aranda and Maude, 1998). Many viruses 
encode  proteins which cause host cell shut off to occur; this includes poliovirus 
proteases (2Apro and 3Cpro), which cleave essential host translation initiation 
factors to allow for viral internal ribosome entry site (IRES)-mediated initiation 
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of translation (Ventoso et al., 1998; Kuyumcu-Martinez et al., 2002). 
Herpesviruses also encode an endonuclease which destroys host mRNAs to 
ensure cap-dependent translation of viral mRNAs (Elgadi et al., 1999). Within 
IAVs both the accessory protein, PA-X, (described in section 1.8.2) and the protein 
NS1 play a role in host cell shut off (Jagger et al., 2012; Nemeroff et al., 1998).  
The host shut off function of IAVs begins before PA-X is produced, coinciding with 
the transcription of viral mRNAs. It has been shown that two mechanisms are 
targeting nascent host transcripts at this stage. First, the cap-snatching ability of 
the polymerase destroys host pre-mRNAs to supply capped primers for viral 
transcription. The second mechanism is via the viral NS1 protein. NS1 acts via 
binding and inhibiting cellular cleavage and polyadenylation factor 30 (CPSF30). 
CPSF30 is essential for the 3’ end processing and subsequent nuclear export of 
host transcripts and NS1 blocks this process (Nemeroff et al., 1998). Therefore, 
these two processes act together to remove competition with the host transcripts 
for nuclear export and translation factors. Then as the infection progresses, the 
host cell shut off function moves to focus within the cytoplasm rather than the 
nucleus to make the translation of viral proteins a priority for the host protein 
synthesis machinery. NS1 again acts at this stage to ensure efficient translation of 
viral gene products by first blocking PKR-mediated sensing of viral dsRNA and 
arresting translation (Lu et al., 1995; Tan et al., 1998) and secondly, supporting 
assembly of translation initiation complexes on the 5’-UTRs of viral mRNAs 
(reviewed in Yanguez and Nieto, 2011). Also, at this stage PA-X can, after its 
gradual accumulation during infection, act to degrade host RNA polymerase II 













Figure 1.9: Schematic for a temporal model of IAV induced host cell shut off. IAV host 
cell shut off acts in two phases. The early phase begins in the nucleus with NS1 mediated 
inhibition of 3’end processing and the use of host mRNA for viral transcription. The late phase 
acts within the cytoplasm where PA-X degrades host mRNAs and NS1 inhibits detection of 
viral dsRNA. Figure taken from Khaperskyy and McCormick, 2015.  
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interplay between IAV NS1 and PA-X proteins to ensure sufficient host cell shut 
off at both early and late stages of infection (Figure 1.9).   
1.10: Chicken innate immune response  
 The avian innate immune response plays a key role in the defence against 
viral infections via the recognition of pathogen associated molecular patterns 
(PAMPS) by pattern recognition receptors (PRRs). Activation of PRRs can lead to 
the induction of the interferon response and the production of cytokines which 
can then activate immune cells such as macrophages, dendritic cells and natural 
killer cells. This process should lead to the control and eradication of virus from 
the host (reviewed by Dzananovic et al., 2018). The signalling pathway for the 
avian innate immune response is summarised in Figure 1.10. 
 The avian innate immune system differs in its viral sensing than the 
mammalian system. Sensing of both double and single stranded RNA is carried 
out by MDA-5 rather than RIG-I, as chickens do not possess RIG-I (Karpala et al., 
2011; Hayashi et al., 2014). Additionally, chickens possess LGP2, which has been 
shown to bind double stranded RNA, although its role in PAMP detection is 
uncharacterised (Uchikawa et al., 2016). Another difference comes further 
downstream of the activation pathway where chickens do not possess IRF-3 and 
IRF-9 with only IRF-7 and -10 being identified within the chicken genome 
(Santhakumar et al., 2017).  
Many cytokines and chemokines are produced when the immune response is 
activated which have wide ranging functions in the maintenance of an antiviral 






















Figure 1.10: Schematic representation of the chicken interferon induction and 
signalling pathways. dsRNA is recognised by either MDA-5, LGP2 or TLR-3 initiating 
downstream signalling via MAVS or TRIF proteins. Downstream transcription factors such 
as IRF-7, NF-κB and AP-1 are activated which allows for their translocation to the nucleus 
and the stimulation of the transcription of IFNs. These transcribed IFNs can act in an 
autocrine or paracrine fashion and activate the JAK-STAT pathway to initiate the 
transcription of interferon stimulated genes (ISGs) which allow for the establishment of an 
antiviral state within the cell. Abbreviations used in the figure and are not described in the 
main text are as follows: IκB kinase (IKK) epsilon (IKKε), alpha (IKKα), beta (IKKβ), and 
gamma (IKKγ); NF-κB essential modulator (NEMO); TANK-binding kinase 1 (TBK1); 
inhibitors of NF-κB (IκB), NF-κB subunits p50 and p65; activating transcription factor 2 
(ATF2); tyrosine kinase 2 (TYK2); Janus kinase 1 (JAK1); signal transducer and activator of 
transcription 1 (STAT1), and STAT2. “P” represents the phosphorylation state of the protein, 
and dotted lines indicate the involvement of multiple intermediary steps. Figure taken from 










Table 1.4: Summary of cytokine functions  
Cytokine Function Reference 
Type 1 
interferons 
Produced by leukocytes (IFN-α) and fibroblasts 
(IFN-β) 
Antiviral by induction of ISGs  
Stimulate macrophages and Natural killer cells  
Platanias., 2005 
IFN-γ 
Produced by NK and T cells  
Regulates the maturation and differentiation of 
immune cells  
Activates Th1 cells and macrophages  
Schroder et al., 
2003 
IL-1β 
Produced by macrophages  
Mediates inflammation  
Involved in cell proliferation, differentiation 
and apoptosis  
Dinarello., 2011 
IL-4 
Stimulates B- and T-cell proliferation  
Involved in differentiation of Th2 cells  
Reduces Th1 cells, macrophages, IFN-γ and IL-
12 production. 
Ul_Haq et al., 
2016 
IL-6 
Produced by macrophages  
Proinflammatory cytokine via activation of the 
NF-κB pathway 
Heinrich et al., 
2003 
IL-18 
Produced by macrophages  
Proinflammatory cytokine  
Induces NK cells and T cells to produce IFN-γ 
Dinarello., 
1999; Lebel-
Binay et al., 
2000 
TGF-β4 
Induces Treg and Th17 cell- proinflammatory 
responses 
Blocks B cell proliferation  
Stimulates monocytes  
Li and Flavell., 
2008 
CXCLi2 




1.11: Aims  
Evidence suggests H9N2 AIVs have become more pathogenic within the 
field and the molecular basis behind this is not understood. If the molecular 
mechanism behind this increased pathogenicity can be understood, there may be 
implications for development of more effective control mechanisms or 
improvements to vaccine design or assisting in disease surveillance. It would also 
increase our understanding of the fundamental biology of pathogenicity within 
AIVs. Previous unpublished work by the Iqbal lab has identified segment 3 to be 
important for this change in H9N2 virulence; therefore the effect of segment 3 
from two H9N2 strains was investigated: A/guineafowl/Hong Kong/WF10/99 
(WF10) a representative early isolate and A/chicken/Pakistan/UDL-01/08 
(UDL-01) a representative novel reassortant strain possessing HA, NA and NP 
genes of a previously enzootic G1/97 like H9N2 virus and the PB2, PB1, PA and 
NP genes derived from HPAIV H7N3 virus.  
The aims of this thesis were: 
Aim 1: Understand the molecular basis of fitness differences between 
H9N2 AIV strains in vitro, identifying any specific polymorphisms within segment 
3 which contribute to this effect.  
Aim 2: Characterise any specific polymorphisms which altered viral 
fitness in vitro within a chicken model of infection. Determining the effect of any 
polymorphisms on viral replication, transmission, pathogenicity and immune 
response in vivo. 
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Aim 3: Investigate if any identified segment 3 polymorphisms alter the 
host cell shut off function of the accessory protein PA-X. Characterise H9N2 PA-X 
from the two different strains and assess the protein function in vitro.  
Aim 4: Characterise the function of H9N2 AIV PA-X within a chicken model 
of infection. Determining the protein’s contribution to viral replication, 



























Chapter 2: Investigating the effect of segment 3 on 
H9N2 AIV fitness in vitro 
 
2.1: Introduction  
Influenza viruses have been shown to swap gene segments between two 
or more strains via a process known as reassortment. Reassortment occurs when 
different influenza viruses co-infect a single cell and viral gene segments are 
exchanged leading to the generation of progeny virions with new combinations 
of viral genes (reviewed by Steel and Lowen, 2014; Scholtissek et al., 1978; 
Burnet et al., 1949). This can result in viruses with increased (Sun et al., 2011) or 
reduced viral fitness (Villa and Lassig, 2017). 
H9N2 AIVs have been shown to undergo extensive reassortment events 
(Dong et al., 2011a). Several viruses have emerged in recent years which contain 
the internal gene cassette derived from H9N2 AIVs.  This includes a novel avian-
origin H7N9 virus which has caused human infections in China; this virus 
contains HA and NA of duck origin and the internal gene cassette derived from an 
enzootic H9N2 (Lam et al., 2013; Liu et al., 2013). Guan et al. (1999) also reported 
the presence of H9N2 internal genes within human H5N1 isolates. Conversely, 
novel genotypes of H9N2 AIV have emerged in poultry populations due to co-
circulation and reassortment with HPAIVs; where the NS gene segments were 
derived from H7N3 and H5N1 and the polymerase genes (PB1, PB2 and PA) 
derived from an Indian/Middle East lineage H9N2 AIV (Iqbal et al., 2009). These 
reassortant viruses have gained fitness such that the earlier ancestral G1/97 
H9N2 strains previously prevalent in this region have been completely replaced 
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by these reassortant viruses and they have now become established within 
poultry in many regions of the Indian subcontinent and Middle East. They have 
been shown to perpetuate in poultry populations and wild terrestrial birds such 
as house sparrows (Iqbal et al., 2013). 
These novel reassortant H9N2 AIVs have been observed to cause 
increased clinical disease signs in poultry in the field compared to the 
predecessor H9N2 viruses causing disease in the late 1990s (Guo et al., 2000; 
Iqbal et al., 2013; Seiler et al., 2018; personal communication M. Iqbal). However, 
the molecular basis for the increased pathogenicity of H9N2 AIVs has not been 
established. Previous unpublished data from the Iqbal lab implicates segment 3, 
which encodes the PA protein, in enhancing fitness of H9N2 AIVs. Gene segments 
were exchanged between A/guinea fowl/Hong Kong/WF10/1999 (WF10, a virus 
representing those that circulated in the late 1990s; G1 lineage) and 
A/chicken/Pakistan/UDL-01/2008 (UDL-01, representative of a novel 
reassortant H9N2 with HA, NA and NP gene of previously enzootic G1/ 97- like 
H9N2 virus and PB2, PB1 and PA and NS gene segments derived from HPAIV 
H7N3) using reverse genetics. It was noted that exchange of either segment 3 (PA 
gene) or segment 8 (NS gene) lead to the reciprocal alteration of plaque 
phenotypes between the two H9N2 virus strains. WF10 WT gives small, hazy 
plaques in MDCK cells whereas UDL-01 produces larger, clear plaques. Therefore, 
this thesis aims to further dissect the molecular mechanism of how the PA gene 
potentially modulates the virus phenotype (increase plaque size), pathotype 
(virulence) and fitness of H9N2 virus.   The aims of research within this chapter 
were to: i) identify molecular motifs in segment 3 which were important for 
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enhancing viral fitness and, ii) if so, defining the functional consequences of these 
polymorphisms in vitro.  
2.2 Results  
2.2.1: Effect of H9N2 segment 3 exchange between two AIV strains on viral 
fitness in vitro 
In order to first assess the effects of exchanging segment 3 between a 
progenitor H9N2 AIV strain (WF10) and a reassortant H9N2 AIV strain (UDL-01), 
reverse genetics (RG) was used to rescue pairs of WF10- and UDL-01-based 
viruses with wildtype (WT) or reciprocally swapped segment 3s. 293T cells were 
transfected with the UDL-01 or WF10 reverse genetics plasmid system in order 
to rescue RG WT viruses. The segment 3 plasmids were then swapped between 
RG-WF10 and RG-UDL-01 and viruses with alternate segment 3s rescued. A 
negative control sample was included within each rescue; this lacked the PA 
plasmid, so was therefore unable to generate infectious virus. 24 hours post-
transfection, 293T cells were co-cultured with MDCK cells and left for up to 96 
hours (until cytopathic effect (CPE) was observed). This was deemed the passage 
zero (P0) stock. Passage one (P1) virus stocks were generated by inoculation of 
10-day old fertilised hens’ eggs with diluted P0 co-culture supernatants; allantoic 
fluid was harvested 48 hours post-inoculation and clarified before aliquoting and 
storage at -80°C. P1 viral stocks were titrated via plaque assays.  
All viruses rescued readily and replicated to titres of at least 106 pfu/ml, 
with the negative control rescues (missing segment 3) producing no detectable 
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virus within the limits of detection (2.5 pfu/ml; data not shown). To validate the 
identity and genetic integrity of the recombinant viruses, RNA was extracted from 
allantoic fluid and segment 3- and 7- specific RT-PCRs were performed. DNA 
sequencing was used to confirm the PA gene and backbone (by sequencing M 
segment) were correct in each of the viruses made and no mutations had been 
introduced during rescue (data not shown).  
Viral plaque phenotype was used as an initial method to screen for viral 
fitness differences, as WF10 WT and UDL-01 WT viruses exhibit drastically 
different plaque phenotypes (Figure 2.1).  Viral plaque phenotype has been 
previously shown to be a good marker for attenuation and fitness differences 
between viruses (Simpson and Hirst, 1961; Hale et al., 2006). Accordingly, viral 
plaques in MDCK cells after 72 hours were immunofluorescently stained with 
anti-NP to visualise virus spread. As expected from previous work in the 
laboratory, WT UDL-01 virus formed larger plaques than the progenitor virus WT 
WF10 (Figure 2.1A). When the plaque size was quantified using ImageJ software, 
this difference was significant, with the average UDL-01 WT plaque diameter 
being 1.5 mm compared to 0.5 mm for WF10 WT (Figure 2.1B). However, the 
reassortant viruses with swapped segment 3s showed the opposite plaque 
phenotypes, UDL-01 carrying WF10 PA produced small plaques, whereas, WF10 
carrying UDL-01 PA produced large plaques (Figure 2.1A). Measurement of 
plaque diameters confirmed a statistically significant reciprocal change (Figure 
2.1B), supporting previous unpublished work from the Iqbal laboratory 






















Figure 2.1: Impact of segment 3 exchange on H9N2 AIV plaque phenotypes. The 
indicated viruses were titrated in MDCK cells via plaque assay under a 0.6% agarose overlay 
and 72 h.p.i., fixed and stained for NP using immunofluorescence. (A) and (C) show 
representative images of plaque sizes of UDL-01 and WF10 RG viruses. (B) and (D) show 
diameter of 20 plaques/ virus measured using Image J analysis software. The graphs 
represent the average plaque diameter +/- SD. (B) Mann-Whitney Test or  (D) Kruskal-Wallis 
with Dunn’s multiple comparison test was used to determine the statistical differences 

















To identify which region of segment 3 was responsible for this alteration 
in viral plaque phenotype, two chimeric segment 3s were produced using the 
Gibson Assembly (New England Biolabs) cloning procedure (kindly provided by 
Tom Peacock). These consisted of the N- terminal 1101 nucleotides from PA of 
one strain and the C-terminal 1047 nucleotides of the other.  These segments, 
denoted U/W or W/U, depending on which virus had donated the N/C-terminal 
halves of the resulting PA polypeptides, were introduced into the backbone of 
both the progenitor WF10 and reassortant UDL-01 H9N2 AIVs using reverse 
genetics. All four viruses rescued readily and grew to titres of at least 106  pfu/ml 
(data not shown). When the plaque sizes were visualised by immunostaining, 
both UDL-01 and WF10 viruses containing the PA gene U/W chimera produced 
large plaques while viruses with the PA gene W/U chimera gave mostly small 
plaques with the occasional large one (Figure 2.1C). Quantification showed that 
on average, the small plaque size conferred by the PA gene W/U chimera within 
UDL-01 and the reciprocal large plaque phenotype resulting from inserting the 
PA gene U/W chimera into WF10 were significantly different from the parental 
viruses (Figure 2.1D). Thus overall, the data indicated that segment 3, 
particularly the PA N-terminus from the first 5’-1101 nucleotides (considering 
plus sense RNA), are important for the differing plaque phenotypes seen between 





2.2.2: Amino acid differences between WF10 and UDL-01 segment 3-
encoded polypeptides 
The simplest hypothesis to explain the molecular basis of the differing 
phenotypes conferred by the WF10 and UDL-01 H9N2 segment 3s was that one 
or more of the polypeptides they encode had functionally important amino acid 
polymorphisms. Accordingly, their sequences were examined to identify any 
coding differences. Using NCBI influenza gene annotation tools, the nucleotide 
sequence of segment 3 of WF10 (GenBank Accession number: KX859443) and 
UDL-01 (GenBank Accession number: CY038457) were predicted and amino acid 
sequences of PA and PA-X were aligned using pairwise alignment (optimal 
GLOBAL alignment; BioEdit). All amino acid differences within known segment 3 
gene products are shown in Table 2.1. In total, there were 30 amino acids 
differences, these included 28 in PA (Table 2.1A) and 2 in X-ORF (Table 2.1B). The 
amino acid differences within PA-N155 and PA-N182 were not considered for the 
purpose of this study. Rather than blindly making a large mutant library, a 
literature search and consideration of the amino acid side chain properties was 
undertaken to decide which positions to focus on. Within the literature search the 
majority of changes had not been previously identified to affect the functional 
properties of IAVs. However, some polymorphisms had been highlighted by 
previous studies. Hu et al. (2013a) identified D101G and E237K changes within 
H5N1 PA as affecting viral replication, polymerase activity and virulence in ducks. 
DesRochers et al. (2016), also implicated PA Q400P to be important in the 
reduction of virulence of H7N3 compared to H7N9 AIVs in mice. This suggested 
that these amino acid positions could also potentially alter H9N2 AIV biology. 
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Furthermore the properties of the amino acid sidechains (Betts et al., 2003) that 
had been altered between the two strains of virus were also considered when 
choosing which mutations to introduce via site directed mutagenesis. Those 
which changed the amino acid properties significantly, for example, from non-
polar to polar, or altered the charge at this position, were prioritised for 
mutagenesis. Together the literature search and amino acid property analysis 
identified 13 likely candidates within the PA gene (highlighted in green within 
Table 2.1). These were spread throughout the protein domains and included 
some within the N-terminal PA endonuclease domain and others in the C-
terminal domain. Two differences within the X-ORF of PA-X were also identified 
(Table 2.1B).   
The candidate amino acid positions were mapped onto the available 
crystal structure of influenza PA (Pflug et al., 2014; PDB ID-4WSB) using PyMol, 
to identify if any of the mutations identified during this screen could affect 
function due to their locations near to known active site regions shown in Figure 
2.2A. Mutations identified within this screen are highlighted in cyan 
(endonuclease domain) or red (C-terminus). Within the endonuclease domain 
(pink), amino acids previously identified to alter endonuclease activity and make 
up the endonuclease active site are highlighted in green. These include H41, E80, 
D108, E119 and K134 (Yuan et al., 2009). Within the endonuclease domain one 
of the mutations, I118T, is located very close to the endonuclease active site. 
Other polymorphisms seen between WF10 and UDL-01, including A20T, E26K 
and I100V_D101E lie in regions surrounding the active site which could 
potentially interfere with endonuclease activity depending on any potential steric 
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hindrance caused by the amino acid alteration. One change (E237K) lies within 
the linker region (yellow) between the endonuclease domain and the C-terminal 
domain and could affect the conformational flexibility of PA. In the C- terminal 
domain (blue), amino acids that have been shown to alter interaction and binding 
of PA to PB1 are highlighted in green. This includes K328, K539, R566 and K574 
(He et al., 2008). K327E lies proximal to one of the known mutations that alter 
PA/PB1 binding. Again, other amino acid changes could lead to conformational 
changes in the structure of PA and thereby alter protein function.  
The locations of the identified mutations in relation to the accessory gene 
products of PA were depicted using the same colour scheme as within the crystal 
structures (green: endonuclease active site /PA-PB1 binding, cyan/red: 
identified mutations) (Figure 2.2B). From this it was observed that the N-
terminally truncated accessory products of PA (PA-N155 and PA-N182) did not 
possess any of the N-terminal mutations identified within the study but would 
contain all the mutations identified within the linker and C-terminal domains. On 
the other hand, the accessory protein PA-X only contained the mutations present 
within the N-terminal endonuclease domain, plus the two identified within the X-
























3 N D Endonuclease domain   
20 A T Endonuclease domain   
26 E K Endonuclease domain   
85 T I Endonuclease domain   
86 L M Endonuclease domain   
184 N S Endonuclease domain   
100 I V Endonuclease domain   
101 E D Endonuclease domain  Hu et al. (2013a) D101G 
118 I T Endonuclease domain   
237 E K Linker Hu et al.  (2013a) E237K 
316 G D C-terminus   
319 D E C-terminus  
323 V I C-terminus   
327 K E C-terminus   
352 E D C-terminus   
367 K M C-terminus   
387 V I C-terminus   
338 S G C-terminus   
394 D Q C-terminus   
400 S L C-terminus DesRochers et al. (2016)  
Q400P 
545 I V C-terminus   
553 A S C-terminus   
602 V T C-terminus   
615 K R C-terminus   
631 S G C-terminus   
651 A S C-terminus   
684 G E C-terminus   















221 R L X-ORF  
250 Q R X-ORF  
Table 2.1A: Amino acid differences between progenitor (WF10) and reassortant 
(UDL-01) H9N2 segment 3s (N-terminal endonuclease, linker and C-terminus).  
 Table 2.1B: Amino acid differences in the PA-X ORF between progenitor (WF10) and 
reassortant (UDL-01) H9N2 segment 3s.   
 
Amino acid differences highlighted in green indicate those taken forward for further 
analysis. Amino acid sequences were aligned using Pairwise alignment (optimal GLOBAL 
alignment: BioEdit). Differences observed in both the PA gene and PA-X were noted and 

































































1 195 256 367 396 713 





1 195 256 367 396 713 
1 195 256 367 396 713 
1 191 252 
Figure 2.2: Mapping of identified mutations onto PA crystal structures. (A) PyMol 
software was used to map the identified PA polymorphisms onto the crystal structure of 
influenza PA protein (PDB ID: 4WSB). The full crystal structure in the centre with zoomed in 
images of the endonuclease domain and C-terminus at top and bottom respectively. PA 
endonuclease: pink, linker: yellow, C-terminus: blue, PA-arch: purple. The amino acids 
previously identified to be important for the endonuclease activity or PB1 binding of PA are 
highlighted in green. The mutations identified in this screen are highlighted in cyan 
(endonuclease domain) or red (C-terminus). (B) Schematic to identify presence of mutations 
within accessory gene products of PA gene (PA-N155, PA-N182 and PA-X). Colour scheme as 
above, X-ORF: lilac, frameshift site represented by cross.  
91 
 
Each of the selected mutations were introduced into both the progenitor 
WF10 segment 3 to make it ‘UDL-01- like’ and the reassortant UDL-01 segment 3 
to make it ‘WF10-like' using site directed mutagenesis. The presence of mutations 
was confirmed via sequencing of the plasmid constructs (data not shown). These 
plasmids were then used for further study to characterise the effect of these 
mutations in transcriptional activity of the polymerase, viral replication, and 
plaque morphology.  
2.2.3: Effect of PA polymorphisms on viral gene expression 
Influenza PA mutations have previously been shown to affect polymerase 
activity due to its position within the heterotrimeric polymerase complex. For 
example, Fan et al. (2014) showed that several PA mutations within H5N1 altered 
viral polymerase activity including D352E which increased polymerase activity 
2- to 3- fold and R185K which significantly decreased polymerase activity.  
Therefore, the consequences of the panel of H9N2 PA mutations identified 
here on the transcriptional activity of the IAV polymerase complex was assessed 
using a “minireplicon” or “RNP reconstitution” assay system. These assays 
constitute the 4 proteins of influenza RNP: the three polymerase components 
(PB2, PB1, and PA) and NP (abbreviated as 3PNP) that allow indirect 
measurement of mRNA production by the viral polymerase from a vRNA mimic 
(Huang et al., 1990; Foeglein et al., 2011). RNA polymerase II expression vectors 
containing expression cassettes of 3PNP were co-transfected into cells to produce 
mRNA in trans and thus functional protein for each viral polypeptide, which 
subsequently form the polymerase complex. Along with the polymerase 
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components a vRNA mimic reporter construct is co-transfected. This reporter 
plasmid contains a firefly luciferase gene in negative sense flanked by segment 8 
UTRs, under the control of either a human or avian RNA polymerase I promotor. 
This allows for RNA to be produced by cellular RNA polymerase I which 
resembles vRNA to the polymerase complex and thus triggers RNP formation. 
This will in turn be transcribed by the IAV polymerase complex into mRNA and 
then translated into luciferase (Lutz et al., 2005). Therefore, luciferase output is 
generally proportional to the transcriptional activity of the viral polymerase 
complex. Some laboratories also include a renilla luciferase transfection control 
that the firefly luciferase values are normalised to (Hu et al., 2015; Long et al., 
2016; McAuley et al., 2010). However, due to the potential for the PA mutations 
examined here to have variable secondary effects on host cell gene expression 
because of their position within the accessory gene PA-X, this control was not 
employed.  
First, the transcriptional activity of a consistent set of viral RNPs with the 
PB2, PB1 and NP (2PNP) derived from PR8 but with H9N2 PAs were screened. 
The PR8 2PNP system was used within mammalian cells due to the presence of 
PB2 627E within UDL-01 and WF10. The presence of this amino acid in PB2 
severely restricts the polymerase complex in mammalian cells (Long et al., 2013). 
293T cells were transfected with expression plasmids for the RNP polymerase as 
well as a vRNA mimic reporter plasmid encoding luciferase. 48 hours post 
transfection cells were lysed and levels of luciferase activity quantified. A 
negative control lacking PA was included (2PNP), since in this case, the viral 
polymerase cannot form and therefore any luciferase observed would not be the 
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result of viral transcription. In the absence of all four RNP polypeptides, only 
background levels of luciferase were seen, whilst the full PR8 vRNP produced 
around 1000 times more luciferase activity (Figure 2.3A). When either of the two 
WT H9N2 segment 3s were added to the PR8 2PNP system, a similar 1000-fold 
increase in luciferase levels were observed compared to the 2PNP control, 
indicating that both WF10 and UDL-01 PAs were compatible with the other PR8 
RNP components in this system.   
Although the activity of an RNP containing the WT WF10 PA was relatively 
lower than one containing the WT UDL-01 polypeptide, this difference was not 
significant. Changing individual residues within the UDL-01 PA to match those 
found in WF10 PA had very little effect on viral gene expression. The converse 
changes in the WF10 protein caused slightly greater fluctuations in average 
activity, with the largest change seen with the introduction of the L331R mutation 
however, this only altered luciferase signal by 0.5 of a log10. Overall, within both 
UDL-01 and WF10 panels of vRNPs, no significant differences were seen in the 
transcriptional activity of the polymerase complex following the introduction of 
the various PA mutations. 
Expression of PA and NP proteins, as well as the cellular protein tubulin- 
used as a protein loading control, were assessed via western blot analysis. Cells 
were lysed in sample buffer and proteins separated on 15% SDS-PAGE gels before 
transfer to nitrocellulose and western blotting with antisera specific for IAV PA, 
NP and tubulin. Tubulin levels were reasonably consistent across all groups, with 
some variances seen in some of the lanes, possibly due to transfer differences 
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across gels (Figure 2.3B). NP expression levels were also reasonably similar 
across groups with no NP observed within the cells only control as expected. 
Similarly, all of the PA constructs exhibited generally similar accumulation levels, 
with no PA expression observed in the 2PNP or cells only controls. Thus overall, 
none of the PA polymorphisms had major effects on the stability or ability of the 
polypeptides to support viral gene expression when assayed in mammalian cells 
in the background of a PR8 RNP.  
The ability of the H9N2 segment 3 polymorphisms to affect the 
transcriptional activity of fully avian RNPs was then investigated. DF-1 (chicken 
immortalised fibroblast) cells were transfected with expression plasmids for 
either the UDL-01 or WF10 RNP polypeptides plus a vRNA mimic encoding 
luciferase under the control of an avian RNA polymerase I promotor. As above, 
cells were lysed and luciferase levels measured after 48 hours. Untransfected 
cells gave only background luciferase levels (cell only control; Figure 2.3C) while 
a very low level of luciferase expression was observed when only PB1, PB2 and 
NP were transfected (2PNP control) indicating the lack of an active polymerase 
complex. When all four RNP polypeptides were included within either the UDL-
01 or WF10 background an approximately 100-fold increase in luciferase 
expression was observed compared to the 2PNP control. This was a relatively 
lower increase compared to that observed within the 293T cell system, likely due 
to differences in transfection efficiency between the cell types. Indeed, Horibe et 
al. (2014), described how differences in the transfection activity of cell lines can 
alter luciferase output. Nevertheless, the increase was enough to robustly 































































































































































































































Figure 2.3: Transcriptional activity of polymerase complexes containing H9N2 
segment 3 mutations. Transcriptional activity of polymerase complexes were assessed 
using minireplicon assays. (A) 293T cells or (C) DF-1 cells were transfected with the 
components of the polymerase complex (PB1, PB2, PA and NP) plus a vRNA mimic encoding 
luciferase under the control of (A) human or (C) avian RNA polymerase I promotors. 48 
hours post transfection cells were lysed and luciferase levels measured. Data represents the 
mean +/- SD of 3 independent experiments. No significant differences were observed in 
transcriptional activity of the various polymerase complexes within 293T cells (one way 
ANOVA with Dunnett’s multiple comparisons). DF-1 cells ** P value = 0.0056 (Kruskal- 
Wallis and Dunn’s multiple comparisons). (B) PA and NP accumulation were analysed in 
comparison to tubulin levels via western blot of 293T cell lysate indicating the level of 




mammalian system, no significant differences were seen in DF-1 cells, between 
the transcriptional activities of polymerase complexes containing WT UDL-01 or 
WF10 PA polypeptides. However, in contrast to the mammalian system, UDL-01 
E26K showed a significantly increased transcriptional activity compared to UDL-
01 WT. There were no further no significant differences seen with any of the UDL-
01 or the WF10 panel of PA polypeptides when comparing the activity of the 
relevant WT to each mutated PA within each group. In summary, these data 
suggest that the differences in plaque phenotype observed between WF10 
(progenitor) and UDL-01 (reassortant) H9N2 AIVs was not related to the segment 
3s ability to support the transcriptional ability of the polymerase. 
2.2.4: Generation of H9N2 viruses with progenitor or reassortant like PAs  
The panel of mutations within PA, including mutations within the 
endonuclease domain, linker region and C-terminal domain were built into full 
WF10 or UDL-01 H9N2 AIV using reverse genetics. Viruses were rescued using 
293T and MDCK co-culture and were then propagated into viral stocks within 10-
day old fertilised hens’ eggs. After 48 hours allantoic fluid was harvested and then 
titrated via plaque assay under 0.6% agarose to examine plaque size at 72 hours 
post overlay. As described previously the full H9N2 WT viruses had contrasting 
plaque phenotypes, with UDL-01 WT giving clear plaques (Figure 2.4A) with an 
average diameter of >1.5 mm (Figure 2.4C) whereas WF10 WT gave more hazy 
plaques with and average plaque diameter of <0.5 mm (Figure 2.4B, C). Within 
the UDL-01 panel of PA mutant viruses, the only visually obvious change in 
plaque size was from the E26K mutant (Figure 2.4A). Quantification showed a 
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highly significant decrease in average plaque diameter from 1.7 mm to 0.6 mm, 
comparable to that of the WF10 WT virus (Figure 2.4C). No other mutations 
introduced into UDL-01 PA led to significantly altered plaque morphology. Within 
the WF10 panel of viruses, the most striking visual difference was caused by the 
introduction of K26E, although the D316G and L400S changes also caused some 
increase in plaque diameter and clarity (Figure 2.4B). Quantification showed a 
highly statistically significant increase of plaque diameter from 0.42 mm to 1.68 
mm for K26E and smaller but also significant increases to 0.76 mm for L400S 
(Figure 2.4C). None of the other mutations introduced into the WF10 H9N2 AIV 
significantly altered plaque morphology.  
The H9N2 plaque phenotype data indicated that mutation to codon 26 
within both WF10 and UDL-01 viruses reciprocally altered the plaque size. These 
mutations restored plaque diameter to the size of the alternate WT virus i.e. E26K 
within a UDL-01 backbone reduced the plaque size to a similar level to WF10 WT 
and vice versa.  Although several other mutations in the UDL-01 and WF10 PA 
gene altered the plaque phenotypes of the viruses, they did not change the plaque 
size to that of the WT viruses or act reciprocally.  This suggests that the mutation 
at position 26 is key for defining the difference in plaque phenotype seen between 












































































Figure 2.4: Phenotypic differences in plaque size between H9N2 AIVs containing 
segment 3 mutations. H9N2 AIVs with either a UDL-01 or WF10 backbone were rescued via 
reverse genetics. The plaque phenotypes of the rescues were assessed via plaque assay on 
MDCK cells under a 0.6% agarose overlay. After 72 hours cells were fixed and stained with 
0.1% crystal violet solution and plaques imaged. (A) Visual representation of UDL-01 virus 
panel containing PA mutations to make them WF10-like. (B) Visual representation of WF10 
virus panel containing PA mutations to make them UDL-01 like. (C) 20 plaque diameters per 
virus were measured using ImageJ analysis software and the average plaque diameter 
calculated. Graph represents the average +/- SD. P values= ****: <0.0001; **: <0.0039 
(Kruskal-Wallis with Dunn’s multiple comparisons). 
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2.2.5: Viral replication of H9N2 AIVs with progenitor-like or reassortant-
like PAs  
 To examine the impact of differing plaque phenotypes on viral replication, 
multi-cycle virus growth was assessed. Firstly, the PA mutant viruses were 
screened with end-point titre experiments. MDCK cells were infected with each 
virus at a low multiplicity of infection (MOI) of 0.01. After 48 hours, supernatants 
were harvested and amount of virus was titrated via plaque assay. Experiments 
were repeated across 3 independent replicates and in all cases, a mock infected 
group was included where cells were ‘infected’ with serum free media rather than 
virus. Viral outputs from these latter controls were negative according to the limit 
of detection via plaque assay (2.5 pfu/ml; data not shown). When the two WT 
viruses were compared, UDL-01 WT showed a significantly increased viral output 
at 48 hours compared to WF10 WT virus (Figure 2.5).  Within the UDL-01 panel 
of PA-altered viruses, only one mutation (E688G) significantly affected end-point 
virus replication at 48 hours, leading to a modest increase in titre compared to 
UDL-01 WT. None of the other mutations within a UDL-01 background had a 
significant impact on viral replication although several, including E26K, T85I, 
I100V_E101D, G316D, K327E and K367M slightly reduced viral output. Within 
the WF10 panel of viruses, no significant differences were seen in viral output of 
any of the mutants compared to WF10 WT. Although two mutations showed 
trended, but not significant, increases in viral output compared to the WT parent 
virus after 48 hours: K26E and D316G. These mutations increased viral output to 
bring replication to a similar level to UDL-01 WT. Both of these mutations also 




















Figure 2.5: Endpoint multi-cycle replication of segment 3 mutant H9N2 AIVs in MDCK 
cells. MDCK cells were infected with a low MOI (0.01). After 48 hours supernatants were 
harvested and titrated via plaque assay. Data represents the mean +/- SD of 3 independent 
experiments. P values: * = <0.02; **=<0.05 (one-way ANOVA with multiple comparisons 
(UDL-01 panel; WT vs. mutant); Krustal-Wallis and Dunn’s multiple comparisons (WF10 
panel; WT vs. mutant); Unpaired T-test (WT vs WT).  
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consistent with the plaque size data, the novel reassortant viruses, represented 
here by UDL-01, displayed an enhanced replicative ability in vitro compared to an 
H9N2 progenitor, represented by WF10, which was sensitive to mutations in the 
PA polypeptide. 
Next the replication kinetics of viruses mutated at position 26 were 
assessed over a time course of infection to test for any differential effect on 
replication the mutations may have had at earlier time points which could have 
been missed by only looking at end-point titres. These mutations were focussed 
on because they had the strongest reciprocal effect on plaque size but gave a less 
clear outcome in the end-point titre assays. Low MOI (0.01) infections of MDCK 
cells were initiated using the H9N2 WT and 26 mutant viruses, supernatant 
samples taken at 4, 8, 12, 24, 36, 48 and 72 hours post infection and viral output 
titrated via plaque assay. As before, the experiments were performed three times 
independently, including a mock infected group in each replicate. On each 
occasion the mock infected output was below the limit of detection for the plaque 
assay (data not shown). All four viruses showed the expected exponential rise in 
titre after 8 h.p.i., reaching a plateau around 48 hours (Figure 2.6A). At earlier 
time points there were no significant differences between WT and mutant 
viruses, with the UDL-01 pair continuing to show no significant difference in viral 
output throughout the time course.  Although the UDL-01 E26K virus did appear 
to have a reduced output at 72 hours albeit not significant. The WF10 virus pair 
showed significantly different replication kinetics at 48 and 72 h.p.i., with the 
introduction of the K26E mutation allowing enhanced replication compared to 
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the parental WT virus. Thus, the identity of PA residue 26 had significant 
reciprocal effects on the replication of UDL-01 and WF10 viruses.  
To test if the effect of PA position 26 polymorphisms held true in avian 
cells, viral replication was also assessed in a primary chicken kidney (CK) cells. 
As with MDCK cells, a low MOI was used (0.01), supernatants were harvested at 
4, 8, 12, 24, 48 and 72 h.p.i. and titrated via plaque assay on MDCK cells. Three 
independent repeats were performed, again all with mock infected cells that 
showed viral levels below the limit of detection (data not shown). The viral 
output from CK cells varied more between experiments in comparison to MDCK 
cells (Figure 2.6B). Nevertheless, there were consistent differences between the 
replication kinetics of the viruses. Viruses with PA 26E (UDL-01 WT and WF10 
K26E) reached peak titres at 24 h.p.i, while 26K-containing viruses replicated 
more slowly, achieving maximum titres at 48-72 h.p.i. (Figure 2.6B). The UDL-01 
virus pair only showed significant differences in viral output at 24 h.p.i. At all 
other time points there was no significant difference in viral titre. With the WF10 
pair, a significant difference in viral output was seen at 8 h.p.i. Thus, in avian cells, 
the PA K26E polymorphism affected the kinetics of virus growth.  
Viral replication was then assessed in ovo. 10-day old fertilised hens’ eggs 
(VALO breed) were infected with 100pfu of the viruses. Samples of allantoic fluid 
were collected from groups of 5 eggs at 4, 8, 12, 24 and 48 h.p.i. and viral titres in 
each egg determined via plaque assay on MDCK cells. In ovo (Figure 2.6C) UDL-
01 WT had significantly higher titres than UDL-01 E26K mutant virus at both 12 





















Figure 2.6: Multi-cycle replication kinetics of H9N2 AIVs with mutated PA codon 26. (A) 
MDCK cells and (B) CK cells were infected with the specified virus (UDL-01 WT, UDL-01 E26K, 
WF10 WT or WF10 K26E) at a low MOI (0.01). (C) 10-day-old fertilised hens’ eggs infected 
with 100pfu of virus. Samples were taken at the indicated time points for titration via plaque 
assay. No virus was detected proior to 8 h.p.i. Data represents the average +/- SD of 3 
independent experiments (cells) or 5 eggs per timepoint. Significant differences (unpaired T-
tests (A; UDL-01 36 and 72 h.p.i. WF10 24, 36, 48 and 72 h.p.i., B: UDL-01 8, 12, 24 and 48 h.p.i. 
WF10 8, 48 and  h.p.i. C: UDL-01 12 h.p.i.) or Mann-Whitney Test: (A; UDL-01 4, 8, 12, 24 and 
48 h.p.i. WF10 4, 8 and 12 h.p.i. B; UDL-01 4 and  72 h.p.i. and WF10 4 , 12 and 72 h.p.i. C: UDL-
01 8, 24 and 48 h.p.i. WF10 all data points) between WT and corresponding mutant at each 
time point depending on distribution of data) are represented via + (UDL-01 pair) and * (WF10 
pair). P values: +/*= <0.035; ++/** = <0.008; **** = <0.0001. UDL-01 WT indicated by dark blue 
line, UDL-01 E26K indicated by the light blue line, WF10 WT virus represented by the red line 





almost equal levels to the WT. Conversely, WF10 WT AIV had significantly lower 
viral titres at 12 h.p.i. compared to WF10 K26E mutant virus. However, after 24 
hours the WT and mutant K26E WF10 viruses displayed similar titres. Thus in 
ovo, the K26E polymorphism did not affect maximum virus titres but significantly 
affected replication kinetics. In general, those viruses which contained an E at 
position 26 appeared to replicate faster with virus being detected at 8 h.p.i 
compared to 12 h.p.i with viruses containing a K at position 26.  
Overall, from these data we can conclude that amino acid substitution at 
position 26 of PA within WF10 and UDL-01 H9N2 AIVs significantly altered the 
replication of the viruses in mammalian cell lines, in avian primary cells as well 
as in the in vivo model of embryonated hens’ eggs. However, this is a cell line 
dependant effect and infection of different cell types alters the timings of the 
replication differences that are observed.   
2.2.6: Stability of PA amino acid 26 mutations upon serial passage in 10-day 
old embryonated hens’ eggs.  
To assess the stability of the introduced mutations at amino acid position 
26, the viruses were serially passaged in 10-day old embryonated hens’ eggs. 
100pfu was inoculated into the allantoic fluid of each egg and 1 egg per virus used 
for passaging. After each passage, virus was titrated via plaque assay and 100pfu 
of the virus was used to inoculate the next egg. This process was repeated until 6 
passages were completed. A mock inoculated egg (PBS only) was included at each 
passage and this was negative for virus, to the limit of detection of the plaque 













Figure 2.7: Viral titres throughout serial passage in 10-day old embryonated hens’ 
eggs. Viruses were serially passaged 6 times at 100pfu inoculation doses. Allantoic fluid 
samples were collected at each passage and then titrated via plaque assay to assess viral 
titre. UDL-01 WT indicated by dark blue line, UDL-01 E26K indicated by the red line, WF10 




this process during independent experiments but the time constraints of the 
project did not allow for this. UDL-01 WT virus showed the most stable output 
titres across the passage period (Figure 2.7). WF10 WT and UDL-01 E26K titres 
decreased from passage 1 to passage 4, after which the viral titres rose. The titre 
of WF10 K26E was relatively stable across all passages, with some fluctuations in 
output being seen; for example, the increase in titre at passage 3. Statistical 
analyses could not be carried out because of the lack of replicate data, but overall, 
no virus titre varied by as much as 10-fold across the experiment. 
Plaque phenotype was previously shown to be a sensitive indicator of 
relative fitness for the UDL-01 and WF10 viruses (Figures 2.1 and 2.4), therefore 
plaque phenotype may give initial clues into any alteration in viral fitness via 
passaging. When P1 and P6 plaque morphologies were compared, UDL-01 WT 
virus and WF10 K26E virus visually retained their large plaque phenotypes after 
6 passages (Figure 2.8A), with quantification showing that the average plaque 
diameter had not significantly altered (Figure 2.8B). However, when P1 and P6 
WF10 WT virus and UDL-01 K26E virus were compared the plaque phenotype 
had increased within the 6 passages. The plaque diameter of UDL-01 K26E 
significantly increased from 0.54 mm to 1.26mm, while WF10 WT plaque 
diameter increased significantly from 0.44 mm to 1.43 mm. This suggested that 
these viruses had mutated over the 6 passages to have an increased fitness in 
vitro.  
As the viral plaque phenotypes had altered upon viral passaging, the 




















Figure 2.8: Viral plaque phenotype after serial passage in 10-day-old embryonated 
hens’ eggs. Allantoic fluid samples from serially passaged virus were titrated via plaque 
assay under 0.6% agarose. 72 h.p.i. plaque assays were fixed and stained using 0.1% crystal 
violet solution. Images were taken and plaque diameter calculated using ImageJ analysis 
software. (A) Visual representation of viral plaque phenotypes comparing passage 1 virus 
with passage 6 virus. (B) Randomly, 20 plaque diameters per virus were measured and 
graphically represented as mean +/- SD. P values (unpaired T–test) comparing passage 1 









allantoic fluid samples of passage 1 (P1) and passage 6 (P6) viruses and RT-PCR 
for viral segment 3 was conducted. This was sent for sequencing (Source 
Biosciences) to determine the codon identity at position 26 as well as to 
potentially identify any further compensatory mutations which may have 
occurred during passaging. A summary of the sequencing data is seen in Figure 
1.9. After 6 passages, all four viruses had reverted to contain a Glutamic acid (E) 
at position 26 of PA. This correlates with the increased plaque phenotype 
observed with the passage 6 viruses in Figure 2.8.  There were no other 
compensatory mutations identified within segment 3 that could have been 
responsible, or partially responsible for the difference in plaque phenotypes 
observed across 6 passages. However, the impact of mutations within other viral 
segments was not assessed. Overall, it appears that having a lysine (K) at position 
26 of PA, as with WF10 WT and UDL-01 E26K viruses, leads to a viral fitness cost. 
This was soon overcome via serial passage in eggs as the 26K altered within 6 



















































Figure 2.9: PA sequence after serial passage in 10-day old fertilised hens’ eggs. Viral 
RNA was extracted from allantoic fluid samples of viruses passaged in 10-day old 
embryonated hens’ eggs either once (Passage 1) or six times (Passage 6). RT-PCR specific for 
influenza segment 3 was completed and products sent for sequencing via GATC. (A) Sequence 
reads were aligned using CLUSTAL multiple alignments. (B-E) Sequence trace for Passage 1 
samples with nucleotide 76 change highlighted with the black arrow. (F-I) Sequence trace for 
passage 6 samples with nucleotide 76 highlighted with the black arrow.  
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2.2.7: Prevalence of amino acid codons at PA position 26 in IAV sequences 
The identification of the prevalence of amino acid codons at PA position 
26 in known IAV sequences, would enable correlations to be made between the 
presence of an amino acid K or E at this position and viral fitness implications.  To 
assess the natural amino acid diversity at position 26 within viral sequences 
available at the public database, bioinformatics analysis was carried out by Dr 
Samantha Lycett at the Roslin Institute. Full length sequences, with coding 
regions marked as complete or nearly complete, were downloaded from the NCBI 
influenza virus resource (23th June 2015). Files were split into 1000 base pair 
regions and aligned using MUSCLE (MEGA6) and then re-joined.  Incomplete 
sequences or sequences with runs of unidentified amino acids (Ns) were 
excluded from the analysis (totalling 88 avian, 14 swine, 55 human and 1 canine-
derived virus sequences).  This left 12,248 avian, 3,082 swine, 12,148 human, 77 
canine and 177 equine virus sequences for further analysis. The data were 
analysed by host and the consensus amino acid as well as the further 3 most 
common amino acids were identified for each position. The fraction of sequences 
with each of the amino acids was also calculated.  
Within each host type E26 (Glutamic acid) was by far the most prevalent 
amino acid, making up 99.9% of avian, swine and human sequences; 99.1% of 
equine sequences and 98.7% of canine sequences (Figure 2.10). Glycine (G), 
Lysine (K), Aspartic Acid (D) and Glutamine (Q) made up minor proportions of 
the amino acids at position 26, although this did not reach more than 1.3% of 
sequences analysed (G26 within canine sequences). There were also a small 
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number of equine, swine and human IAV sequences where the amino acid at this 
position was not defined (X).  
Table 2.3 lists the viruses which contain amino acids other than glutamic 
acid at position 26. Most are derived from avian species, although the numbers 
are small.  They were isolated across a range of years from 1983 to 2011 and a 
number of viral subtypes (H5N8, H7N1, H9N2, H5N2, H5N1, and H3N2). 
Interestingly, the other H9N2 virus which has K26 was isolated in 1999 (the same 
year as WF10) suggesting this polymorphism could have been circulating in 
China at the same time as WF10 was circulating in Hong Kong. However, it 
appears that K26 does not persist in the field and this could be due to the 
reduction in viral fitness seen throughout this chapter for viruses containing PA 
K26. Conversely, E26 is the predominant amino acid in circulating in viral strains, 













Figure 2.10: Prevalence of individual residues at amino acid 26 of PA across IAV 
strains from various hosts. Bioinformatics analysis of 12,248 avian, 3,082 swine, 12,148 
human, 77 canine and 177 equine sequences was conducted by Dr Samantha Lycett at the 
Roslin Institute. Sequences were split into 1000 base pair sections, aligned using MUSCLE 
(MEGA 6) and then re-joined. The consensus codon at each amino acid position was 
identified as well as the 2nd and 3rd most frequent amino acid. The fraction of sequences 
containing each of the amino acids was plotted. Glutamic acid: red, Glycine: green, Lysine: 










Virus Name Host 
species 
Subtype Amino acid at 
26 
A/duck/Ireland/113/1983 Avian  H5N8 Aspartic Acid (D) 
A/softbill/CA/33445-158/1992 Avian  H7N1 Glycine (G) 
A/chicken/Guangxi/4/1999 Avian  H9N2 Lysine (K) 
A/mallard/Maryland/792/2002 Avian H5N2 Glutamine (Q) 
A/goose/Guangdong/72/2004 Avian  H5N1 Glycine (G) 
A/mallard/Maryland/708/2005 Avian  H3N2 Glycine (G) 
A/Vietnam/HN31388M1/2007 Human H5N1 Lysine (K) 
A/canine/Guangdong/05/2011 Canine  H3N2 Glycine (G) 
Bioinformatics analysis was carried out on 12,248 avian, 3082 swine, 12,148 human, 77 
canine and 177 equine PA sequences by Dr Samantha Lycett at the Roslin Institute. Those 
sequences which did not have the consensus E26 amino acid were identified.  
Table 2.3: Summary of viruses which do not contain 26E within their PA gene. 
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2.2.8: Assessing the predicted impact of the PA E26K polymorphism on 
endonuclease domain structure 
As the amino acid present at position 26 of PA appeared to be responsible 
for alteration in viral plaque phenotypes and replication, it is likely that there are 
alterations within the protein structure which influence viral fitness. The impact 
of E26, K26 and G26 (as this mutation frequently appeared within field isolates 
of viruses) mutations on the structure of the N-terminal domain of the PA protein 
were modelled using the I-TASSER server for protein structure. The I-TASSER 
server has been developed as an integrated platform for automated protein 
structure analysis. It takes the amino acid sequence of the protein of interest and 
generates 3-D atomic models from multiple threading alignments and iterative 
structural assembly situations (Roy et al., 2010). First, the secondary structural 
elements of the UDL-01 and WF10 WT endonuclease domains were compared 
(Figure 2.11A). There are two occasions when an extended or reduced α-helix 
was observed (highlighted in brackets); between codon 11-24 (helix 1) and 
between codon 126-136 (helix 2). There is the potential for the amino acid at 
position 26 to affect these structures due to the close localisation to helix 1 and 
downstream effects on helix 2. The structures of UDL-01 WT and WF10 WT PA 
endonuclease domains were then modelled (Figure 2.11B, C; UDL-01 WT- violet, 
WF10 WT- green; E26- magenta, K26 –light pink). A shorter α-helix was observed 
in the UDL-01 WT endonuclease domain as expected from the sequence analysis 
in helix 1 (Figure 2.11B-highlighted by the white arrow). The region around 
amino acid 26 appeared to be similar between both WT endonuclease domains. 
The shortened α-helix within WF10 WT between codons 126 and 136 (helix 2) 
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was observed within the predicted crystal structures (Figure 2.11C-highlighted 
with the white arrow).  
When amino acid changes were introduced into the UDL-01 endonuclease 
domain structure and the secondary structures analysed, helix 1 appeared to 
alter in length depending on the amino acid present at position 26 (Figure 2.11D). 
E26 (WT) had the shortest helix 1, K26 had a slightly increased helix 1 and G26 
had the longest helix 1 making it comparable to WF10 WT helix 1 in length. None 
of the mutations affected the length of helix 2 within UDL-01. The effect of 26 E, 
K or G was then modelled onto the predicted UDL-01 endonuclease domain 
structure. When the protein structures of the endonuclease domain of UDL-01 
with either E26 (purple), K26 (blue) or 26G (light blue) were compared (Figure 
2.11E, F), the alteration of length of helix 1 could be visualised (Figure 2.11E). No 
difference was seen in the length of helix 2 within the predicted crystal structure 
(Figure 2.11F).  
When the amino acid changes were introduced into the WF10 
endonuclease domain sequence and the secondary structures analysed, the 
amino acid present at position 26 did not alter the length of helix 1. However, 
introduction of 26G into WF10 PA appeared to increase the length of helix 2 
(Figure 2.11G). This was mapped onto the predicted proteins structures of WF10 
PA with either E26 (bright green), K26 (olive green) or G26 (dark green) changes 
within the endonuclease domain  (Figure 2.11H and I). As with the predicted 
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Figure 2.11: Modelling the endonuclease domain of PA with alterations to amino acid 
position 26. The I-TASSER server for the analysis of protein structure was used to ascertain 
models for the structure of the PA endonuclease domain with mutations at amino acid 
position 26. (A) structural markers of the endonuclease domain by sequence (B) predicted 
structures of UDL-01 WT ( purple) and WF10 WT (olive green) endonuclease domains front. 
(C) predicted structures of UDL-01 WT (purple) and WF10 WT (olive green) endonuclease 
domains back. (D) structural markers of the endonuclease domain by (E) predicted 
structures of UDL-01 WT ( purple), UDL-01 E26K (blue) and UDL-01 E26G (light blue) 
endonuclease domains front. (F) predicted structures of UDL-01 WT (purple), UDL-01 E26K 
(blue) and UDL-01 E26G (light blue) endonuclease domains back. (G) structural markers of 
the endonuclease domain by sequence (H) predicted structures of WF10 WT (olive green), 
WF10 K26E (bright green) and WF10 K26G (dark green)endonuclease domains front. (F) 
predicted structures of WF10 WT (olive green), WF10 K26E (bright green) and WF10 K26G 
(dark green) endonuclease domains back. Throughout structural diagrams: blue: α-helix, 
pink: β-sheet, peach: loop, shortened loops highlighted with brackets. White arrows indicate 
locations of shortened loops in predicted crystal structures. 
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2.11H), however, the lenghtened helix 2 can be seen within the WF10 K26G 
predicted structure (Figure 2.11I). There appeared to be some differences 
between the effect of mutations at PA position 26 between UDL-01 and WF10 
endonuclease domains and the functional basis of these predicted structral 
alterations was not identified. 
2.3: Discussion  
In this chapter, the amino acid differences within the PA gene of 
progenitor (WF10) and novel reassortant (UDL-01) H9N2 AIVs were screened in 
vitro to investigate the molecular basis of the drastically altered plaque 
phenotype between the viral strains (UDL-01; large, clear plaques. WF10; small 
hazy plaques). A panel of PA mutations were selected (Table 2.1) and site directed 
mutagenesis used to alter these amino acid positions within each PA gene. Within 
this panel of mutants, once mapped onto the crystal structures of the 
endonuclease domain of PA (Figure 2.2A), several of the mutants showed 
promising potential due to their external locations on the structure suggesting a 
potential for alterations of interactions which could affect protein function. Other 
mutations lay next to or close to the endonuclease active site so could potentially 
have effects by interfering with the metal ion binding of the endonuclease. 
Reverse genetics was used to build a panel of viruses which differed by only a 
single amino acid, compared to the WT parental counterpart virus. Within this 
chapter the key domain for the difference in viral fitness previously observed was 
identified to be the N-terminal 1101 nucleotides of the PA gene (Figure 2.1).  
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It was observed that a single amino acid change, E26K, was able to 
reciprocally alter the plaque phenotypes of WF10 and UDL-01 viral strains: WF10 
viruses produced a larger plaque phenotype and UDL-01 plaque formation was 
restricted.  Although previous literature has been published on the impact of 
some of the introduced mutations on viral replication, pathogenicity and 
polymerase activity (Hu et al., 2013a; DesRochers et al., 2016), the same affect 
was not observed within the H9N2 AIVs tested in this study.  
Although the majority of mutants had no effect on the transcriptional 
activity of the polymerase complex, the UDL-01 E26K mutation did show a 
significant increase in output compared to UDL-01 WT within DF-1 cells. This 
however, did not correlate with the decreased replicative ability of viruses with 
this mutation. Overall, the transcription rates were similar throughout the panel 
suggesting that vRNA production was not affected. However, further work to 
determine the differences in vRNA, cRNA and mRNA levels produced by each of 
the polymerase complexes could be completed by performing primer extension 
assays with the RNP complexes (Hara et al., 2006). This would allow for further 
insights into the mechanism of action of the mutants. The similarity in 
transcription levels between the RNPs with different PA mutations also suggests 
that PA cap snatching is not affected, as cap snatching by the PA protein is 
required for effective transcription of vRNA to occur (Reich et al., 2014), although 
this was not tested in detail. It would therefore be interesting to test the 
endonuclease activity and cap snatching ability of the mutant PA complexes to 
determine if these PA functions are altered. Another limitation of the data is the 
lack of a high quality antibody for the detection of the PA protein. The western 
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blot data presented in Figure 2.3B is of poor quality and repetition of this 
technique would have been preferable to gain a better quality image and to 
quantify levels of the PA protein to perhaps determine protein stability.  
The plaque phenotypes of viruses containing each mutation showed that 
only a mutation at position 26 within the PA endonuclease alters plaque 
morphology to the same degree as when the entire segment is switched (Figure 
2.4). With UDL-01 E26K displaying a small plaque phenotype and WF10 K26E 
displaying a large plaque phenotype. This did not necessarily correlate with 
replication differences within low m.o.i infections where at 48 hours post 
infection viruses did not have a significantly different viral outputs. However, 
when looking across a time course of infection, there was a general trend for 
viruses contain 26E to replicate faster and to higher titres than those with 26K. 
However, on some occasions, particularly in eggs, the peak titres were similar 
between groups. This suggests that having a 26E is beneficial for viral fitness in 
terms of replication. However, this increased titre and initial replication of the 
viruses with 26E could be an artefact of the larger plaque phenotype meaning it 
is easier to determine positive samples. To overcome this it may have been 
beneficial to immunostain the plaque assays or use a semi-solid overlay as this 
may be a more sensitive method or allow for larger plaque to form (Baer and 
Kehn-Hall, 2014; Juarez et al., 2013). Another possibility of the increased 
replication and plaque phenotype of the 26E containing viruses could be 
explained by the ability of these viruses to control the host IFN response. 
(Solorzane et al., 2005; Newby et al., 2007) has previously shown that plaque 
phenotype links with host immune response, with those viruses with an 
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enhanced ability to control the host immune response, displaying increased 
spread throughout cell culture and therefore cause a larger plaque phenotype. 
This could therefore suggest that the difference in plaque phenotype could be 
related to the accessory protein present in segment 3, PA-X, something which is 
further investigated in Chapter 4. Or it could be due to a separate and currently 
unknown function of segment 3 involved in the control of the host IFN response, 
something which could be easily investigated using in vitro methods such as 
assessing viral replication in the presence of IFN, or using reporter cell lines to 
assess the amount of IFN produced during infection. Unfortunately these studies 
were not conducted as part of this thesis but would be an interesting point to 
follow up.  
When viruses containing mutations at position 26 were passaged in eggs, 
they quickly reverted (after 6 passages) to contain a glutamic acid at position 26. 
(Figures 2.7 and 2.8). Throughout the passaging viral titres were measured and 
the majority of viruses showed a decrease in viral titre until passage 4, after 
which titres recovered. Unfortunately this was only repeated once so statistical 
analysis could not be carried out and it could not be determined if this was only 
the result in this experiment or it occurred on multiple occasions after passaging. 
The increased titre after passage 4 was most pronounced in those viruses 
containing 26K, so it could suggest that this is the point where reversion to 26E 
occurred. This cannot be fully determined as sequencing analysis was not carried 
out at this point. In future studies it would be beneficial to sequence multiple 
passages across the course and to analyse plaque phenotype throughout the 
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experiment duration as this could elucidate the point at which the change 
occurred.  
The reversion of K26 seen was supported by bioinformatics analysis 
showing that the majority of viral sequences in avian, human, canine, equine and 
swine hosts possessed E26 (up to 99.9%) with only a handful of sequences 
possessing K26 with this amino acid not circulating readily in field strains. This 
suggests that having PA K26 is detrimental to the polymerase somehow affecting 
its function or stability. Functional assays to test PA cap snatching or 
endonuclease activity would be useful to determine the mechanism of action and 
role of positon 26 in PA function. Another potential avenue to follow up is the 
impact of amino acid residues on PA protein or viral stability. If the PA protein 
has increased stability or the stability of the polymerase complex is altered by 
changing the amino acid at position 26 this could explain the reversion to 26E 
and the predominance of 26E within the virus population. The production of 
defective interfering particles (DIs) has previously been suggested to be involved 
in an unstable polymerase. Previous work has shown that increased DI 
production was caused by a mutation in PA (R638A), interestingly this virus also 
produced pin head plaques, as our mutants with 26K do (Fodor et al., 2003). This 
would again be an interesting topic to follow up in future studies to determine if 
the 26K mutation leads to an unstable polymerase and therefore the production 
of increased DIs.  
The predicted modelling of the structures of the PA endonuclease domain 
(Figure 2.9), altering the amino acid present at position 26 appeared to 
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differentially affect predicted protein structure depending on the viral strain and 
could not provide conclusive evidence of a mechanism of action for the 
differences seen between viruses. Alteration of changes to amino acid 26 within 
UDL-01 altered the length of a α-helix located between codons 11-24, whereas 
within WF10, alterations to amino acid 26 changed the length of the α-helix 
between codons 126-136.  There did not appear to be a correlation between 
plaque size and helix length. However, the exact mechanisms of action of these 
alterations in α-helix length on viral fitness were not further investigated. 
However, as both of these regions lie within the endonuclease domain it is 
possible that endonuclease function could be affected by the alteration of helix 
lengths. This is cemented as Dias et al., (2009) has shown amino acid 134 (in helix 
2) is important for endonuclease function. This could be followed up further by 
investigating endonuclease function of PA’s containing 26E vs 26K vs 26G. 
The impact of K26 on influenza viruses within the field remains to be seen 
as very few viruses have been identified to contain this consensus codon. One of 
the limitations of this work is that due to the low frequency of K26 within viral 
sequences and reversion of K26 when passaged, the original sequence of WF10 
containing K26 could have resulted from sequencing or cloning error at this 
position. This would suggest that potentially another factor is responsible for the 
differences seen between early and reassortant H9N2 AIVs. One suggestion could 
be the NS1 segment, which was also implicated in the earlier screen. Jackson et 
al. (2007), showed viruses which differ in the C-terminus of NS1 can have 
alterations in viral plaque phenotype and pathogenicity. This would be an 
interesting factor to investigate further if time and resources allowed.  
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Within this chapter, a single amino acid change has been identified which 
can alter H9N2 viral fitness within cell culture and although this mutation could 
be an artefact, it still gives important mechanistic insights into the role of the 
endonuclease domain of segment 3 in viral replication. The effect of this mutation 























Chapter 3: How do PA mutations modulate H9N2 virus 
pathobiology within avian models in vivo? 
3.1: Introduction  
 The results displayed within chapter 2 identified a single mutation (E26K) 
responsible for altering various phenotypes of viruses containing the UDL-01 and 
WF10 segment 3. Therefore, within this chapter, the role of this mutation was 
assessed in vivo. No previous work has identified an amino acid change at position 
26 of PA as influencing influenza virus pathogenesis in vivo. However, several 
amino acid positions within PA have previously been shown to alter viral 
pathobiology. For example, within H9N2 AIVs, PA K356R has been shown to 
increase mammalian replication and pathogenicity, causing lethal infection 
within a mouse model (Xu et al., 2016a). Whereas in a mouse model of 2009 
pandemic H1N1 challenge, a combination of PA P224S and A70V reduced the 
viral dose required for lethal infection of 50% of the animals (LD50) by 
approximately 1000-fold (Sun et al., 2014). Similarly, several other studies have 
shown different amino acid changes within the PA genes of H5N1 (Fan et al., 
2014), H7N3 (DesRochers et al., 2016), H1N1 (Llompart et al., 2014) and H7N7 
(Zhao et al., 2016) viruses which can alter pathogenicity within mouse models. 
Thus single amino acid alterations within the PA gene of IAV can distinctly alter 
the viral pathogenesis in mammalian systems; therefore, based on in vitro results, 
it was predicted that the E26K mutation poses the potential to alter the 
pathogenicity of the H9N2 virus investigated in this study.  
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However, none of these previous, even those using avian-derived viruses, 
assessed role of PA mutations within a more natural avian model of infection.  
Therefore, the aims of this chapter were i) to assess the role of PA E26K change 
on the pathogenicity of H9N2 AIVs in ovo; ii) to assess the role of the PA E26K 
change on virus infectivity, shedding, transmission and pathogenicity in vivo 
using a chicken model of infection. 
3.2: Results 
3.2.1: Effect of mutations in ovo 
In the first instance, the effect of the key mutation in the PA protein   
previously identified to effect virus replication and plaque phenotype (amino acid 
26: Glutamic Acid or Lysine) was investigated in ovo in 10-day old embryos. This 
allowed for an insight into the differential phenotypes of wild type and mutant 
viruses in a less developed animal model (up to 14-day old embryos) prior to 
using post-hatch chickens adopting 3Rs principles. 
3.2.1.1: H9N2 in ovo infection of embryos and gross pathological 
observations 
The gross pathology of the 10-day old chicken embryos infected with RG 
H9N2 AIVs was assessed to gain insights into pathogenicity differences between 
viruses as the more pathogenic the virus, the more likely it would cause gross 
pathological signs within an infected chicken embryo. The embryos were infected 
with viruses containing either WT PA or PA with a substitution (K or E) at amino 
acid position 26. This makes the virus either progenitor (WF10)-like with PA-K26 
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or reassortant (UDL-01)–like with PA-E26. Groups of 6 10-day old embryonated 
SPF white leghorn (VALO breed) hens’ eggs were infected with 100 pfu of each 
UDL-01 or WF10 virus, or sterile PBS for the mock group, via inoculation into 
allantois. The embryos were candled twice daily to check embryo viability for 48 
hours; any embryos which reached humane end points (see chapter 7 for details) 
were discarded. 48 hours post-infection the remaining embryos were chilled, 
removed from the shell, washed twice in PBS and then photographed to 
document gross pathology. Samples of allantoic fluid were taken from each egg 
and viral titres assessed via plaque assay. Any embryos from virus inoculated 
embryonated eggs which were not positive for virus were removed from the 
remainder of the study. UDL-01 E26K mutant virus replicated to a significantly 
lower titre compared to its WT counterpart. Whereas the WF10 K26E mutant 
virus replicated to a higher titre than its WT counterpart virus, although this was 
not significant (Figure 3.1H).  
Images of 4 washed embryos per virus group were selected from those 
that passed the criteria described above. On initial investigation, both UDL-01 WT 
and UDL-01 E26K mutant groups (Figure 3.1B and C) had several embryos which 
looked to have more severe gross pathological lesions compared to mock infected 
embryos (Figure 3.1A), with marked bleeding and a macerated appearance of the 
embryo. The WT WF10 and mutant WF10 K26E infected embryos exhibited less 
pronounced gross pathophysiological changes compared to mock infected 
embryos; none of the embryos showed clear bleeding and all remained intact 
(Figure 3.1D and E). The gross pathology of the embryos was then blindly scored 
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Figure 3.1: Effect of PA E26K mutation on in ovo replication and pathology of H9N2 
AIVs. Groups of 6 10-day old VALO eggs were infected with 100 pfu of the indicated viruses. 
Eggs with virus-negative allantoic fluid or which displayed early embryo death were 
removed from the experiment. (A-E) Embryos were removed from the shell and washed 
twice in PBS before imaging to assess gross pathology. (F) Images were blindly scored for 
gross pathology by 3 independent people. Scoring was based on the following criteria: 0- no 
obvious bleeding, 1- subtle bleeding, 2- considerable bleeding, 3- very obvious bleeding 
and/or embryo not intact. Data represent the mean of 3 independent scorers, each scoring 4 
embryos per group. (G) Embryo size was estimated using ImageJ analysis software by 
normalising to the diameter of the petri dish each embryo was imaged in. Data represents 
average length +/- SD. (H) Viral titres of allantoic fluid taken from positive eggs assessed via 
plaque assay. One-way ANOVA with multiple comparison (G), unpaired T-test (H) or 
Kruskal-Wallis with multiple comparisons (F); P values =*: 0.015, ***: 0.0004. 
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The scoring criteria were as follows: 0= no obvious bleeding, 1= subtle 
bleeding, 2= considerable bleeding and maceration, 3= very obvious bleeding 
and/or embryo not intact. There were a large range of scores within each group 
and not all embryos exhibited the same pathology scores (Figure 3.1F). 
Nevertheless, by this measure, embryos from mutant UDL-01 E26K infected eggs 
had significantly higher gross pathology scores compared to the mock infected 
group, while those from UDL-01 WT, WF10 WT and mutant WF10 K26E infected 
eggs were not significantly different.  However, several of the UDL-01 infected 
embryos did display enhanced gross pathology scores compared to mock, 
although the range of disease presentations meant this was not significant. 
ImageJ analysis software was also used to estimate the length of the embryos, as 
a potential measure of the effects of infection on embryo growth. However, there 
were no significant differences in the average size of embryos compared to 
uninfected specimens for any of the infected groups (Figure 3.1G). Despite no 
significant difference being seen in gross pathology score of the embryos 
comparing WT UDL-01 and mutant UDL-01 E26K viruses, a significant reduction 
in viral titre in the allantoic fluid of eggs infected with this viral pair was seen 
(Figure 3.1H); this could suggest a reduced level of mutant UDL-01 E26K virus 







3.2.1.2: Infectious dose differentials between the viruses 
As no difference in gross pathology was seen between the UDL-01 and 
WF10 virus pairs in ovo, further investigation into the egg infectious dose (EID) 
required to cause infection in embryos was conducted. James et al. (2016) 
previously used EID comparisons to facilitate in characterisation of AIVs. To 
calculate the infectious dose required to lead to productive infection in ovo,  10-
fold serial dilutions of each virus (10,000 pfu to 0.001 pfu) was made and used to 
infect 5 eggs (10-day old SPF VALO breed) per virus per dilution. A mock infected 
group was also included in which the eggs were inoculated with sterile PBS. 
Embryos were candled twice daily throughout the study period to check for 
embryo viability (up to 84 h.p.i.). At either the end of the study period or once an 
end point had been met (see chapter 7 for details), embryos were chilled. Samples 
of allantoic fluid were taken and “in-cell westerns” assays were performed to 
determine infection via staining for viral NP protein. Briefly, monolayers of MDCK 
cells were infected with allantoic fluid and 12 h.p.i. cells were fixed via 
methanol/acetone and then stained using immunofluorescence for viral NP 
protein. None of the ‘mock-infected’ eggs gave a positive signal for viral NP 
protein (data not shown).  
The Egg Infectious Dose 50 (EID50; defined as the dilution of virus in which 
50% of the inoculated eggs show viable infection), of each virus was then 
calculated via the Reed-Muench method to determine any subtle differences in 
infection ability of the viruses (Table 3.1). Similar EID50 values were calculated 



















Virus  EID50 
UDL-01 WT 0.024 
UDL-01 E26K 0.01 
WF10 WT  0.032 
WF10 K26E 0.0015 
Five 10-day old hens’ eggs were infected with 10-fold serial dilutions (10,000 to 0.001 pfu) 
of the indicated H9N2 AIVs. Samples of allantoic fluid were taken and screened for presence 
of viral NP protein. The Egg Infectious Dose 50 (EID50) was calculated via the Reed- Muench 
method and is defined as the dose where 50% of inoculated eggs were infected.  
Table 3.1: Summary of virus dose of wild type and mutant viruses required to cause 
infection in 10-day old fertilised hens’ eggs.  
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EID50 of mutant WF10 K26E was approximately one log10 lower at 0.0015. Thus 
introduction of a K26E change into PA of WF10 AIV lead to a reduced EID50 
compared to WT WF10 virus and indicating that the mutant virus is more 
infectious. 
3.2.1.3: Embryo survival rate following infection with wild type and mutant 
viruses. 
As the K26E mutation lowered the EID50 value of WF10, further 
investigation into embryo survival after infection at different viral doses was 
conducted.  James et al. (2016) previously used this technique to assess viral 
pathogenicity in ovo, with viruses lacking the accessory protein PB1-F2 showing 
a decreased pathogenicity compared to WT. Therefore, in order to assess the 
pathogenicity of the H9N2 AIVs used within this study in ovo, 10-fold serial 
dilutions of each virus (10,000 pfu to 0.001 pfu) were made and used to infect 5 
eggs per virus per dilution as above. Mock infected eggs inoculated with sterile 
PBS were included in the experiment. Embryos were candled twice daily up to 84 
h.p.i. to check for embryo viability, as judged by lack of movement of the embryo 
and/or disruption of blood vessels within the egg. Samples of allantoic fluid for 
each embryo were collected to determine if the embryo death was the result of 
productive viral infection and “in-cell western” assays were performed as 
described above. All mock-infected samples were negative (data not shown). Any 
eggs which did not produce virus positive allantoic fluid were removed from the 
survival analysis: this included the 0.001 pfu group from all viruses (WT UDL-01, 
mutant UDL-01 E26K, WT WF10 and mutant WF10 K26E) and the 0.01 pfu group 
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from the WT UDL-01 virus group. None of the viruses caused any embryo death 
before 48 h.p.i. 
An estimation of the Lethal Dose 50 (LD50) was determined from survival 
curves of each virus although accurate LD50 values could not be calculated due to 
100% mortality not being reached in the majority of groups. The LD50 estimation 
for UDL-01 WT virus was somewhere between 1000 and 0.1 pfu. This LD50 range 
was large as there was resurgence in mortality at lower doses. The estimated LD50 
for UDL-01 E26K virus was between 10 and 1pfu, so fits in the middle of the UDL-
01 WT range. Therefore, no firm conclusions can be drawn over the effect of E26K 
within the UDL-01 background using this measure.  Within the WF10 pair; no 
death observed at the lowest dilution (0.01 pfu) within any of the infected 
embryos. A higher number of total embryos across the whole dilution range died 
throughout the study period with the mutant WF10 K26E infected embryos 
(52.5% of total compared to 27.5% with WF10 WT). From the survival curves 
(data not shown), it was observed that within WT WF10 the most mortality was 
seen throughout the time course with the 10,000 pfu and 1000 pfu dilutions, with 
little mortality seen with the other doses. However, within the mutant WF10 
K26E virus a more general mortality is seen across viral dilutions throughout the 
time course with all viral doses leading to similar levels of mortality. Estimated 
LD50 values suggest that WF10 WT virus needs an increased viral dose compared 
to WF10 K26E virus to lead to 50% embryo death; with LD50 values of 1000-100 










10000 1000 100 
UDL-01 WT 80% 60% 20% 
UDL-01 
E26K 
100% 100% 100% 
WF10 WT 70% 60% 30% 
WF10 
K26E 
60% 60% 60% 
Table 3.2: Summary of embryo mortality data 84 hours post infection with different 
H9N2 AIV.   
In each group 5 eggs per virus per dilution were infected and candled every 12 hours for up 
to 84 hours post-infection. Once an egg displayed any of the end points signs (such as lack of 
movement of the embryo or disruption of the blood vessels lining the shell), it was chilled and 
classified as dead. Allantoic fluid samples were tested for presence of viral NP in order to 
determine viral infection. Any eggs which did not display virus-positive allantoic fluid were 
removed from the study. The death rate for each dilution at 84 hours post-infection is 
displayed above.  
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Embryo mortality levels at 84 hours post infection were assessed for the 
highest viral dilutions at the lower dilutions more variability was seen and a lack 
of repeat data made this difficult to interpret (Table 3.2). Both of the WT virus 
strains appeared to have a dose-dependent effect on embryo mortality within 
100,000 to 100 pfu, whereas within the 26 mutant viruses there was no effect on 
embryo mortality with the decreased infectious dose. Therefore using this 
measure no firm conclusions can be draw on the effect of the amino acid present 
at position 26 of PA on pathogenicity.  
3.2.2 Effect of PA E26K change on viral fitness in vivo 
Since the PA 26 mutation altered viral pathogenicity in ovo and the WT 
UDL-01 AIV is well characterised in recently published literature (James et al., 
2016; Iqbal et al., 2013; Iqbal et al., 2013; Long et al., 2016) the WT UDL-01 and 
mutant UDL-01 E26K virus pair were taken forward into in vivo studies to 
investigate the effect of the E26K mutation within the chicken (Gallas gallas 
domesticus), a natural host of AIVs. For this experiment, the Rhode Island Red 
(RIR) breed of chicken was used at three weeks of age. Groups of 20 birds housed 
in self-contained isolators were inoculated with 100µl of a 105 pfu/ml stock of 
each virus (WT UDL-01 or mutant UDL-01 E26K) or sterile PBS via the intranasal 
route. These birds are hereafter termed ‘directly infected’. One day post-infection, 
8 naïve ‘contact’ birds were introduced into the isolator alongside the directly 
infected birds to assess viral transmission. Before infection (day -1) and then 
throughout the experiment, birds were swabbed in the buccal and cloacal cavities 




















Figure 3.2: In vivo experimental design summary. 3-week-old RIR chicks were divided 
into two groups of 20 birds housed within 2 isolators and each bird was inoculated with 
100µl of 105pfu/ml of WT UDL-01 or mutant UDL-01 E26K virus intranasally.  A 3rd group 
was kept in a pen as mock infected group and was inoculated with sterile PBS. One day post 
infection, 8 naïve contact birds were introduced into each virus infected groups. Birds were 
swabbed daily between day 1 and 8 and then on day 10 and 14 via both the buccal and cloacal 
cavities. On Day 1 and 3 post-infection, 3 directly infected and mock infected birds were 
culled and post mortem tissues were collected. On Day 2 post-infection, 3 directly infected, 
contact and mock birds were culled and post-mortem tissues collected. Environmental (food 
and water) samples were collected throughout the study duration. Clinical signs were 
monitored throughout. Remaining birds were culled on day 14.  
Day 0: Infection 
N=20, 3-week-old RIR 




UDL-01 WT or UDL-01 
E26K virus. Mock 




All birds swabbed in 
buccal and cloacal 
cavities 
Day 1: Contacts 
N=8, naïve contact 
birds introduced 




infected birds per 
group. Panel of 
tissues taken in 
RNA later and 
snap frozen. 
Day 2: Scheduled cull 
3 birds per group 
(direct and contact) 
culled. Panel of tissues 
taken in RNA later and 
snap frozen. 
Day 14: Experiment 
end 
All remaining birds 
culled 
Day 1-14: Swabbing 
Birds were swabbed every day from day 1 to 
day 8 and then on day 10 and day 14 via both 
buccal and cloacal cavities. 
Day 1-14: Environmental samples 
Food and water samples from each group 
collected 
Day 3: Scheduled cull 
N=3, directly infected 
birds per group. Panel 
of tissues taken in RNA 




shedding (Figure 3.2). Additionally, environmental samples (taken from food and 
water) from each group were also collected on a daily basis throughout the 
experiment duration. On experimental day 2 (day 2 post-infection for directly 
infected and day 1 post-exposure for contact birds), 3 animals per group were 
culled and a panel of post-mortem tissues taken. On experimental days 1 and 3, 
three birds were culled from the directly infected and mock groups. Tissue 
sections were stored in both RNA later and snap frozen. The experiment was 
terminated on day 14 post initial inoculation, and all birds were humanely culled. 
Birds were observed twice daily by members of animal services and whilst 
procedures were carried out for the presence of clinical signs of infection. Mild 
clinical signs expected during the study included, ruffled feathers, pale 
comb/wattles, eye and nasal discharge, reddened eyes, snicking and depression. 
Additional moderate clinical signs that were expected included drooping wings, 
swollen heads and sporadic diarrhoea.  If any signs of severe disease including 
laboured breathing, persistent diarrhoea, sitting alone and showing no signs to 
evade capture and, in the most extreme instances, paralysis and unconsciousness 
were observed birds were euthanised via a schedule one method. 
3.2.2.1: Viral shedding analysis from infected and contact birds  
To assess the ability of the H9N2 viruses, which only differ by a single 
amino acid within the PA gene (E26K), to replicate within the natural host, 
chickens infected (or mock infected) with WT UDL-01 or mutant UDL-01 E26K 
viruses were swabbed via both the buccal and cloacal cavities throughout a two 
week period. Viral titres were then determined via plaque assay. All mock 
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infected birds were below the limit of detection via plaque assay (2.5 pfu/ml) in 
both buccal and cloacal swabs (data not shown). All directly infected birds shed 
virus into the buccal cavity, peaking early in infection (day 1 or 2) and then  
declining over the next few days (Figure 3.3A). However, the UDL-01 E26K virus 
showed a significant reduction in the quantity of virus shed. Details of shedding 
on day one and two seen in Figures 3.3 B and C to show the variation in virus shed 
between birds. Virus was also cleared sooner when an E26K mutation was 
present(Figure 3.3D), by day five post infection the birds infected with UDL-01 
E26K had ceased shedding whereas those infected with UDL-01 WT were mostly 
still shedding virus. When the area under the shedding curves (AUC) were 
calculated to assess the total virus shed throughout the study period, birds 
directly infected with WT UDL-01 virus showed a marked increased AUC 
compared to birds infected with the mutant UDL-01 E26K virus (215,517 versus 
23,886). Therefore the mutant UDL-01 E26K virus showed a reduced total 
shedding throughout the study by RIR birds directly infected with virus.  
The same trend was seen in contact birds introduced at day 1 post-
infection (Figure 3.3E). A significant reduction in buccal shedding was seen in 
contact birds infected with mutant UDL-01 E26K from day 1 through to 4 post-
exposure. Details of bird to bird varitations in shedding seen in Figures 3.3 F and 
G. However, the delayed clearance of the mutant virus was not seen in the contact 
bird group, with both groups of birds clearing virus by day 6 post-exposure and 
similar levels of virus being shed on day five post infection (Figure 3.3H). All 
contact birds became infected in both groups, showing that the introduction of an 



























Figure 3.3: Buccal and cloacal shedding profiles of RIR birds infected with WT UDL-01 
and mutant UDL-01 E26K H9N2 AIV. Groups of 20 chickens were infected with 100µl of 
10
5
pfu/ml stock of either WT UDL-01 or mutant UDL-01 E26K viruses (directly infected). One 
day post infection 8 naïve contact birds were introduced into each group (contacts). Birds 
were swabbed in the buccal and cloacal cavities throughout the study duration. Swabs were 
stored in viral transport media before being clarified and titrated via plaque assay. (A) 
average buccal shedding profile of directly infected birds (B,C and D) buccal shedding on 
separate days post infection for directly infected birds with each bird represented by a single 
point. (E) average buccal shedding profile of contact birds (F, G and H) buccal shedding on 
separate days post introduction for contact birds with each bird represented by a single point.  
(I) cloacal shedding detected throughout study duration. Unpaired T-test (Contact Days 2, 3, 
4 and 5 (E, G, H)) or Mann-Whitney Test (all direct (A, B, C and D) + contact day 1 (F)) 
depending on distribution of data; P values = ****:<0.001, **: <0.0082, *:<0.033. Error bars 
represent +/- SD of all birds swabbed (at least 4 birds/group).  
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virus. When the AUC was calculated to assess the total virus shed throughout the 
study period, contact birds infected with WT UDL-01 virus again showed an 
increased AUC compared to birds infected with the mutant UDL-01 E26K virus 
(187,915 versus 17,367). Therefore the mutant UDL-01 E26K virus showed a 
reduced total shedding throughout the study by contact RIR birds infected with 
virus. 
The profile of cloacal shedding from the birds was more sporadic (Figure 
3.3I). This was expected as cloacal shedding by chickens has been reported to be 
more sporadic in a number of viral subtypes (H9, H7 and H5) and virus is not 
always shed via the cloacal route (James et al., 2016; Swayne and Beck, 2005; Van 
der Goot et al., 2003). In total 7 UDL-01 WT infected and 6 mutant UDL-01 E26K 
infected animals gave virus-positive cloacal swabs, including 1 from each of the 
contact groups.  More birds shed virus on consecutive days within the WT UDL-
01 infected group (4 birds compared to 1). However, it was difficult to draw firm 
conclusion as the numbers of birds shedding were too low for statistical analysis 
to be carried out. Overall, the shedding profiles of the infected birds suggested 
that WT UDL-01 viruses were more fit within the chicken host compared to 
mutant UDL-01 E26K virus. This supports the previously described data where 
mutant UDL-01 E26K virus had a reduced viral fitness in vitro (see chapter 2).  
3.2.2.2: Stability of the E26K mutation during replication in infected 
chickens. 
It is well established that during replication of viruses in infected animals, 
mutations can occur within the virus genome (Taubenberger and Kash, 2010). 
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Indeed, as reversion of the UDL-01 E26K mutation was seen when the mutant 
UDL-01 E26K virus was passaged in eggs (Table 2.2) it was important to 
determine if the outcome of the in vivo challenge experiment was potentially 
affected by reversion or adaptive mutations within the IAV genome, or if the E26K 
change remained fixed through the study. Initially, the plaque phenotypes of the 
viruses isolated from swab samples was examined, as this was previously 
identified to be a defining factor of E versus K at position 26 (Figure 2.4).  If PA 
26K had remained within the viral population the maintenance of a smaller 
plaque phenotype might be expected. Plaque titrations of the input viruses and 
swab samples were imaged and the diameter of 20 plaques per group measured 
using ImageJ analysis software, with the exception of the cloacal mutant UDL-01 
E26K sample where only 6 plaques were measurable. As expected, the inoculum 
WT virus showed a large plaque phenotype while the E26K mutant produced 
small, hazy plaques (Figure 3.4A). The UDL-01 WT virus retained an obvious 
large plaque phenotype throughout the experiment. Conversely, the mutant UDL-
01 E26K output virus appeared to have retained a small plaque phenotype in both 
directly infected and contact bird populations. However, when plaque diameters 
were measured (Figure 3.4B), both the viruses isolated from contact buccal and 
direct cloacal swabs showed a significantly larger plaque size than the mutant 
UDL-01 E26K input virus. Although the plaque size did not reach the same 
diameter as WT UDL-01, this was suggestive of mutations leading to increased 
viral fitness. Similarly, viruses recovered from cloacal swabs from birds that were 

















Figure 3.4: Plaque phenotypes of viruses recovered from chickens infected with WT 
UDL-01 or mutant UDL-01 E26K AIVs. RIR chickens were swabbed and virus plaque 
morphologies characterised via plaque assay under 0.6% agarose. After 72 hours cells were 
fixed and stained with 0.1% crystal violet solution. (A) Representative images of plaque 
phenotypes from viruses obtained from buccal swabs from directly inoculated and contact 
birds and cloacal swabs of directly inoculated birds. (B) The average diameter of 20 plaques 
per virus (with the exception of cloacal UDL-01 E26K where only 6 plaques were available) 
was measured using ImageJ analysis software. Graph represents the average +/- SD. Kruskal 
Wallis with Dunn’s multiple comparisons, P values = *: <0.02, **: <0.0077, ***: 0.0005. 









diameter compared to the inoculum virus again suggesting potential chicken-
adaptive mutations within this group. 
To determine if the increase in plaque diameter of the mutant UDL-01 
E26K virus isolated from the infected chickens was the result of reversions at PA 
position 26, RNA was extracted from the swab supernatants and PCR completed 
to enable samples to be sent for Next Generation sequencing (NGS). The 
consensus sequences for each segment were analysed and time constraints of the 
project did not allow for additional sequence analysis of minor variants to be 
assessed. The input viruses all contained the desired PA mutations with WT 
displaying 26E and the mutant displaying 26K. Within the output virus samples, 
sequencing did not indicate any other compensatory mutations in the PA gene at 
the consensus level. All samples tested were identical to the input virus in the 
remainder of the viral gene segments including within the X-ORF of the accessory 
protein PA-X. Focussing on the codon present at amino acid 26, the WT UDL-01 
samples tested from both buccal and cloacal swabs remained at 26E at consensus 
level. Within the mutant UDL-01 E26K samples, 26K remained in the consensus 
sequence within the viral population isolated from buccal swabs. However, 
within the cloacal swab sample tested the amino acid reverted to 26E. This could 
explain the increased plaque phenotype seen within the mutant UDL-01 E26K 
virus isolated from cloacal swabs (Figure 3.4). However, only a limited number 
of samples were sequenced and it is not known if other birds within the mutant 




3.2.2.3: Persistence of virus within the environment  
In order to assess the presence and persistence of virus within the 
environment of each isolator, samples of water and food were taken, as these 
communal areas are likely to be points of viral dissemination (James et al., 2016; 
Brown et al., 2007; Hinshaw et al., 1979). Samples (1 gram of food and 1 ml of 
water) were taken daily from each of the isolators and from the pen where mock 
infected birds were housed. Food samples were homogenised in 1 ml of serum-
free DMEM, clarified and supernatants stored at -80°C. Water samples were 
clarified and stored at -80°C. Presence of virus in each sample was assessed using 
plaque assays. No detectable virus was found in any of the food or water samples 
from the mock pen or within any food samples from the infected groups (data not 
shown). However, virus was detected within the water samples taken from both 
the WT UDL-01 and mutant UDL-10 E26K infected isolators (Figure 3.5). Virus 
was detected up to day 7 post-infection, despite virus being cleared from birds 
(as assessed by detection of virus in buccal swabs) by this point (Figure 3.3). 
Virus was more commonly detected within water collected from the water feeder 
of WT UDL-01 infected birds, with positive water samples detected on days 1-3, 
5 and 7 post-infection. However, within the mutant UDL-01 E26K infected 
isolator, virus was only detected on days 1 and 6 post-infection but the latter 
sample gave the highest recorded titre (>104 pfu/ml). These data were broadly 
consistent with the higher shedding rates of the WT UDL-01 virus potentially 
leading to higher levels of virus within the water systems. They also suggest that 














Figure 3.5: Environmental water contamination within isolators. Water samples were 
collected throughout the study duration and virus load determined. UDL-01 WT: purple, 
UDL-01 E26K: red.  
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3.2.2.4: Virus pathogenicity  
 To study the impact of the E26K mutation on viral pathogenicity, birds 
were monitored for clinical signs throughout the study duration and anything of 
note was recorded. These included diarrhoea, respiratory clinical signs (such as 
snicking), red eyes and swollen wattles and combs. Clinical end points were also 
in place to ensure that birds were not unduly suffering from the infection, 
including clinical signs such as difficult breathing and a lack of movement (more 
details in chapter 7). Any birds which reached these latter criteria were 
euthanised promptly via a schedule one method and then subjected to post-
mortem to determine a potential cause of death.  
Clinical signs throughout the study duration were mild for the most part. 
With the majority of birds only showing signs of mild diarrhoea with depression 
as expected from previous reports of H9N2 infection (Sun et al., 2010). 
Throughout the study duration (from days 3 to 6), 33% of birds (30% directly 
infected and 37.5% of contact birds) within the WT UDL-01 infected group died 
(either spontaneously or due to reaching end points and being culled) despite 
UDL-01 being classified as a LPAIV (Figure 3.6), and the survival curve profiles 
were significantly different from each other. This supports data showing that 
H9N2 AIVs have become more pathogenic in recent years (Guo et al., 2000; Iqbal 
et al., 2013; Zhong et al., 2014). The onset of the severe clinical signs was rapid 
and few observations were made prior to the point of euthanasia, the details of 
which can be seen in Table 3.3. Birds were either found dead (4/9) or had to be 
euthanised (5/9) due to severe clinical signs such as difficulty breathing. These 
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birds were observed to have a lack of control of their movement suggestive of a 
neurological impact of viral infection. When the single amino acid E26K change 
within the PA gene to make the UDL-01 virus WF10-like at this position, 
pathogenicity of the virus was clearly attenuated and all birds survived challenge 
(Figure 3.6). 
During post-mortem examination, several birds which had been recorded 
before death as having difficulty breathing showed a thickening of the tracheal 
lining (Figure 3.7A, B). This has previously been seen in H9N2-infected birds the 
field in outbreaks in Pakistan (Zhang et al., 2014b; Li et al., 2005; personal 
communication M. Iqbal), although it was previously thought to be linked with 
secondary bacterial infections. Here, the presence of any potential secondary 
infection was not investigated and the composition of the tracheal thickening was 
not examined further. However, within HPAI infection, thickening of the tracheal 
mucosa has previously been identified to be the result of increased cellular 
proliferation of the epithelium (Acland et al., 1984). Several birds also had empty 
crops and digestive tracts, suggesting they had not been eating for a period prior 
to their deaths (Figure 3.7C, D). No other significant post-mortem changes were 
observed to elucidate the cause of death. The shedding profiles of those birds 
which died were not noticeably different from those which survived infection 
(data not shown). Tissue samples were taken for further processing to determine 
any differences in viral tissue dissemination between survivors and those which 














Figure 3.6 Percentage survival within H9N2 infected birds. Directly infected and contact 
birds infected with WT UDL-01 (purple line) and mutant UDL-01 E26K (red line) were 
monitored for clinical disease signs throughout the study duration. Several birds were either 
found dead or reached the humane end points and were culled due to ethical reasons (N=9). 
This graph shows the percentage mortality rate across the study duration. Survival curves 

















Group  PM 
observations  
130 3 Found dead  UDL-01 WT 
direct 
None 





112 4 Lack of control of 




120 4 Lack of control of 






121 5 Difficulty breathing  UDL-01 WT 
direct 
Trachea 
thickened   








132 6 Lack of control of 









Those WT UDL-01 infected birds which were culled due to reaching humane end points or 
found dead were examined via post-mortem. Prior observations are outlined plus any 
additional post-mortem observations.  





















Figure 3.7: Post mortem observations. Birds which were found dead or euthanised due 
to reaching experimental end points (difficulty breathing, loss of control of movement) were 
examined via post mortem. (A) and (B) show representative images of the thickened trachea 
lining observed within 3 birds either in situ (A) or removed (B) (C) shows a representative 














3.2.2.5: Viral dissemination in tissue and organs of directly inoculated birds  
 A panel of tissues were taken during scheduled post-mortem examination 
on experimental days 1 and 3 from the directly and mock infected birds and 
stored either in RNA later or snap frozen. This allowed for viral dissemination 
throughout the visceral organs to be investigated and to determine whether the 
more severe clinical signs and post-mortem presentations seen in the WT UDL-
01 group was the result of enhanced viral dissemination within the birds.  
3.2.2.5.1: Estimation of viral M gene RNA levels in the tissues from wild type 
and mutant virus infected birds  
RNA extracted from tissue samples was used for qRT-PCR reactions to 
detect the viral M gene vRNA as a marker for presence of virus within tissues. 
This was performed alongside an M gene RNA standard which allowed for the 
segment copy numbers to be calculated. James et al. (2016), showed a good 
correlation between M gene and live virus isolation between influenza infected 
tissues from chickens, showing this is a robust method to measure viral presence 
within tissues. All the mock samples fell below the limit of detection, further 
confirming no infection within this group (data not shown). In directly infected 
animals, M gene copy number was highest in the nasal and tracheal tissues but 
was also readily detectable within the lung, colon, kidney, and spleen and 
intermittently detected in the liver (at least within UDL-01 WT infected birds). 
Overall, amounts were variable between days but levels were highest on day 3 
post infection. Within these animals, WT UDL-01 virus was present at increased 
levels in a number of tissues compared to birds infected with the mutant UDL-01 
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E26K virus, particularly on days 1 and 3. On day 1 (Figure 3.8A) there was 
significantly higher copy number of segment 7 RNA (with increases of 10-to 30-
fold copies being seen) within the  lung,  kidney, spleen and liver of the WT UDL-
01 infected birds compared to mutant UDL-01 E26K infected birds. On day 3 
(Figure 3.8B), UDL-01 E26K mutant virus had mainly been cleared from the 
visceral organs, with levels of viral RNA mostly below the limit of detection except 
in the nasal tissue where levels remained high (104 to 105 copies of viral M gene). 
The mutant UDL-01 E26K virus appeared to be being cleared from trachea whist 
the WT UDL-01 WT was still present at this point (101-3 versus 105 copies of M 
gene). The lung, colon and kidneys also showed significantly higher levels of WT 
UDL-01 RNA compared to the mutant UDL-01 E26K. This suggested that while 
the mutant UDL-01 E26K virus was able replicate efficiently in the upper 
respiratory tract, it was less able to disseminate through the bird and was more 
rapidly cleared. 
3.2.2.5.2: Detection of virus in the tissues from wild type and mutant virus 
infected birds  
In order to determine whether the isolation of viral RNA from tissues 
corresponded to ‘live’ virus, tissues snap frozen at the time of post-mortem were 
processed from the birds on day 2, as this time point allowed a comparison 
between directly infected and contact birds. 30mg of each tissue section was 







Figure 3.8: Detection of viral M gene within tissues of infected birds. On days 1 
and 3 post infection 3 birds per group were culled and a panel of tissues taken and 
stored in RNA later. Total RNA was extracted from homogenised tissue samples and 
qRT-PCR for viral M gene carried out. CT values were compared to a M gene standard 
curve in order to determine copies of viral M gene from directly infected birds on day 
one post infection (A), and day 3 post infection (B).  UDL-01 WT infected tissues shown 
in purple, UDL-01 E26K infected tissues shown in red. Each data point represents the 
copies of M gene from a single bird. Error bars represent average +/- SD. Unpaired T-
test (Day 1- Trachea, Kidney, Spleen and Liver, Day 3- Nasal, Trachea, Colon, Kidney, 
Spleen) or Mann Whitney Tests (Day 1- Lung and Colon, Day 3- Lung and Liver) 
between UDL-01 WT and UDL-01 E26K infected birds; P values = *: <0.0147, **: 
<0.0057, ***: <0.0005, ****: <00001.  
156 
 
plaque assay. No virus was detected from any tissues collected from mock 
infected birds or from lung, colon, kidney, spleen and liver of infected animals 
(data not shown). This was in agreement with the qRT-PCR results which 
detected RNA at levels only marginally above the limit of detection at day 2 (data 
not shown).  Potentially, the vRNA detected in these tissues was either derived 
from contamination, RNA levels were low and lost viability during storage and 
processing or the detected RNA was not the result of productive infection in these 
tissues. However, viable virus was isolated from nasal tissue (Figure 3.9A) and 
trachea (Figure 3.9B), albeit not from all birds in each group.  Titres were higher 
from WT UDL-01 birds compared to the mutant UDL-01 E26K virus infected 
birds. Contact-infected birds in each group had relatively low levels of virus 
present (100-fold reductions in viral titre) in nasal and tracheal tissues compared 
to the directly infected birds, although this was perhaps expected as they had only 
been introduced to the isolator 1 day prior to culling. These data showed that WT 
UDL-01 virus was better able to replicate within the nasal tissue and trachea 
compared to the mutant UDL-01 E26K virus again supporting the buccal 



























Figure 3.9: Virus titres from tissues collected from infected birds. Snap frozen tissue 
samples were homogenised with serum free DMEM. Supernatants were clarified and titrated 
via plaque assay. (A) Viral isolation from nasal tissue (B) Viral isolation from tracheal tissue. 
Data points represent titres from individual birds along with bars indicating the mean +/- 
SD. Mann-Whitney test, no significant differences. UDL-01 WT from directly infected: dark 
purple, UDL-01 WT from contact birds: light purple, UDL-01 E26K from directly infected: 
red, UDL-01 E26K from contact birds: pink. 
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3.2.2.5.3: Viral dissemination in birds culled due to reaching a humane end 
point 
 In order to ascertain if the birds that died during the experiment had 
increased levels of viral dissemination or viral presence within tissues which 
could have contributed to their mortality, qRT-PCR for viral M segment copy 
number was completed as described above. RNA was extracted from stored 
tissues including nasal tissue, trachea, lung, colon, liver and spleen and M gene CT 
values compared to an M segment standard curve in order to calculate copy 
number.  Tissues from those birds’ outlined in Table 3.3 were included in this 
experiment. One of the limitations of this study was that the birds taken for the 
scheduled culls were not taken on the same days as those which died or had to be 
euthanised. Therefore, for the purposes of comparison, these data were plotted 
against the corresponding data from day 3 already shown in Figure 3.8 where 
overall viral loads were at their highest. However, the levels of vRNA detected did 
not differ substantially from the levels found in birds from scheduled culls, with 
highest levels in nasal and tracheal tissues and lowest levels in liver and spleen 
(Figure 3.10). Generally those birds which were culled or died as a result of 
infection did not have differing vRNA levels within tissue compared to the WT 
infected birds scheduled for cull on day 3 of the experiment. However, as some of 
these birds were removed from the study up to day 6 of the experiment 
comparisons cannot be made on infection levels in the healthier birds at this 
point. In general those birds, culled at later time points (points coloured red, 






















Figure 3.10: Viral RNA present in tissues from birds which reached experimental 
humane end points. Tissues were collected from birds which reached experimental end 
points or were found dead during the study duration via post-mortem examination. All birds 
from the UDL-01 WT group. RNA was extracted from tissues and qRT-PCR for viral M gene 
was conducted. The copy number of M gene was calculated via comparison of CT values to an 
M gene standard curve. Data plotted in comparison to previously described data from 
scheduled cull birds infected with UDL-01 WT virus at day 3 (Figure 3.9). Each data point 
represents the M gene levels in an individual animal and error bars show average +/- SD. 
Orange data points represent those birds culled on day 3, green those culled on day 4, blue 
those culled on day 5 and red those culled on day 6.  
160 
 
3.2.2.6: Cytokine expression in infected tissues  
 Next the immune responses of the chickens infected with the different 
viruses was assessed as mutations within the PA gene have previously been 
shown to affect host innate immune response. For example, Hu et al. (2013a) 
showed that a K237E change within PA enhanced the immune response against 
H5N1 AIVs in ducks. Nasal tissue from chickens culled at day 2 (as well as from 3 
mock infected birds) was chosen for analysis, as all birds had high levels of vRNA 
and all bar one were positive for live virus at this time point.  This also allowed 
for a transcriptomic comparison of the immune responses between the directly 
infected and contact birds with respect to the baseline values from uninfected 
animals. RNA was extracted from homogenised tissues and used to complete 
qRT-PCR to quantify host transcripts for a range of chicken cytokines and 
interferon response genes. Three reference host genes (RPLPO-1, RPL13 and 28S 
rRNA) were selected for normalisation and the most stable gene across the 
samples chosen for normalisation.  
 Nasal tissue of directly infected birds showed little differences in the 
cytokine transcript levels between UDL-01 WT and UDL-01 E26K infected birds 
(Figure 3.11A), this included IFN-α, IFN-β, IFN-γ, IL-18 and TGF-β4. Several 
cytokines had marginally increased levels in the UDL-01 WT infected birds 
including IFN-γ, IL-4, IL-18 and Mx although these levels did not reach 
significance. The only cytokine that had  significantly different levels, between the 
WT UDL-01 and mutant UDL-01 E26K infected birds was Interleukin-6 (IL-6), a 
proinflammatory cytokine which promotes B cell maturation and T cell 
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differentiation (reviewed by Heinrich et al., 2003), with the UDL-01 WT infected 
birds showing higher levels of cytokine expression.  
Within the nasal tissues of contact birds culled 24 hours post-exposure to 
the infected group (Figure 3.11B), there was again few differences in cytokine 
transcript levels between the infected groups. Again several cytokines showed 
marginally increased expression in UDL-01 WT infected birds with increases 
seen in IL-4 and Mx levels compared to UDL-01 E26K infected birds. As with the 
directly infected birds, IL-6 levels were significantly different between the UDL-
01 WT and UDL-01 E26K infected birds, with the former showing increased 
levels. 
Overall, these data showed that the both virus infections induced an 
immune response within the nasal tissues of the birds, with UDL-01 WT infected 
birds showing a marginally enhanced response compared to UDL-01 E26K 
infected birds. The UDL-01 WT virus induced a strong proinflammatory response 
with increased IL-6 induction in both directly infected and contact birds. Time 
and resource constraints have restricted the cytokine profiles to the nasal tissue. 
However, for future work, it may be beneficial map the cytokine profiles of all 
tissues that at least show variability of vRNA levels between the wild type and 


























Figure 3.11: Cytokine expression compared to reference gene. RNA was extracted from 
nasal tissue of WT UDL-01 and mutant UDL-01 E26K infected chickens. qRT-PCR was 
performed for a panel of cytokines and levels compared to RPLPO-1 reference gene were 
calculated. Cytokine expression for each bird is represented in a single dot, with error bars 
displaying mean +/- SD of nasal tissue from n=3 chickens. Unpaired T-test  (IFN-α, IFN-β, 
IFN-γ, IL-1β, IL-6, IL-18, CXCLi2, Mx and direct TGF-β4) or Mann-Whitney Test (IL-4 and 
contact TGF-β4) P values = **= 000021, *= 0.0316.  
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3.3: Discussion  
 In this chapter, the effect of the PA E26K mutation in vivo was investigated. 
Initially infectivity, replication and virulence of WT UDL-01, mutant UDL-01 
E26K, WT WF10 and mutant WF10 K26E viruses was assessed in ovo, using 
fertilised hens’ eggs as a model for studying viral pathogenicity. Within in ovo 
studies, embryos infected with either WT UDL-01 or mutant UDL-01 E26K 
viruses had higher gross pathology scores when compared to mock and the WT 
WF10 and mutant WF10 K26E virus pair. Introduction of an amino acid change 
at position 26 in the PA gene did not significantly alter the gross pathology score 
compared to WT UDL-01 virus (Figures 3.1). However, a reduced viral output was 
observed in the mutant UDL-01 E26K compared to WT UDL-01 infected eggs and 
the reciprocal alteration to viral output was seen within the WT WF10 and 
mutant pair (Figure 3.1H). This could suggest that a reduced quantity of virus is 
required to lead to the same gross pathology. The reasons behind this were not 
determined during this study period although one such factor could be an 
increased immune response caused by the UDL-01 E26K virus which could lead 
to increased infiltration of immune cells and enhanced gross pathology. Samples 
could have been taken from the embryo and qRT-PCR used to assess the cytokine 
levels, histopathology could have also been adopted to determine the infiltration 
of immune cells into the embryo to determine their contribution to gross 
pathology. However, reduced viral replication usually correlates with a reduced 
viral pathology (Xu et al., 2017; Xu et al., 2016 and Hu et al., 2013).  Although 
enhanced immune responses have been shown to increase pathology in 
numerous cases (Baskin et al., 2009, Kobasa et al., 2007). Overall, the in ovo 
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method used here was not sensitive enough to determine any pathological 
differences between the viruses studied, although perhaps repeat experiments 
would enhance the sensitivity of the data collected or inclusion of addition 
measures such as histopathology would enhance the ability to draw conclusions 
from this section.   
Introduction of E26K into UDL-01 PA gene did not affect the EID50 within 
eggs of the white leghorn breed (VALO). However, in the WF10 background, 
introduction of PA K26E reduced the EID50 compared to WT (Table 3.1), showing 
a lower viral titre was needed to cause productive infection in 10-day-old 
embryos. This could suggest an increased viral fitness of the WF10 K26E virus 
supporting in vitro data described in Chapter 2.  Again the LD50 values could not 
further elucidate any pathogenicity differences between the virus pairs, with 
broad ranges of estimated LD50’s observed. However, the UDL-01 E26K virus 
showed a lack of dose response in mortality across the three highest dilutions 
(Table 3.2), showing 100% mortality, higher than UDL-01 WT at these points. 
This high mortality could have been due to human error with artificially high 
levels of mortality seen with artificially high amounts of virus put into eggs based 
on problems with dilution, repeat experiments would enable this to be 
determined. Another factor that could account for the enhanced mortality of UDL-
01 E26K virus at high dilutions is the transfer of contaminant RNAs, IFNs or egg 
artefacts, which may be increased in this stock if the virus has a reduced stability. 
This effect would be reduced at lower dilutions as the effect of the artefacts is 
diluted, however the data from the lower dilutions was inconclusive due to large 
variations in mortality between doses. Despite this, one of note trend seen was 
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that viruses which contained 26E (UDL-01 WT and WF10 K26E) appeared to 
have an increased mortality at lower doses than those viruses which contained 
26K (WF10 WT and UDl-01 E26K). This is in contrast to the data at the higher 
doses and could be due to the lack of artefacts transferred at lower doses. Repeat 
experiments would allow for this to be confirmed.  
 The impact of the amino acid change at position 26 on virus fitness and 
pathogenesis in chickens was then investigated. In these studies, the buccal 
shedding of chickens infected with mutant UDL-01 E26K virus was significantly 
reduced throughout the shedding period compared to the WT UDL-01 infected 
birds (Figure 3.3). This supports data seen in vitro (Chapter 2), where UDL-01 
E26K virus produced a smaller plaque phenotype and reduced viral replication. 
This suggest that the UDL-01 E26K virus has a reduced fitness in vivo and this 
position of the PA gene is important for viral replication in the chicken host, 
supporting the lack of PA 26K seen within bioinformatics analysis of ~27,700 
sequences (Chapter 2). The UDL-01 E26K virus was also cleared from shedding 
faster than the UDL-01 WT virus but only within the directly infected birds. 
Although the contact bird population showed a reduced overall shedding 
throughout the study period, by day 5 the enhanced clearance of the UDL-01 
E26K virus was no longer present. It is possible that those birds still infected on 
day 5 in the UDL-01 E26K group contained viruses which had mutations present 
allowing them to persist for longer periods. In fact, some reversion to 26E was 
seen within sequence analysis of the cloacal swab sample tested. Some reversion 
to 26E would be expected as this was also observed within passaging of the 
viruses in eggs (Chapter 2). Unfortunately, samples that were sequenced were 
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from Day 2 post infection so it is possible that by Day 5 an increased level of 
reversion would be seen.  
 UDL-01 WT virus appears to have an increased fitness within the chicken 
model of infection used within these studies, particularly in terms of virus 
shedding. This also correlated with the enhanced environmental deposition of 
UDL-01 WT compared to UDL-01 E26K (Figure 3.5). The increased 
environmental presence of WT UDL-01 virus could suggest that the virus is more 
stable in this environment and give it an advantage in transmission events 
(although no evidence of this was observed within this study). Further studies 
may evaluate a scenario in which an additional naive contact group could be 
included at a later period post-infection to assess if the differences seen within 
water samples could alter virus transmission dynamics at later time. It would also 
be beneficial to test the stability of each of the viruses in water systems within 
more controlled studies in vitro in order to ascertain if the mechanism of action 
of the 26 mutation is to contribute to the stability of the virus.  
The reduction in viral replication within the buccal cavities of the UDL-01 
E26K infected birds probably contributed to a reduction in severe disease and 
mortality (Figure 3.6). No deaths were observed in mutant virus infected birds, 
in contrast to a 33% mortality rate with UDL-01 WT infected animals. This 
increased mortality corresponded with enhanced clinical signs within the UDL-
01 WT (26E) infected birds and enhanced gross pathology, such as thickened 
tracheal linings (Table 3.3 and Figure 3.7). The enhanced mortality rate could 
have potentially been due to an increased viral dissemination of WT UDL-01 
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compared to mutant UDL-01 E26K, where at day 3 post-infection, vRNA could be 
isolated not only from the respiratory tract but also from the colon, kidney and 
spleen tissues. Due to space constraints within the isolators, it was not possible 
to increase the group size and cull birds at different time points as the viral 
infection progresses and then regresses, so post-mortem samples were not 
collected beyond day 3 post-infection. In future studies, it would be interesting to 
analyse the tissue samples at later stages of infection, to determine if viral 
persistence within the host visceral organs contributes to the enhanced 
pathogenesis of WT UDL-01 virus compared to the mutant UDL-01 E26K AIVs. 
The enhanced mortality of the WT UDL-01 virus was not due to mutations within 
the viral genome, at least at consensus level. All of the samples sequenced showed 
no consensus level changes to any IAV genome segments and the inoculums 
confirmed isogenic mutants, only differing in the single mutation introduced 
within PA. This suggests that the difference in pathogenicity is either due to the 
E26K change within the virus or other external factors such as secondary 
bacterial infection not assessed within this study. Environmental factors such as 
hen pecking could have also contributed to the pathogenicity seen or exacerbated 
the outcomes. Some hen pecking was seen during the experimental duration, 
however, this occurred within both groups so could not be deemed an external 
factor in the pathogenic outcome of the infection. Viral RNA was also isolated 
from the brain of the birds that died during the course of the experiment (data 
not shown). Interestingly those with the highest detected viral M gene in the 
brain were also those birds which exhibited neurological symptoms (lack of 
control of movement) prior to euthanasia or were found dead (Table 3.3; wing 
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band numbers- 112, 116, 125 and 120). As this is a LPAI it was not expected that 
it will be able to disseminate throughout the host as LPAI should have a restricted 
replication within the respiratory and digestive tracts (Spickler et al., 2008; 
Swayne and Beck, 2005; Zepeda and Salman, 2007). Unfortunately, brain samples 
were not taken from those birds routinely culled, so a comparison could not be 
made regarding presence of vRNA within brain tissue of birds which succumbed 
to infection. In those tissues collected from birds culled as the result of infection 
(Figure 3.10, all birds from the UDL-01 WT group), there was a general decrease 
in the copies of the vRNA isolated the later the bird was culled. As there were no 
routinely culled birds collected at this later time points it was not possible to 
correlate whether birds which survived infection also still showed presence of 
vRNA within their tissues. However, studies conducted by James et al. (2016), 
collected tissues on day 5 following infection with the UDL-01 WT virus and virus 
had cleared from the lungs and spleen at this point but was still present in the 
upper respiratory tract and colon. This suggests that it is not unusual to be able 
to isolate vRNA from tissues at later time points post infection so an extended 
dissemination was not responsible for these birds’ deaths.  
 An upregulation of the proinflammatory cytokine, IL-6, was also observed 
in both directly infected and contact chickens infected with UDL-01 WT 
compared to those birds infected with the mutant UDL-01 E26K virus. This could 
suggest the enhanced pathogenicity could be due to an increased 
proinflammatory response. Enhanced pro-inflammatory cytokine expression 
within the respiratory tissues has previously been shown to correlate to severe 
influenza virus infection within both human infection and animal models 
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(Perrone et al., 2008; Zeng et al., 2015); therefore the increased pathogenicity 
observed within these studies could be accounted for by the increased pro-
inflammatory cytokine responses within wild type infected chicken nasal tissue. 
However, within these studies, only cytokine transcript levels were investigated. 
It would have been interesting to further investigate protein levels of cytokines 
and perhaps to look in more details at the infiltration of immune cells to the 
respiratory tract between UDL-01 WT and UDL-01 E26K viruses. In addition, 
time and money constraints only allowed for the cytokine profiles to be assessed 
from one tissue. However, it might have been beneficial to assess the cytokine 
profiles in another tissue with high levels of vRNA such as the trachea   or to have 
assessed the kinetics of the cytokine response across day 1-3 post-infection. 
Within this study it is possible that the differences in immune modulation seen 
between WT and mutant viruses could just be the result of higher replication 
leading to higher immune responses, although this is difficult to correlate.  
 In order to better understand the impact of the amino acid present at 
position 26 it would have been useful to undertake a similar study, but in a gain-
of-function, rather than loss-of-function format, with the WF10 WT and mutant 
pair of viruses, to ascertain if the reciprocal effect would have been observed; i.e. 
does WF10 carrying K26E mutation become more pathogenic than the WT 
WF10? However, due to the limitations in availably of our animal facility and time 
scales for the project this experiment was not performed.  
 Overall, within this chapter the effect of a single amino acid change to PA 
position 26 (E or K) was investigated within avian in vivo models. An E to K 
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change in PA at amino acid 26 in UDL-01 led to reduced viral replication and 
pathogenicity in vivo, correlating with a reduction in the pro-inflammatory 
cytokine responses and viral dissemination. It is possible that the addition of the 
UDL-01 E26K mutation makes the virus less stable within both the environment 
and within the host. This is supported by the reduced environmental deposition 
of the virus, the reduced shedding and the reduced dissemination observed. 
However, it would be beneficial to transfer these findings back into an in vitro 
setting to determine the stability of the viruses within different, controlled 
conditions and also to determine if the stability of the polymerase at a molecular 
level leads to the production of differential levels of DI’s which could alter the 
pathogenic outcome of infection and therefore determining the mechanism of 












Chapter 4: Investigating the contribution of PA-X to 
H9N2 AIV fitness in vitro 
4.1: Introduction 
  Influenza virus segment 3 also encodes several accessory proteins 
alongside the main PA gene, including PA-X. PA-X comprises of the N-terminal 
endonuclease domain of the PA protein, along with a (typically) 41 or 61 amino 
acid X-ORF (Jagger et al., 2012). The X-ORF is translated from the +1 frame of the 
PA gene which is accessed via ribosomal frameshifting. PA-X has been shown to 
play a role in host cell shut off (Jagger et al., 2012); the phenomenon by which 
viruses are able to inhibit cellular gene expression to hamper the induction of 
antiviral responses. This allows for translation to be shifted towards the 
production of viral rather than cellular proteins (reviewed by Aranda and Maule, 
1998). PA-X acts in a global fashion, degrading mRNA within the cytoplasm which 
in turn reduces host protein synthesis (Khaperskyy and McCormick, 2015). 
Within H9N2 AIVs, Gao et al. (2015c) have previously shown that an active PA-X 
protein is present in some strains, whose removal led to a reduction in the ability 
of the virus to control host protein synthesis and reduced replication in A549 
cells, as well as reducing virulence within a mouse model of infection.  
Several amino acid polymorphisms within our H9N2 strains were 
identified which altered viral replication both in vitro (Chapter 2) and in vivo 
(Chapter 3), as well as altering viral pathogenicity in chickens (Chapter 3). 
Several of these amino acids lie within the N-terminal endonuclease domain 
common to PA and PA-X, including the key position (26) identified in chapter two. 
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It was therefore decided to further investigate the effect of these mutations on 
the main known function of PA-X; shut off of host cell protein synthesis. 
Consequently, the aims of this chapter were i) to identify if any of the previously 
identified mutations, which also lie in PA-X, are able to affect functions of PA-X, in 
particular host cell shut off. ii) and if so, to further investigate the role of PA-X 
within these H9N2 AIV strains.  
4.2: Results  
4.2.1: The effect of amino acid alterations in PA-X on host cell shut off 
activity 
4.2.1.1: Rescue of PR8 7:1 H9N2 PA reassortant viruses  
In order to test host cell shut off within a viral context to determine if other 
viral factors may interfere with the host cell shut off and to determine if plaque 
phenotype is affected in a similar way to previously shown data, reverse genetics 
was used to rescue A/Puerto Rico/8/1934 H1N1 (PR8:H1N1) reassortant viruses 
which contained WT and mutated segment 3s derived from either WF10 or UDL-
01 H9N2 AIVs, termed PR8 7:1 UDL/WF10.  Reassortant viruses were initially 
used as the laboratories at the Roslin Institute were not set up for use of AIVs at 
the time of performing this work. 293T cells were co-transfected with reverse 
genetics plasmids containing 7 segments (PB1, PB2, NP, HA, NA, NS, and M) 
derived from PR8 and the segment 3 (PA) derived from the relevant AIV. 72 hours 
post-transfection the resulting supernatants (P0 stocks) were clarified and used 
to infect MDCK cells for growth of P1 viral stocks. MDCK cells were monitored for 
presence of CPE for up to 72 hours, supernatants harvested and stored at -80°C 
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for use in subsequent experiments. Presence of the correct segment 3 with or 
without the desired mutation was confirmed via sequencing (data not shown). 
Viral plaque phenotype was then examined in MDCK cells at 48 hours post-
overlay. The PR8 7:1 H9N2 PA viruses containing the WT segment 3s exhibited 
similar plaque phenotypes, of reasonably large, clear plaques (Figure 4.1B) which 
when quantified showed average plaque diameters of just over 1mm (Figure 
4.1A). This was unexpected, as within the parental H9N2 AIVs, UDL-01 WT had a 
much larger plaque size compared to WF10 WT (Figure 2.1B) suggesting that 
other factors within the H9N2 backbone could affect the plaque morphology. The 
7:1 reassortant UDL-01 panel of mutants showed some differences in plaque size, 
in particular those with A20T and T118I changes (Figure 4.1A). However, when 
average plaque diameters were taken, the E26K mutation showed a significantly 
smaller plaque size than PR8 7:1 UDL-01 WT, none of the other mutations 
showed significant changes compared to PR8 7:1 UDL-01 WT (Figure 4.1A). 
Within the WF10 panel, the K26E change within the endonuclease domain of PA 
was the only mutation which caused a visually obvious change in plaque size 
(Figure 4.1B). Quantification showed a significant increase in plaque diameter 
from ~1mm to 2.5mm. Two other mutations also significantly increased the 
plaque size of the WF10 7:1 reassortant viruses: I85T and R250Q, albeit to a 
smaller extent than the K26E change (Figure 4.1A). 
  In order to further assess the replicative abilities of the PR8 7:1 H9N2 PA 
viruses, low MOI (0.01) infections of MDCK cells were conducted. 48 hours post 
































































Figure 4.1: Characterisation of PR8 7:1 H9N2 PA viruses. PR8 reassortant viruses 
containing the indicated H9N2 segment 3s were rescued using reverse genetics and growth 
properties in MDCK cells examined. (A) Average +/- SD plaque diameter of 20 plaques per 
virus, measured using ImageJ analysis software. (B) Example of plaque phenotypes. (C) 
Viruses were used to infect MDCK cells at a low MOI (0.01) and 48 hours post-infection 
supernatants harvested and viral titres assessed via plaque assay.  Mean +/- SD of three 
independent experiments. P values = *:0.0282, ***:0.0003, ****: <0.0001 (Kruskal- Wallis 
analysis with multiple comparisons). 
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However, in 3 independent experiments, all viruses replicated to comparable 
levels to the parental WT virus after 48 hours (Figure 4.1C). Thus, in the context 
of the PR8 background, the H9N2 segment 3 mutations had only minor effects on 
virus replication in vitro. 
4.2.1.2: Reporter assays to determine host protein synthesis levels with the 
addition of H9N2 PAs 
To test if polymorphisms within the shared domain of PA and PA-X, seen 
in strains of H9N2 AIVs, affect the host cell shut off activity of PA-X, a β-
galactosidase (β-gal) reporter assay was used. This type of assay, in which cells 
are transfected with “effector” plasmids containing cDNA from segment 3 and a 
reported plasmid encoding β-gal under the control of a constitutive RNA pol II 
promoter have previously been used to characterise the ability of influenza PA-X 
to control host gene expression (Jagger et al., 2012). Enzymatic read out of β-gal 
accumulation gives a measure of host cell gene expression in the transfected cell 
and the ability of the polypeptides encoded by the effector plasmid to inhibit it. 
Transfected segment 3 will produce all four known PA-related polypeptides, but 
comparison of WT segments with those in which the PA-X frameshift site has 
been mutated suggest that the majority of the inhibition comes from PA-X (Jagger 
et al., 2012). 
Cells of either mammalian (293T) or avian (DF-1) origin were transfected 
with differing segment 3 plasmids with or without mutations in PA-X (see chapter 
2), along with a β-gal reporter plasmid. 48 hours post-transfection, cells were 
lysed and β-gal accumulation quantified by a colorimetric enzyme assay. Within 
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each transfection set up an empty vector control for the effector plasmid was 
included; to give an indication of β-gal levels in the presence of a further plasmid 
but in the absence of an encoded inhibitor; all data were normalised to this 
control. Background levels of absorbance were assessed using a “cells only” 
control. Within 293T cells, PR8 WT segment 3 was also included. This segment 3 
has previously been shown to have low host cell shut off ability via this technique 
(unpublished data from Digard lab; Naffakh et al., 2001).  
In 293T cells, transfection of the β-gal plasmid and empty vector resulted 
in enzymatic activity substantially above that seen in the cells only control 
(Figure 4.2A). Addition of the WT UDL-01 segment 3 significantly reduced levels 
of β-gal in comparison to the empty vector control indicating shut off of host gene 
expression. In contrast, neither WT WF10 nor PR8 segment 3s repressed β-gal 
accumulation. When plasmids with single codon changes, within the shared PA 
endonuclease domain or X-ORF, (characterised in chapter 2), were assessed, 
several of the alterations had no effect on the PA-X  shut off ability in either UDL-
01 or WF10 backgrounds compared to their parental WT segment 3s; notably the 
reciprocal mutations at position 20, 85, 100, 101 and 250. Two mutations had 
non-reciprocal effects on shut off activity. I118T, which lies within the PA 
endonuclease domain, removed shut off activity from UDL-01 PA-X but did not 
rescue repressive activity when introduced into WF10 segment 3. Similarly, 
L221R, which lies within the X-ORF, introduced host cell shut off activity to WF10 
PA-X but did not remove it from UDL-01. However, a single amino acid change, at 




























Figure 4.2: Ability of H9N2 PA-Xs to repress cellular gene expression. WT or mutant 
segment 3 plasmids were co-transfected into (A) 293T cells or (B) DF-1 cells with a β-gal 
reporter plasmid. 48 hours post-transfection cells were lysed and levels of β-gal assessed by 
colorimetric enzyme assay. Results were normalised to a sample where the PA plasmid was 
replaced with the empty vector control. Graph represents the average of 3 independent 
experiments +/- SD. P values:  ****= <0.0001; ***= 0.0003; * = <0.003 (one-way ANOVA with 
multiple comparisons (all 293T and WF10 panel in DF-1) or Kruskal Wallis with multiple 





UDL-01 and WF10 PA-Xs. Interestingly, this change was the same one that altered 
plaque phenotype and pathogenicity of the UDL-01 virus (chapters 2 and 3).   
Within DF-1 cells the same assay was completed, cells were transfected 
with the β-gal reporter plasmid and “effector” plasmids. Again, transfection of the 
β-gal plasmid and empty vector resulted in enzymatic activity substantially above 
that seen in the cells only control (Figure 4.2B). Only those key changes seen 
within 293T cells were carried forward to test in DF-1s and the same patterns 
were observed. Within UDL-01 segment 3, introduction of E26K and I118T 
changes removed shut off activity in a trended but non-significant manner 
compared to UDL-01 WT whereas introduction of R221L did not. Within WF10 
segment 3, introduction of K26E and L221R led to a trended but non-significant 
alteration of shut off activity and T118I had no effect. 
4.2.1.3: Host cell shut off activity within the context of viral infection 
To assess whether the differences observed within plasmid-based shut off 
activity experiments transpired into differences within viral infection, first the 
PR8 7:1 H9N2 reassortant viruses were used in metabolic labelling experiments 
of infected cells. Labelling of newly synthesised cellular proteins with 35-S 
methionine has been shown on multiple occasions to be a reliable method for 
observation of viral host cell protein synthesis shut off (Read et al., 1993; Frolov 
and Schlesinger, 1994; Salvatore et al., 2002; Rowe et al., 2007; Jagger et al., 
2012).  Duplicate sets of CEF cells were infected at an MOI of 3 with a subset of 
the 7:1 viruses, selected due to the mutations effect on host cell shut off within 





















Figure 4.3: Immunofluorescent detection of NP during infection of CEF cells.  CEF cells 
were infected (in parallel with 35-S methionine pulsed cells) at an MOI of 3 and 7 hours post-
infection cells were fixed with 4% formaldehyde. Cells were permeabilised with 0.2% 
Triton-X 100 and probed for presence of viral NP. They were imaged on via an epi-




methionine for 1 hour or fixed with formaldehyde. The latter step was to assess 
viral infection levels via immunostaining for NP protein, as variations in the levels 
of infection could lead to misleadingly high levels of measured cellular protein 
synthesis. Mock infected cells did not show the presence of NP and all virus 
infected samples showed similarly high infection levels (Figure 4.3). 
The 35-S methionine pulsed cells were lysed after 1 hour with protein lysis 
buffer and proteins separated on SDS-PAGE gels, fixed and then labelled 
polypeptides were detected by autoradiography (Figure 4.4A).  Mock infected cell 
lysates allowed for constituent host cell protein synthesis levels to be assessed, 
showing the expected variety of polypeptide species. No viral proteins (HA0, NP 
and M/NS1) were observed in the mock sample but all were detected in the 
virally infected cell lysates. Actin levels were used as a measure of host protein 
synthesis; this was the most prominent band within the uninfected sample, 
sitting at approximately 42kDa.  PR8 WT virus has been previously shown not to 
induce high levels of host cell shut off, because of low PA-X activity (Jagger, 2012) 
so was included as a point of reference. As expected, the levels of newly 
synthesised actin were clearly reduced in PR8 WT infected cells compared to 
mock, however host protein synthesis was not fully ablated. Conversely, PR8 7:1 
UDL-01 WT infected cells had a further decreased actin level compared to mock 
infected cells suggesting that this virus was better able to shut down host cell 
protein synthesis levels. When an E26K change was made within UDL-01 PA, 
newly synthesised actin levels were increased compared to PR8 7:1 UDL-01 WT 
infected cells but not following the I118T and L221R changes. PR8 7:1 WF10 WT 
infected cells showed even less shut off of actin synthesis compared to WT PR8, 
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and the addition of a K26E change to lead to a visible reduction in actin synthesis 
compared to PR8 7:1 WF10 WT infected cells. T118I and R221L mutations 
appeared to have less of an effect on shut off activity, with actin levels comparable 
to PR8 WT or PR8 7:1 WF10 WT infected cells.  
Densitometry of the actin band from the autoradiograms of three 
independent experiments was performed as a quantitative measure of cellular 
protein synthesis levels (Figure 4.4B).  By this criterion, host protein synthesis 
was not fully ablated in PR8 WT infected cells but reduced by around 50%. The 
PR8 7:1 UDL-01 WT virus reduced radiolabelled actin levels to below 10% of 
uninfected cells whereas PR8 7:1 WF10 WT virus only reduced it by a similar 
level to PR8 WT virus (50% compared to mock). This was consistent with the 
plasmid-based assays of PA-X mediated shut off (Figure 4.1) where the same 
trend was observed. In both PR8 7:1 UDL-01 and WF10 viruses, when either the 
118 or 221 mutations were introduced, no affect was seen on actin levels in 
comparison to the relevant PR8 7:1 WT virus (Figure 4.4B). This was in contrast 
to the plasmid-based data (Figure 4.1), indicating that other viral factors perhaps 
affected host cell shut off to alter this phenotype. The PR8 7:1 UDL-01 E26K virus 
showed a significant reduction in host shut off activity compared to the parent 
WT virus (Figure 4.4B).  Radiolabelled actin levels increased, from ~10% to 
>50% of uninfected cell levels, similar to that seen with the PR8 7:1 WF10 WT 
reassortant. The reciprocal affect was observed with the introduction of the K26E 
mutation into WF10 PA, where actin synthesis was significantly reduced from 
~50% of the mock value to 30%. Therefore, the change at position 26 was the 

























Figure 4.4 Protein synthesis levels within CEF cells infected with PR8 7:1 H9N2 PA 
viruses. CEF cells were infected with a high MOI (3) of virus. 7 hours post infection cells 
were pulsed with 
35-
S methionine for 1 hour then lysed and proteins separated by SDS-PAGE. 
Radiolabelled proteins were detected by autoradiography. (A) Representative SDS-PAGE gel 
with specific proteins and the positions of molecular mass (kDa) markers indicated. (B) 
Levels of radiolabelled actin were quantified by densitometry using ImageJ analysis 
software. Graph represents the average of 3 independent experiments +/- SD P values = *: 




reporter assay further cementing the importance of position 26 in determining 
the shut off activity of H9N2 AIVs. 
The effect of these amino acid changes on host cell shut off within full 
H9N2 AIVs was then tested. Since by then, work had shifted to the Pirbright 
Institute, a different approach was adopted, using puromycin as label rather than 
35-S methionine. This method has been developed as an alternative method for 
measuring cellular protein synthesis without using radioactive materials. 
Puromycin is a structural analogue of aminoacyl tRNAs and therefore can be 
incorporated into the newly synthesised polypeptide chain and prevents 
elongation of the peptide, therefore reflecting the rate of mRNA translation in 
vitro. Puromycin labelled peptides can then be visualised via western blotting 
(Schmidt et al., 2009).  It has been used by multiple groups to study the impact of 
viral infection on host protein synthesis (White et al., 2011; Liao et al., 2016; 
Kainulainen et al., 2016) and was identified as a valid alternative technique to 
radiolabelling by Goodman and Hornberger (2013).  
MDCK cells were infected with either WT or 26 viruses, as this mutant 
showed reciprocal effects on host cell shut off activity within both the plasmid-
based and 7:1 reassortant virus assays, at a high MOI (5) and 7 h.p.i., cells were 
pulsed with puromycin for 30 minutes to allow incorporation into newly 
synthesised proteins. Cells were lysed and run on a 15% SDS-PAGE gel before 
western blotting for puromycin (Figure 4.5A).  Puromycin signal was detected in 
all conditions except for a control sample where no puromycin was included 
























Figure 4.5: Protein synthesis levels within MDCK cells infected with H9N2 AIVs. MDCK 
cells were infected with a high MOI (10) of each virus.  7 hours post infection cells were 
pulsed with puromycin for 30 minutes. Cells were lysed, run on SDS-PAGE gels and western 
blotted for puromycin. (A) Representative western blot gel probed for puromycin. (B) The 
bracket in (A) covering the areas above 45.7kDa indicates the region quantified using ImageJ 
analysis software to measure the area under the curve following densitometry of this region. 
Data were converted to a percentage of the value seen in mock infected cells.  Graph 
represents average +/- SD of 3 independent experiments. P values = *: 0.0124, **: 
0.007(unpaired T-test).  
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within mock infected cell lysate. Two major polypeptide species were induced by 
viral infection, migrating at approximately the same positions as the 46 and 33 
kDa molecular mass markers. The area of the gel above these bands (highlighted 
by the bracket on the figure), was quantified by densitometry to assess host 
protein synthesis levels within the cell, on the grounds that it was free of 
obviously viral-derived products. UDL-01 WT virus lead to a noticeable reduction 
in labelled protein levels compared to mock infected cells, which was then 
reversed with the introduction of the E26K mutation. The reciprocal affect was 
observed with the WF10 viral pair; labelling in cells infected with WT virus 
appeared more similar to uninfected cells while the K26E mutant reduced 
puromycin incorporation.  Densitometry was measured using ImageJ to quantify 
protein synthesis within cells from 3 independent experiments and confirmed 
that this pattern was reproducible (Figure 4.5B). There was a significant increase 
in cellular protein synthesis in UDL-01 E26K infected cells compared to UDL-01 
WT infected cells; 70% of mock compared to 50%. Conversely, there was a 
significant decrease in puromycin incorporation in WF10 K26E infected cells 
compared to WF10 WT infected cells. This confirmed within a full avian H9N2 
virus background that codon 26 of segment 3 was important for the host shut off 
differences between UDL-01 and WF10 strains.  
4.2.2: Production of H9N2 constructs which lack PA-X expression 
As host cell protein synthesis shut off (a known function of the accessory 
protein PA-X (Jagger et al., 2012)) seemed to be important for the differences in 
pathogenicity between UDL-01 and WF10 H9N2 AIVs, it was decided to further 
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investigate the role of PA-X within H9N2 AIVs. In order to do this, the technique 
used by Jagger et al. (2012) was adopted to remove PA-X expression from 
segment 3 by introducing a series of synonymous (in the PA ORF) mutations 
within the frameshift site (Figure 4.6A). Mutation of the highly conserved UCC 
UUU CGU motif to AGC UUC AGA would be predicted to drastically reduce PA-X 
expression by removing the translational pause and frameshift-permissive 
sequences that prompt a low percentage of ribosomes into accessing the +1 ORF 
(Jagger et al., 2012, Firth et al., 2012).  In addition, several premature stop codons 
(also synonymous in the PA ORF) were introduced into the X-ORF to determine 
the effect of truncating PA-X on shut off activity. These are termed PTC mutations 
(see Figure 4.6A and Table 4.1 for details). 
The mutations were introduced into the reverse genetics constructs for 
UDL-01 and WF10 segment 3 and confirmed via Sanger sequencing (data not 
shown). In vitro translations (IVTs) were then completed for each of the plasmids 
to test if they produced the correct protein products. IVTs have been shown to be 
useful for looking at production of smaller protein products as seen with PB1-
N40 and PA-X itself (Wise et al., 2009; Jagger et al., 2012). Coupled in vitro 
transcription-translation reactions radiolabelled with 35S-methionine were 
carried out using the TnT rabbit reticulocyte lysate system and protein products 
analysed using SDS-PAGE and autoradiography (Figure 4.6B). The empty vector 
control did not show expression of any protein products via this method, as 
expected. Within the UDL-01and WF10 panel of mutants PA expression was 
similar across all constructs, as seen with the clear band at ~75 kDa, which was 








































































































 UDL-01 WF10 
PA 
PA-X 
Figure 4.6: PA-X mutations made within H9N2 segment 3s. A panel of mutations were 
made within UDL-01 and WF10 segment 3s via site directed mutagenesis that altered PA-X 
expression. (A) Location of mutations within frameshift site and X-ORF. Light blue rectangle 
represents PA, darker blue rectangle represents X-ORF. Dark grey line represents location 
of the frameshift site (FS), light grey lines represents location of PTC mutations. (B) Coupled 
in vitro transcription-translation reactions radiolabelled with 
35
S-methionine were carried 
out using the TnT rabbit reticulocyte lysate system and protein products analysed using 
SDS-PAGE and autoradiography. PA and PA-X expression are marked via black arrows. (C) 
quantification of the AUC of the densitometry analysis of the PA band using ImageJ analysis 
software. (D) quantification of the AUC of the densitometry analysis of the PA-X band 



















Original NT Mutated 
NT 
NT position(s) Amino 
acid 
change 






PTC1 C A 621 I207 stop 
PTC2 C, C, G  A, G, A 634,636,642 R212 stop, 
L214 stop 
PTC3 T A 678 L226 stop 
PTC4 G A 699 V233 stop 
Site directed mutagenesis was used to mutate sites within the UDL-01 and WF10 segment 3 
to alter PA-X expression. Mutations to the frameshift site (FS) were predicted to reduce PA-
X expression and while premature termination codons (PTC) within the X-ORF would 
terminally truncate PA-X to various degrees.  
Table 4.1: Summary of PA-X mutations 
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(Figure 4.6C). PA levels did not vary considerably, with the highest variation 
observed with WF10 WT producing lower PA levels than the other plasmids. As 
this experiment was only conducted once it is not possible to determine if this is 
the result of this experiment or a more general trend. Several other unidentified 
protein products were also produced from the segment 3s using this method. The 
accessory protein PA-X was visualised within the UDL-01 WT lane by a faint band 
at just above 25kDa in size. Expression of this protein was drastically reduced 
with mutations to the frameshift site which was confirmed via quantification of 
the densitometry of the PA-X band (Figure 4.6D). When PA-X was C-terminally 
truncated, a ladder effect was observed where truncation to the X-ORF altered 
the protein size. Quantification of expression levels showed that although 
expressed to a higher level than with the introduction of the FS mutation, both 
the PTC 1 and PTC 2 mutation reduced expression of PA-X in UDL-01 and WF10 
compared to the WT plasmid. Both the PTC 3 and PTC 4 mutations expressed 
similar levels of PA-X to the WT plasmids. However, again as this is only one 
repeat of the experiment no firm conclusions can be draw over the stability of the 
protein with these mutations introduced. Overall, PA expression was not altered 
with introduction of the PA-X mutations, whereas PA-X expression was, with 
protein sizes seen as expected.  
4.2.2.1: Effect of PA-X expression on host cell protein synthesis shut off  
As PA-X has previously been shown to contribute to IAV host cell shut off 
function (Jagger et al., 2012), the effect of the presence of  PA-X mutations on the 
ability of transfected H9N2 segment 3s to repress cellular gene expression was 
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tested using β-gal reported assays. 293Ts were transfected with the β-gal plasmid 
along with various segment 3 plasmids or an empty vector control and β-gal 
accumulation measured by enzyme assays 48 hours later.  Shut off activity is 
displayed as a reduction in absorbance compared to the empty vector control 
(Figure 4.7A). As seen previously, the WT segment 3s displayed significantly 
different shut off activity; UDL-01 segment 3 proficiently repressed host β-gal 
accumulation while WF10 segment 3 had no ability to shut off host protein 
synthesis. When PA-X expression was reduced from UDL-01 segment 3 by the FS 
mutation, shut off activity was removed, with levels of β-gal produced returning 
to levels similar to the empty vector control. However, when the PA-X slip site 
was removed from WF10, no alteration in shut off activity was observed, this was 
expected as the WT WF10 segment 3 showed no activity in the first place. This 
same trend was also seen when the assay was performed in DF-1 cells (Figure 
4.7B). Truncating PA-X had little effect on shut off activity, either positively in the 
WF10 background, or negatively in the UDL-01 gene. Within the UDL-01 
background there was a gradual re-introduction of shut off activity the less the X-
ORF was truncated, although the shut off differences were not significantly 
different to UDL-01 WT.  
4.2.2.2: Effect of PA-X on transcriptional activity of the viral polymerase 
complex 
Influenza PA-X has previously been suggested to affect polymerase 
activity; for example Hu et al. (2015), showed that removal of PA-X expression 


























Figure 4.7: Effect of PA-X mutations on host cell shut off ability of H9N2 segment 3s. 
(A) 293T cells or (B) DF-1 cells were transfected with a β-gal reporter plasmid alongside the 
indicated segment 3 expression plasmids with or without PA-X mutations. 48 hours post-
transfection cells were lysed and levels of β-gal enzymatic activity assessed by colorimetric 
assay. Results were normalised to an empty vector control. Graphs represent the average +/- 
SD of 3 independent experiments. P value: ***= 0.0002, *= <-0.05 (Kruskal Wallis with 
multiple comparisons (293T UDL-01 panel), one-way ANOVA within multiple comparisons 




shown mutation of PA-X lowers activity of the pH1N1 polymerase complex (Lee 
et al., 2017). Therefore, these apparent effects of PA-X on polymerase activity 
appear to be strain dependant, consequently it was decided to investigate the 
effect of PA-X expression on polymerase activity within our H9N2 backgrounds. 
To test if altering PA-X expression had any effect on the transcriptional 
activity of the IAV polymerase complex, “minireplicon” or “RNP reconstitution” 
assay systems were adopted. These assays indirectly measure mRNA production 
by the viral polymerase from a vRNA mimic (Huang et al., 1990; Foeglein et al., 
2011). Plasmids encoding the RNA polymerase complex (PB2, PB1, PA), as well 
as NP (abbreviated as 3PNP) were co-transfected into cells to produce mRNA and 
thus protein for each viral polypeptide. Along with the protein components, a 
vRNA mimic reporter construct was co-transfected. This reporter plasmid 
expresses a firefly luciferase gene in negative sense flanked by segment 8 UTRs, 
under the control of either a human or avian RNA polymerase I promotor. This 
allows for RNA to be produced by cellular RNA polymerase I which resembles 
vRNA to the viral polymerase complex and thus triggers RNP formation. This will 
in turn be transcribed by the IAV polymerase complex into mRNA which is then 
translated into luciferase (Lutz et al., 2005). Luciferase output is assumed to be 
generally proportional to the transcriptional activity of the viral polymerase 
complex. Some laboratories also include a renilla luciferase transfection control 
that the firefly luciferase values are normalised to (Hu et al., 2015; Long et al., 
2016; McAuley et al., 2010). However, due to the potential for the mutations 
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examined here to have variable secondary effects on host cell gene expression 
because of their position within the accessory gene PA-X, this control was not 
employed.   
First, the transcriptional activities of a consistent set of viral RNPs with 
PB2, PB1 and NP derived from PR8 but with swapped PA polypeptides derived 
from either UDL-01 or WF10 H9N2 strains were assessed. The PR8 2PNP system 
was used within mammalian cells due to the presence of PB2 627E within UDL-
01 and WF10. The presence of this amino acid in PB2 often severely restricts the 
polymerase complex in mammalian cells (Long et al., 2013). 293T cells were co-
transfected with expression plasmids for RNP polypeptides as well as a vRNA 
mimic encoding luciferase. 48 hours later cells were lysed and luciferase activity 
quantified. A negative control lacking PA was included (2PNP), since the viral 
transcriptase cannot form in the absence of PA and therefore any luciferase 
observed would not be the result of viral transcription. In the absence of all four 
RNP polypeptides, only background levels of luciferase were seen, whilst the full 
PR8 RNP produced around 1000-times more luciferase activity (Figure 4.8A). 
When either of the two WT H9N2 segment 3s were added to the PR8 2PNP system 
similar 1000-fold increases in luciferase levels were observed compared to the 
2PNP control, indicating that both WF10 and UDL-01 PAs were compatible with 
the other PR8 RNP components. There was a significant reduction in 
transcriptional activity after transfection of WF10 WT segment 3 compared to 
UDL-01 segment 3. This was not observed previously in chapter 2 (Figure 2.3). 
However, changing PA-X expression in either PA background had very little 
impact on viral gene expression, with only minor fluctuations in activity being 
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seen. Overall, no significant differences were seen in the transcriptional activity 
of the polymerase complex following mutation of PA-X. This suggests that in this 
system, PA-X does not affect the transcriptional activity of the polymerase.  
The effect of changing PA-X expression on the transcriptional activity of a 
fully avian RNP was then assessed.  DF-1 (chicken fibroblast) cells were 
transfected with expression plasmids for either UDL-01 or WF10 RNP 
polypeptides plus a vRNA mimic encoding luciferase under the control of an avian 
RNA polymerase I promotor. As above, cells were lysed and luciferase levels 
measured after 48 hours. Untransfected cells gave only background levels of 
luciferase (cells only control; Figure 4.8B) while minimal luciferase expression 
was observed when only PB1, PB2 and NP were transfected (2PNP control) 
indicating the lack of an active polymerase complex. When all four RNP 
polypeptides were included within either the UDL-01 or WF10 backgrounds an 
approximately 100-fold increase in luciferase expression was observed 
compared to the 2PNP control. As with the mammalian system, no significant 
differences were seen between the transcriptional activities of the polymerase 
complexes with different expression of PA-X when compared to the activity of the 
relevant WT. Therefore, PA-X did not affect transcriptional activity of the 
polymerase complex within either an avian or a mammalian adapted setting.  
Expression of PA, as well as tubulin as a loading control, were analysed via 
western blot (Figure 4.8C). Tubulin levels were reasonably consistent across all 
groups, with variances seen in some samples. Similarly, all of the PA constructs 






























































































Figure 4.8: Transcriptional ability of polymerase complexes with H9N2 segment 3s with 
differing PA-X expression. (A) 293T cells or (B) DF-1 cells were transfected with the 
components of the polymerase complex (PB1, PB2, PA and NP) or as a negative control with 
PB1, PB2 and NP (2PNP) plus a vRNA mimic encoding luciferase. 48 hours post transfection 
cells were lysed and luciferase levels measured.  Data are the average of 3 independent 
experiments +/- SD. No significant differences were seen within UDL-01 or WF10 groups 
(Kruskal Wallis with multiple comparisons). WT vs WT 293T cells P value - ***=0.0002 (Mann- 
Whitney Test) (C) PA and tubulin expression levels were determined via western blot analysis 




accumulation observed particularly within WF10 PTC1. No PA expression was 
observed in the 2PNP or cells only controls. Thus overall, alteration of PA-X 
expression did not have any major effect on the stability of PA or the ability of 
polypeptides to support viral gene expression when assayed in mammalian cells 
in the background of a PR8 RNP. 
4.2.2.3: Production of H9N2 AIVs with differential PA-X expression 
To investigate the effect of PA-X expression within a viral context for 
example, on replication or host cell shut off, segment 3s with different PA-X 
expression levels were introduced into full WF10 and UDL-01 H9N2 AIVs using 
reverse genetics. Viruses were rescued using 293T cell and MDCK cell co-culture 
and then propagated into viral stocks within 10-day old fertilised hens’ eggs. 
After 48 hours allantoic fluid was harvested and titrated via plaque assay. The 
presence of the desired mutations was confirmed via sequencing using segment 
3- specific primers, M segment was also sequenced to confirm the correct virus 
backbone was present (data not shown). When the plaque morphology was 
examined as a first test of virus fitness, the UDL-01 panel of viruses displayed 
clear plaques within MDCK cells, with no obvious visual differences amongst the 
mutants. Within the WF10 panel of viruses, small, hazy plaques were observed 
within MDCK cells. However, the introduction of the PTC1 mutation produced a 
more distinct plaque within MDCK cells compared to the other WF10 viruses 
(Figure 4.9A). When the diameters of 20 plaques per virus were measured using 
ImageJ, a small but significant reduction in plaque diameter was observed within 






















Figure 4.9: Plaque phenotypes of H9N2 AIVs with altered PA-X expression. Viruses were 
rescued using reverse genetics and titrated under a 0.6% agarose overlay in order to 
ascertain the plaque phenotype. (A) After 72 hours cells were fixed and stained with 0.1% 
crystal violet solution and plates imaged. (B) ImageJ analysis software was used to measure 
the diameter of 20 plaques per virus. Graph represents average diameter of 20 plaques +/- 









Average plaque diameters decreased from 1.7mm to 1.2mm, 1.25mm, and 
1.36mm respectively. There was no significant difference in plaque size with the 
removal of full length PA-X from WF10 PA. However, when PA-X was truncated 
maximally (PTC1), the average plaque diameter increased significantly from 
0.44mm to 0.60mm. Truncation of PA-X with the PTC4 mutation also significantly 
reduced the viral plaque diameter compared to WF10 WT from 0.44mm to 
0.27mm. 
4.2.2.4: Replication kinetics of viruses containing differential expression of 
PA-X 
Previous work has shown that, although non-essential, PA-X can affect 
viral replication. Lee et al. (2017) showed that removal of PA-X from a pH1N1 
strain reduced viral replication in MDCK cells. Conversely, Hu et al. (2015) found 
that removal of PA-X from H5N1 virus increased replication. Closer to this study, 
Gao et al. (2105c) showed that within an H9N2 background, removal of PA-X had 
no effect on viral replication. Therefore, the effect of removal or truncation of PA-
X on virus replication appears to be strain dependant so was assessed within our 
H9N2 strains.  Following on from assessing the impact of differing plaque 
phenotypes multi-cycle virus growth was measured. First, the full panel of 
viruses were screened by completing end-point titre experiments. MDCK cells 
were infected with each virus at a low MOI (0.01). After 48 hours supernatants 
were harvested and titrated via plaque assay. Experiments were repeated across 
3 independent replicates and in all cases, a mock infected group was included 
where cells were infected with serum free media rather than virus. Virus outputs 
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from these latter controls were negative within the limit of detection via plaque 
assay (2.5 pfu/ml; data not shown). Viral output within the UDL-01 virus panel, 
showed a trend towards decreased viral output with the FS, PTC1, PTC2 and PTC3 
viruses with only the PTC2 mutant reaching significance (Figure 4.10). Within the 
WF10 panel, significant reductions in viral titre were only seen with the 
introduction of the PTC3 mutation, although addition of PTC2 and PTC4 showed 
trended decreases in viral output. 
Next, the replication kinetics of viruses with or without the presence of 
PA-X were assessed over a time course of infection to test for any differential 
effects on replication at earlier time points post-infection that could have been 
missed by only looking at end-point titres. The FS mutations were focussed on as 
removal of PA-X had the strongest effect on viral plaque phenotypes in UDL-01 
and also lead to a change in the host cell shut off ability of the virus. MDCK cells 
were infected with a low MOI (0.01) of H9N2 WT and FS viruses, supernatant 
samples were taken at 4, 8, 12, 24, 48 and 72 h.p.i and viral output titrated by 
plaque assay.  As before, the experiments were performed three times 
independently, including a mock infected group in each replicate. On each 
occasion the mock infected output was below the limit of detection for the plaque 
assay (data not shown). All four viruses showed the expected exponential rise in 
titre after 8 h.p.i. reaching a plateau around 48 h.p.i (Figure 4.11A).  WF10 WT 
and FS viruses did not exhibit any significant differences in viral replication over 
the time course of infection. However, UDL-01 WT virus displayed significantly 
higher titres at 72 h.p.i in comparison to UDL-01 FS virus at these time points. 












Figure 4.10: Low MOI infections of MDCK cells with H9N2 AIVs with altered expression 
of PA-X. MDCK cells were infected with a low MOI (0.01) of H9N2 AIVs with the indicated 
PA-X mutations. 48 hours post-infection cell supernatants were harvested and clarified 
before being titrated via plaque assay under 0.6% agarose. Graph represents the average of 




UDL-01 FS compared to UDL-01 WT, thus within a UDL-01 background, PA-X 
expression does enhance viral replication, at least within MDCK cells. 
To test if the effect of removal of PA-X on viral replication held true in 
avian cells, viral replication kinetics were then assessed within primary chicken 
kidney (CK) cells. As for MDCK cells, a low MOI was used (0.01), supernatants 
were harvested at 4, 8, 12, 24, 48 and 72 h.p.i and titrated via plaque assay on 
MDCK cells. Three independent repeats were performed, again all with mock 
infected cells which showed viral levels below the limit of detection (data not 
shown). The viral output from CK cells varied more between experiments in 
comparison to MDCK cells, likely due to their primary nature. Nevertheless, there 
were consistent differences between the replication kinetics of the viruses, with 
both WF10 WT and FS viruses exhibiting a reduced replication compared to the 
UDL-01 pair (Figure 4.11B). However, in contrast to the results seen within 
MDCK cells there was no significant difference in viral replication of the UDL-01 
pair at any time point within CK cells, indicating cell-specific effects. Therefore, 
as a further test, replication kinetics were assessed in ovo; 10-day old fertilised 
hens’ eggs (VALO breed) were inoculated with 100 pfu of each virus. Eggs were 
chilled and allantoic fluid was harvested at 4, 8, 12, 24 and 48 h.p.i. Allantoic fluid 
samples were titrated via plaque assay to determine viral load at each point. No 
virus was detected prior to 8 h.p.i for all viruses or 12 h.p.i. for the WF10 pair. In 
ovo, UDL-01 WT and FS viruses nor WF10 WT and FS viruses exhibited any 
significant differences in viral replication throughout the course of infection 
(Figure 4.11C). Overall, the impact of PA-X on the replication of H9N2 AIVs was 

























Figure 4.11: Effect of PA-X expression on replication kinetics of H9N2 AIVs with (WT) 
or without (FS) expression of PA-X. (A) MDCK cells or (B) CK cells were infected with a 
low MOI (0.01) of a H9N2 virus which expressed (WT) or did not express (FS) the accessory 
protein PA-X. Cell supernatants were harvested at 4, 8, 12, 24, 36, 48 and 72 h.p.i. and titrated 
via plaque assay in MDCK cells under 0.6% agarose. Graphs represent an average of 3 
independent experiments +/- SD.  (C) 10-day old fertilised hens’ eggs were infected with 100 
pfu of each virus. Allantoic fluid was collected at 4, 8, 12, 24 and 48 h.p.i. clarified and titrated 
via plaque assay. No virus was detected before 12 h.p.i in WF10 WT infected eggs. Graph 
represents an average of 5 eggs per virus per time point +/- SD. P values =*:0.0355, 
(unpaired T-test ( A- UDL-01 36 and 72 h.p.i. WF10 24, 36, 48 and 72 h.p.i. B- UDL-01 4, 8, 
12, 24 and 48 h.p.i. WF10 8, 12, 48 and 72 h.p.i., C- UDL-01 8, 12 and 24 h.p.i.) or Mann 
Whitney test ( A- UDL-01 4, 8, 12, 24 and 48 h.p.i. WF10 4, 8 and 12 h.p.i., B- UDL-01 72 h.p.i. 
WF10 4 and 24 h.p.i, C- UDL-01 48 h.p.i. WF10 all data points)).  
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4.2.2.5: Effect of PA-X on host cell protein synthesis during viral infection   
Previously, the host cell shut off activity of constructs with altered PA-X 
expression was assessed using plasmid-based assays (Figure 4.7). To determine 
if the effect of different PA-X expression held true within a viral context 
puromycin labelling of newly synthesised cellular proteins was adopted. This 
would allow the ability of H9N2 AIVs, with (WT) or without (FS) PA-X expression, 
to control host protein synthesis to be determined. MDCK cells were infected with 
virus at a high MOI (5), 7 h.p.i. cells were pulsed with puromycin for 30 minutes, 
which incorporated into protein synthesis at this point, before being lysed, 
separated on a 15% SDS-PAGE gel and western blotted for puromycin (Figure 
4.12A). Puromycin signal was detected in all conditions except when no 
puromycin was included within the pulse. Constitutive levels of cellular protein 
synthesis were seen within mock infected cell lysate. Two proteins products were 
induced by viral infection: bands seen at approximately 46 and 33 kDa. The area 
of the blot above these bands was therefore used to assess host protein synthesis 
levels within the cell.  UDL-01 WT virus reduced cellular protein synthesis 
compared to uninfected cells. This was then partially restored with the removal 
signal did not obviously affect host protein synthesis. To quantify protein 
synthesis levels, densitometry of top section of the gel (marked in brackets on the 
figure) was performed on 3 independent experiments (Figure 4.12B). UDL-01 
WT infected cells displayed less than half the normal amount of puromycin 
incorporation than mock infected cells but this was significantly increased 

























Figure 4.12: Host cell protein synthesis in MDCK cells infected with H9N2 AIVs with or 
without PA-X expression. MDCK cells were infected with a high MOI (5) using viruses 
expressing PA-X (WT) or with PA-X expression removed (FS). Seven hours post infection 
cells were pulsed with puromycin for 30 minutes and then lysed and samples run on SDS-
PAGE gels. Membranes were probed for presence of puromycin. (A) Representative SDS-
PAGE gel with the area quantified highlighted in brackets. The approximate position of 
molecular mass markers (kDa) is also indicated. (B) Quantification of the densitometry of 
the highlighted area (above 47 kDa) performed using ImageJ analysis software. Graph 
represents the average of 3 independent experiments +/- SD. Each data group is normalised 
to mock levels of protein synthesis. P value: **=0.0015 (unpaired T-test). 
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PA-X. However, no significant differences in the ability of WF10 WT and FS 
viruses to alter host protein synthesis were observed; neither virus showed any 
significant shut off activity above mock infected cells. These data are in 
agreement with the plasmid-based methods previously used, and showed that 
UDL-01 expresses a classically active PA-X protein; whereas, WF10 PA-X appears 
to possess no host protein shut off activity.  
4.2.3: Investigation into the effect of introduction of both an amino acid 
change at position 26 and removal of PA-X 
To elucidate if the change at amino acid 26 exerts its function on alteration 
of host cell shut off as part of PA-X or in an independent manner, constructs were 
produced which had both the relevant mutation at amino acid 26 (E26K: UDL-01; 
K26E: WF10) alongside the mutation which removes PA-X expression (FS).  This 
also enables the investigation into the effect of the 26 mutation in the absence of 
PA-X.  
4.2.3.1: Replication kinetics of H9N2 AIVs containing both PA position 26 
and FS mutations  
To test for the interplay between the FS and E26K mutations on virus 
replication, the double mutants were then built into full WF10 or UDL-01 H9N2 
AIVs using reverse genetics. Viruses were rescued using 293T cell and MDCK cell 
co-culture and then propagated in eggs as before. The presence of the desired 
mutations was confirmed via sequencing using segment 3 specific primers and 
the M segment was also sequenced to confirm the correct virus backbone was 


























Figure 4.13 Plaque phenotypes of H9N2 AIVs with double mutations at PA codon 26 
and the PA-X frameshift site. Reverse genetics was used to rescue viruses which contained 
both a mutation at amino acid 26 and did not express PA-X. Viral plaque phenotypes were 
assessed in MDCK cells under 0.6% agarose. 48 hours post infection cells were fixed and 
stained with 0.1% crystal violet solution and (A) plaques imaged. (B) ImageJ analysis 
software was used to measure the diameters of 20 plaques per virus. Graph represents 





of virus replicative fitness. When both 26 and FS mutations were introduced into 
the H9N2 viruses, the plaque phenotype altered similarly to that previously seen 
with viruses only containing the 26 mutation (section 2.2.4). The E26K + FS UDL-
01 virus had a reduced plaque size compared to WT but still produced clear 
plaques within MDCK cells (Figure 4.13A). Conversely, WF10 K26E +FS virus had 
a greatly increased plaque size, generating clear plaques compared to small hazy 
plaques produced by WF10 WT. Plaque diameters were quantified and the 
average diameter of UDL-01 virus plaques decreased from 1.7mm to 0.6mm with 
the introduction of the double mutation. The average plaque diameter of K26E + 
FS WF10 increased from 0.44mm to 1.6mm compared to WF10 WT, all changes 
were statistically significant when compared to the WT parental virus (Figure 
4.13B).   
Next, as a further test of virus replicative fitness, the replication kinetics 
of viruses containing the double mutation were assessed over a time course of 
infection. MDCK cells were infected with a low MOI (0.01) of H9N2 WT and 
double mutant 26 + FS viruses, supernatant samples were taken at varying times 
post infection and viral output titrated via plaque assay.  As before, the 
experiments were performed three times independently, including a mock 
infected group in each replicate which gave an output below the limit of detection 
(data not shown). The UDL-01 E26K + FS virus did not have a significantly 
different replication to UDL-01 WT virus, although by 48 h.p.i viral output was 
reduced in a trended but not significant way (Figure 4.14). Conversely, WF10 
K26E + FS virus showed higher titres at all time points with significantly higher 






















Figure 4.14: Replication kinetics of H9N2 double mutants. MDCK cells were infected 
with a low MOI (0.01), cell supernatants were harvested at various time points post- 
infection and viral titres determined via plaque assay. Graph represents the average of 3 
independent experiments +/- SD. P values =, ***= 0.006 (unpaired T-test – UDL-01 4 and 24 
h.p.i. WF10 8, 12, 24, 48 h.p.i. or Mann Whitney – UDL-01 8, 12 and 48 h.p.i. WF10 4 h.p.i.).  
*** = between WF10 WT and WF10 K26E +FS 
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mutations increased replication of WF10 and decreased replication of UDL-01 
within MDCK cells. This was a similar pattern to that seen when only the 26 
mutation was introduced (Chapter 2; Figure 2.6), so this residue is therefore an 
important mediator of viral fitness. 
4.2.3.2: Host cell shut off ability of H9N2 PA-Xs with amino acid change at 
position 26 and removal of PA-X (FS) 
The effect of the double mutation on the ability of PA-X to control host cell 
protein synthesis was tested, as previously codon 26 was seen to affect this 
function of PA-X. 293T cells or DF-1 cells were co-transfected with the constructs, 
possessing both an FS mutation to remove PA-X expression and a mutated codon 
26, plus a β-gal reporter plasmid as described previously. 48 hours post 
transfection cells were lysed and β-gal accumulation quantified by enzyme assay. 
Data were normalised to an empty vector control where no host cell shut off 
would be expected. Background levels of absorbance were assessed using a cell 
only control. Within both 293T cells (Figure 4.15A) and DF-1 cells (Figure 4.15B), 
the same pattern of host cell shut off as seen previously for the WT and position 
26 mutant genes was observed. UDL-01 WT and WF10 K26E plasmids effectively 
induced protein synthesis shut down compared to the empty vector control 
whereas WF10 WT did not have the ability to control host protein synthesis. 
Unusually, the UDL-01 E26K construct did show some repressive activity 
compared to the empty vector control which was not seen with previous 
experiments, although the reduced shut off was still significantly different from 





















































  UDL-01 WF10 C D 
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Figure 4.15: Host cell shut off ability of segment 3s containing both an amino acid 
change at position 26 and removal of PA-X expression. H9N2 segment 3s with differing 
mutations were transfected into (A) 293T cells or (B) DF-1 cells alongwith a β-galactosidase 
(β-gal) reporter plasmid. 48 hours post transfection cells were lysed and then levels of β-gal 
assessed by colorimetric enzyme assay. Results were normalised to an empty vector control 
where no shut off host gene expression was expected. Graph represents the average of 3 
independent experiments +/- SD., P values:  ***= 0.0001; **= <0.0097 * = <0.045 (one-way 
ANOVA – 293T all and DF-1 WF10 panel or Kruskal Wallis – DF-1 UDL-01 panel with multiple 
comparisons). Host cell shut off within viral infection was then assessed, MDCK cells were 
infected with each virus at a high MOI (5). 7 hours post infection cells were pulsed with 
puromycin for 30 minutes. Cells were lysed in SDS-PAGE buffer and (C) western blotted for 
puromycin. (D) The section highlighted in the bracket was quantified by densitometry using 
ImageJ analysis software. The area under the curve for each section was calculated and then 
compared to the mock infected sample. The Graph displays average +/- SD of 3 independent 




segment 3 by the FS mutation, the ability of this plasmid to induce host cell shut 
off was also removed as previously observed. When both the E26K and FS 
mutation were introduced into UDL-01 PA-X, it was similarly unable to effectively 
control host cell protein synthesis. The same outcome resulted when both the 
K26E and FS mutation were introduced into WF10 PA-X. This construct was also 
unable to repress host cell gene expression acting like UDL-01 WT where shut off 
activity was removed after inhibition of PA-X expression. This indicated that the 
effect of the K26E mutation on shut off activity lies within PA- X rather than 
within PA.  
As the double mutant constructs appeared to affect host cell shut off 
activity within plasmid-based assays, the ability to control host protein synthesis 
of viruses containing both an amino acid change at position 26 (UDL-01: E26K, 
WF10: K26E) plus removal of PA-X via mutation of the frameshift site (FS), was 
investigated using the puromycin assays described previously. MDCK cells were 
infected with each virus at a high MOI (5), then 7 h.p.i cells were pulsed with 
puromycin for 30 minutes before being lysed and western blotted for 
puromycylated polypeptides. As expected, the blot showed multiple bands which 
in samples from mock infected cells indicated the constitutive levels of cellular 
protein synthesis. UDL-01 WT virus showed a reduced intensity of puromycin 
incorporation compared to the uninfected control, but when the double mutation 
was introduced (E26K and FS) the ability of the virus to control host protein 
synthesis was removed. Within WF10 viruses neither the WT nor double mutant 
(K26E + FS) was able to dampen host protein synthesis compared to mock levels 
(Figure 4.15C). The average amount of cellular protein synthesis compared to 
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mock infected cells was calculated for 3 independent experiments, via 
densitometry of the upper region of the blot, as before. UDL-01 WT reduced 
cellular protein synthesis by approximately 75% compared to mock, but when 
both E26K and FS mutations were introduced into the virus cellular protein 
synthesis was only reduced by about 25% compared to mock. No significant 
difference was seen between WF10 WT and WF10 K26E + FS viruses (Figure 
4.15D). This data supports that seen with the plasmid-based methods (Figure 
4.13A and B ), and suggests that with respect to shut off activity, the amino acid 
change at position 26 exerts its affect via its location in PA-X rather than PA. 
4.3: Discussion  
Within this chapter, the ability of H9N2 AIV segment 3s to induce shut off 
of host protein synthesis was investigated. In order to complete some 
experiments at the Roslin Institute the mutations previously identified in Chapter 
2 which also lied within PA-X were built into 7:1 PR8 reassortant viruses as the 
laboratories were not set up for AIV use. Interestingly, the introduction of UDL-
01 and WF10 PA’s into the PR8 backbone did not alter the plaque phenotypes 
seen as expected, with UDL-01 PA expected to confer a larger plaque size (Figure 
1.1). This suggested that the segment 3 is not the only responsible factor for the 
enhanced plaque phenotype, at least outside of the H9N2 background. Other viral 
segments that have previously been identified to alter influenza plaque size 
include segment 2 (Pappas et al., 2008), segment 7 (Yasuda et al., 1994), segment 
8 (Solorzano et al., 2005) so this could suggest interactions of the H9N2 PA with 
other polymerase components could alter viral fitness within the PR8 model, or 
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interactions with NS1 could affect the innate immune response produced by the 
PR8 reassortant viruses and in turn affect cell spread. The mechanisms behind 
the altered plaque phenotype within the PR8 7:1 viruses with H9 segment 3’s was 
not investigated further within this thesis although may make an interesting 
point to follow up.  These studies did however, replicate the increased plaque size 
of the WF10 K26E virus and partially replicated the decreased plaque size of the 
UDL-01 E26K virus, cementing this mutations importance in viral replication and 
fitness, as seen within the previous two chapters. The replication of the viruses 
with any of the mutations within the PR8 7:1 background was not significantly 
affected within MDCK cells (Figure 4.1C). This suggests that there was not an 
incompatibility of the polymerase as the viruses were able to replicate as well as 
the PR8 WT in terms of viral output.  
The main known function of PA-X, host cell shut off, was first investigated 
using the panel of mutations previously screened which lie in the shared domain 
of PA and PA-X. Initially, it was noted that a difference in host cell shut off ability 
was seen between progenitor (WF10) and reassortant (UDL-01) segment 3s, with 
WF10 WT segment 3 not being able to repress host protein synthesis and UDL-
01 displaying activity (Figure 4.2). Several of the mutations screened altered the 
host cell shut off activity significantly, either removing it within a UDL-01 
background or introducing it within a WF10 background. Within WF10 this 
included E26K and L221R and within UDL-01, included E26K and I118T (Figure 
4.1). The E26K mutation previously identified to alter viral replication and 
pathogenicity reciprocally altered host cell shut off, although at this point it could 
not be determined if the alteration of shut off activity is the reason the virus 
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replication is also affected. Two other non-reciprocal mutations were also shown 
to alter shut off activity, as it was previously seen that WF10 and UDL-01 WT PA-
X’s have differing shut off activities, it is not inconceivable that the mechanism by 
which they act are different and therefore the mutations which alter host cell shut 
off could differ. Previously, others have identified different residues which can 
alter PA-X shut off activity based on viral strain used. For example, several H1N1 
virus strains have been shown on separate occasions to have different 
combinations of amino acids which can alter the host cell shut off activity. In one 
study, residues 85, 86, 911, 100, 114 and 186 were shown to be responsible for 
shut off differences between two H1N1 strains (Desmet et al., 2013), whereas a 
separate study identified the region between amino acids 192 and 206 to be 
important for H1N1 shut off activity (Oishi et al., 2015). This shows that it is 
possible for different strains of the same viral subtype to have different amino 
acids which can alter PA-X shut off activity.  
However, when these mutations were built into PR8 7:1 reassortant 
viruses no difference in shut off activity compared to WT was observed with the 
221 and 118 mutations, although the importance of PA residue 26 was confirmed 
(Figure 4.4).  The lack of change in shut off activity observed in a virus context 
could be due to other compensatory mechanisms within the PR8 background, 
perhaps these mutations affect interactions with the NS-1 protein of PR8 and this 
either prevents or enhances its action depending on the strain. More likely is that 
the plasmid based assays were not accurate, particularly the UDL-01 I118T 
within 293Ts has large error bars suggesting large differences between 
replicates. It is therefore important to use both plasmid and virus based methods 
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to determine which mutations actually alter host cell shut off in any future 
studies. Potentially the ability of the virus to control host cell protein synthesis 
shut off activity due to the presence of an E at position 26 is at least partly 
responsible for the differing pathogenicity seen between UDL-01 and WF10 
viruses, although the cytokine responses seen in vivo (Figure 3.13), do not 
necessarily correlate with this. It would be expected that as the UDL-01 E26K 
virus does not exhibit host cell shut of in vitro, in vivo there would be an enhanced 
host response. However, the opposite of this actually occurs with UDL-01 E26K 
showing reduced immune responses. This could be an artefact of the reduced 
virus replication within the host, where less virus is produced so therefore less 
immune response occurs. Although nasal tissue M segment titres were largely 
similar between UDL-01 WT and UDl-01 E26K infected birds so this may be a true 
effect.  
As the E26K mutation lies in PA-X and alters shut off activity the 
differences between UDL-01 and WF10 PA-X’s were next examined. A panel of 
mutations were made using site directed mutagenesis to produce plasmids with 
altered PA-X expression; either amount or length, following the protocol 
described by Jagger et al. (2012).  Although the expression of PA-X could be 
visualised using the IVT technique provided it would have perhaps been better to 
use α-PA-X or α-PA-N (N-terminal) antibodies to target PA-X or for completion of 
immunoprecipitations from the IVT product. This would give an increased 
accuracy to the quantification of protein expression conducted.  
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When this panel was screened for shut off activity UDL-01 acted as 
expected; when PA-X expression was removed, by mutating the frameshift site, 
so was the ability to control host cell gene expression. This ability was also 
gradually reduced by increasing truncation of the X-ORF. However, within the 
already inactive WF10 background, no difference in shut off activity was seen 
with the introduction of any of the mutations (Figure 4.7). WF10 therefore does 
not possess an active PA-X protein. These shut off activity differences within each 
strain did not transpire into differences in transcriptional activity of 
reconstituted RNPs with differing PA-X expression (Figure 4.8). This is in contrast 
to data from Gao et al. (2015c) and Hu et al. (2015), who previously found that 
H5N1 and pH1N1 polymerase activities were increased in systems which lack PA-
X.  However, Lee et al. (2017) showed that PA-X knockout within a H1N1 system 
decreased polymerase activity. It is known that PA-Xs from different viral strains 
have differing impacts on pathogenicity (discussed further in chapter 5), so the 
differential effects on viral transcription are not unwarranted. However, 
minireplicon assays rely on RNA Pol II-mediated expression of the RNP 
polypeptides, which will potentially be confounded by PA-X activity, as could the 
virally-synthesised transcript encoding the reporter gene. Therefore data from 
such an approach needs to be treated with some caution. 
When investigating the effect of PA-X on H9N2 viral replication, it was 
observed that within full H9N2 AIVs, UDL-01 viruses showed a reduction in 
plaque diameter with all PA-X mutations other than PTC4 (Figure 4.9). This 
agrees with data from Khaperskyy et al. (2016), where a reduction in plaque size 
with PR8 without PA-X was also seen. Within the WF10 background, only PTC1 
218 
 
and PTC4 altered plaque size although this was not to any great extent and the 
complete removal of PA-X (WF10 FS) did not alter plaque size compared to WF10 
WT. Supporting data from Lee et al. (2017), who found no difference in plaque 
size with knockout of PA-X from H1N1 viruses. The plaque alteration between 
UDL-01 WT and FS viruses was not as drastic as when E26K is introduced. This 
is the first instance which suggests that the E26K mutation’s effect on virus 
replication and host cell shut off may occur by different mechanisms, particularly 
supported by the lack of alteration in plaque size between WF10 WT and FS 
viruses.  
The minor differences in plaque phenotype observed did not transpire in 
differences in viral output (Figure 4.10). Only the UDL-01 PTC2 and WF10 PTC3 
showed any alterations in virus replication, significantly decreasing titres 
compared to their respective parental WT virus. Although there was a general 
trend which matched the plaque size data seen previously. It would perhaps be 
expected that the FS mutation would have a larger effect on replication especially 
in UDL-01. If the virus cannot actively control the host immune response as with 
the UDL-01 FS virus, it would be expected that virus output would decrease as 
the host can more rapidly respond and control virus replication. This has been 
previously shown by Hayashi et al., 2015, who showed that Cal09 H1N1 virus 
without PA-X expression had reduced viral replication due to an increased 
expression of IFN-β within the cells. On the other hand, Jagger et al. (2012), only 
saw minor decreases in viral replication with the removal of PA-X from 1918 
H1N1. It therefore, appears that the effect of PA-X on viral replication is very 
much strain dependant and in this case, with our H9N2 strains no difference in 
219 
 
viral replication was seen in vitro with removal of PA-X. These data suggest that 
perhaps the mechanism of action of the E26K mutation in host cell shut off and 
viral replication occurs by two different methods.  
To confirm the theory that the two function observed with the E26K 
mutation within H9N2 viruses are in fact acting via two mechanisms a double 
mutation was introduced into the H9N2 PA-X’s, where both the amino acid at 26 
was altered and PA-X expression removed. Within these studies (Figures 4.13 to 
4.15), the UDL-01 E26K +FS mutant acted like WF10 +FS, displaying a small 
plaque phenotype and a reduced viral replication compared to UDL-01 WT. 
Conversely, WF10 K26E + FS behaved like UDL-01 +FS, with increased plaque 
diameter and viral replication compared to WF10 WT. These experiments 
indicate that the two phenotypes seen with the 26 mutation, alteration of host 
cell shut off (this chapter) and alteration of plaque size/virus replication (chapter 
2), potentially occur via two independent mechanisms. With 26 in PA-X affecting 
shut off and 26 in PA affecting viral replication, as when PA-X is removed but the 
26 mutation remains, the viral replication differences are still observed. The 
mechanisms responsible for these different functions of the E26K mutation were 
not fully investigated within this thesis, but it could be speculated that the E26K 
mutation may affect the stability of the PA protein or polymerase complex and 
therefore alter virus replication. On the other hand, the E26K mutation may alter 
PA-X interaction with unknown proteins or alter PA-X localisation within the cell 
to change the host cell shut off ability of the proteins. As the full mechanism of 
action for PA-X to induce host cell shut off is not well characterised it is difficult 
to determine if interaction with another viral or host protein was affected. To 
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investigate this further, the PA-X proteins could be tagged with GFP and GFP-
TRAP pull downs followed by mass spectrometry conducted to determine if any 
protein interactions change between the viral subtypes or with introduction of 
the E26K mutation. Some preliminary studies were conducted to assess the effect 
on subcellular localisation of PA-X, and all of the constructs tested showed the 
same localisation of small puncta within the cytoplasm, so the function did not 
seem to be linked to localisation.  
Within this chapter, the impact of a single amino acid change on the host 
cell shut off ability of H9N2 AIV has been investigated. The role of influenza 
accessory protein, PA-X, in H9N2 AIV in vitro has also been determined. It appears 
that position 26 can alter viral replication and host cell shut off via two 
independent mechanisms although further research is needed to determine the 
exact mechanisms by which these effects materialise. It is also not possible to 
discriminate between the pathogenicity effects seen with the UDL-01 E26K virus 
and its impact on viral replication or host cell shut off. This will somewhat be 
addressed in chapter 5 where the effect of removal of PA-X from H9N2 AIV in vivo 







Chapter 5: How does mutating H9N2 PA-X alter AIV 
pathobiology in vivo? 
5.1: Introduction 
Chapter 4 characterised the function of H9N2 PA-X polypeptides in vitro 
and identified differences in host cell shut off ability between the UDL-01 and 
WF10 virus strains. Therefore, in this chapter, the role of PA-X in an in vivo setting 
was examined. Previous research has investigated the role of PA-X in 
pathogenicity and host immune responses mainly with a focus on mouse models. 
For example, Lee et al. (2017), showed that removing PA-X expression from a 
pH1N1 2009 virus reduced viral replication and pathogenicity in mice, which also 
corresponded with a reduced host immune response. In contrast, using a 
different strain of pH1N1 2009 virus, Gao et al. (2015b), found that mutating PA-
X increased virus replication in mice with consequently higher mortality. Other 
studies have shown that altering PA-X expression can decrease viral replication 
and transmission and lead to a delayed pro-inflammatory response within the 
lungs of pigs infected with swine H1N2 IAV (Xu et al., 2017).  
 In terms of AIVs, several studies have explored the effect of PA-X, although 
groups still tend to use mice as the model organism rather than an avian species. 
Only one study has been conducted which assesses PA-X in HPAIV H5N1 viruses 
in both chickens and ducks where PA-X removal increased viral virulence and 
downregulated genes associated with inflammation and cell death (Hu et al., 
2015). Conversely, within a LPAIV H9N2 background, PA-X has been shown to be 
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a pro-virulence factor, with viruses expressing PA-X showing an enhanced 
mortality in mice corresponding to an upregulation of cytokine and chemokine 
expression within the mouse lung (Gao et al., 2015c). All of these previous studies 
suggest that the effect of PA-X is very much dependent on the strain of virus and 
the host species in which the work is carried out. 
 Although one study has investigated PA-X function in an H9N2 AIV 
background, the in vivo work was carried out within a mouse model, rather than 
in the natural infection system of the chicken (Gao et al., 2015c). Therefore, the 
aim here was to assess the pathogenicity of H9N2 AIVs with different PA-X 
protein expression profiles and functionality in the natural host, first using 
fertilised hens’ eggs and then using an in vivo infection model in White Leghorn 
chickens. 
5.2: Results  
5.2.1: Effect of removal of PA-X expression on virus infection in ovo 
 In the first instance the impact of removal of PA-X expression (via the FS 
mutation) from UDL-01 and WF10 viruses was assessed within 10-day old 
fertilised VALO (white leghorn) hens’ eggs. Adopting the 3Rs principles, this 
would allow for insights to be gained into the effect of PA-X expression in a less 





5.2.1.1: Embryo survival rate following infection with wild type and mutant 
viruses  
As PA-X has previously been shown to alter viral pathogenicity in animal 
models (Jagger et al., 2012, Gao et al., 2015a+b; Gong et al., 2017), the 
pathogenicity of our H9N2 AIV strains within an embryonated egg model was 
first assessed. Ten-fold serial dilutions of each virus (10,000 pfu to 0.001 pfu) 
were made and used to infect 5 eggs per virus per dilution. Groups of 10-day old 
SPF white leghorn (VALO breed) hens’ eggs were used as per the previous study 
(section 3.2.1.3). Mock infected embryos were included which were inoculated 
with sterile PBS. Embryos were candled twice daily up to 84 hours post-infection 
to check for embryo viability. If a lack of movement of the embryo and/or 
disruption of blood vessels was seen within the egg they were deemed to be dead. 
If the embryos survived until the experiment end (84 hours post-infection) they 
were culled via refrigeration. Samples of allantoic fluid from each egg were 
collected and “in-cell western” assays were performed to assay for infectious 
virus. Briefly, MDCK cells were infected with allantoic fluid and 12 hours later 
cells were fixed and stained using immunofluorescence for viral NP protein in 
order to determine if death was the result of productive viral infection. All mock-
infected samples were negative via the screening method described above (data 
not shown). Any eggs which did not produce virus-positive allantoic fluid were 
removed from the survival analysis. This included the 0.001 pfu group from all 
viruses and the 0.01 pfu group from the UDL-01 WT and UDL-01 FS virus groups. 
The resultant survival curves only reflect eggs that were definitely infected (data 
not shown).   
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An estimation of the LD50 was determined from the survival curves of each 
virus, although accurate LD50 values could not be calculated due to 100% 
mortality not being reached in the majority of groups. With UDL-01 WT virus, the 
highest viral dose (10,000 pfu) leads to high levels of mortality from 48 hours 
onwards which is not seen with the UDL-01 FS counterpart at this dose (data not 
shown). However, lower doses of infection (1 pfu) appear to have increased 
mortality, up to 100%, in UDL-01 FS infected eggs compared to WT. The LD50 
estimation for UDL-01 WT virus ranges from 1000 to 0.1 pfu, as a resurgence in 
mortality was seen at lower doses. With the UDL-01 FS virus it was difficult to 
estimate LD50 as mortality above 50% was only observed with the 1 pfu dilution 
and it did not occur in a dose dependant manner. However, from these data it can 
be estimated to be between 1 and 0.1 pfu. This falls within the LD50 range of UDL-
01 WT so no firm conclusions can be draw over the effect of removal of PA-X 
expression on UDL-01 virus pathogenicity in this model. However, when % 
survival is plotted against viral dilution a clear difference can be seen in the 
trends of data (Figure 5.1), UDL-01 WT survival occurs in a dose dependant 
manner as seen by the ascending trend line, whereas the UDL-01 FS survival is 
not dose-dependent. Within the WF10 virus pair, the highest dose of virus 
(10,000 pfu) led to substantial amounts of mortality from around 60 hours 
onwards; something that was not seen with the FS counterpart (data not shown). 
Conversely the WF10 FS virus appeared to have an increased mortality 
throughout the study duration at 100 pfu compared to WF10 WT. However, 50% 
mortality was not reached from any dose of either virus until 84 hours post 
























Figure 5.1: Mortality analysis versus virus dose of embryos infected with differing 
dilutions of H9N2 AIVs. At 84 hours post infection, total embryo mortality after infection 
with the indicated viruses at each viral dose was calculated. Line represents non-linear fit of 
data with each data point represent % mortalityl at the viral dilution.  
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The estimated LD50 value for WF10 WT virus was between 1000 and 100 
pfu whereas for WF10 FS it was between 10,000 and 100 pfu. There was not a 
substantial difference in LD50 values between the WF10 virus pair.  Both WF10 
WT and FS have similar dose-dependent effects on survival (Figure 5.1).  
The total number of embryos, across the entire dilution range, which died 
in each of the viral groups was similar between pairs; UDL-01 WT versus UDL-01 
FS (40% and 43% respectively), WF10 WT versus WF10 FS (27.5% and 32% 
respectively). However, there were some differences in the overall end point 
mortalities amongst the virus dilutions (Table 5.1). UDL-01 FS virus had an 
increased mortality at 100, and 10 pfu compared to UDL-01 WT. However, at the 
higher viral dilutions (10,000 and 1000 pfu) lower mortality rates were observed 
within UDL-01 FS infected embryos. The WF10 virus pair showed generally 
similar end point mortality rates with some minor differences between the virus 
pair. Overall, these data did not clearly elucidate to pathogenicity differences 
amongst viruses with or without PA-X expression. 
5.2.1.2: H9N2 in ovo infection of embryos and gross pathological 
observations  
 The gross pathology of the 10-day old chicken embryos infected with RG 
H9N2 AIVs was investigated to gain insights into the pathogenicity differences 
between viruses resulting from expression or not of the accessory protein PA-X. 
Six 10-day old embryonated SPF white leghorn (VALO breed) hens’ eggs were 
infected with 100pfu of each virus, or sterile PBS for the mock group, via 





10000 1000 100 10 
UDL-01 WT 80% 60% 20% 0% 
UDL-01 FS 20% 40% 40% 20% 
WF10 WT 70% 60% 30% 30% 
WF10 FS 50% 50% 40% 10% 
 









Five embryos per virus per dilution were infected, eggs were candled every 12 hours for up 
to 84 hours post-infection. Once an egg displayed any of the experimental end points it was 
chilled and classified as dead. Allantoic fluid samples were tested for presence of viral NP 
to determine viral infection within the eggs. Any eggs which did not display virus-positive 
allantoic fluid were removed from the study. % mortality at 84 hours post-infection are 
tabulated 
Table 5.1: Summary of embryo mortality at 84 hours post-infection. 
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was seen within the survival experiment described above up to 48 hours post 
infection and the overall end point mortalities were generally similar. The 
embryos were candled twice daily to check viability for 48 hours; any embryos 
which died were refrigerated and removed from the study. 48 hours post-
infection the remaining eggs were chilled, the embryos removed from the shell, 
washed twice in PBS and then photographed to document their gross pathology. 
Samples of allantoic fluid were taken from each egg and viral titres assessed via 
plaque assay. Any virus-inoculated embryonated egg which was not positive for 
live virus was removed from the study to ensure that any pathological differences 
were likely the result of viral infection. There were no significant differences in 
viral titres between the UDL-01 WT and UDL-01 FS or WF10 WT and WF10 FS 
infected eggs (Figure 5.2H). Therefore any differences seen in the gross pathology 
of the embryos were not obviously related to increased viral load within the eggs.  
 Images of 3 or 4 embryos per group were selected based on virus-positive 
allantoic fluid samples and removal of early dead embryos. Mock infected 
embryos showed little in the way of gross pathological changes, as expected 
(Figure 5.2A). On initial investigation, both UDL-01 WT and UDL-01 FS viruses 
led to several embryos displaying severe gross pathological lesions compared to 
mock infected embryos, with marked bleeding and a macerated appearance of 
the embryo (Figure 5.2 B and C). WF10 WT virus caused less pronounced changes 
compared to mock infected embryos; none of the virus-infected embryos showed 
clear haemorrhaging and all remained intact (Figure 5.2D). However several 





































Figure 5.2: Effect of removing PA-X on in ovo replication and pathology of H9N2 AIVs. 
Groups of 6 10-day old VALO eggs were infected with 100 pfu of the indicated viruses. Eggs 
with virus-negative allantoic fluid or which displayed early embryo death were removed 
from the experiment. (A-E) Embryos were removed from the shell and washed twice in PBS 
before imaging to assess gross pathology. (F) Images were blindly scored for gross pathology 
by 3 independent people. Scoring was based on the following criteria: 0- no obvious bleeding, 
1- subtle bleeding, 2- considerable bleeding, 3- very obvious bleeding and/or embryo not 
intact. Data represent the mean of 3 independent scorers, each scoring 4 embryos per group. 
(G) Embryo size was estimated using ImageJ analysis software by normalising to the 
diameter of the petri dish each embryo was imaged in. Data represents average length +/- 
SD. (H) Viral titres of allantoic fluid taken from positive eggs assessed via plaque assay. 
Unpaired T-test (F, H) or Kruskal-Wallis with multiple comparisons (F); P values =*: <0.033. 
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UDL-01 virus pair, with obvious bleeding and disruption of the embryo body 
(Figure 5.2E). 
The gross pathology of the embryos was then blindly scored by 3 group 
members using the integer scale of 0-3 described in chapter 3. WF10 WT, UDL-
01 WT and UDL-01 FS virus infected embryos did not have significantly different 
gross pathology scores than uninfected embryos. However, UDL-01 WT and UDL-
01 FS did contain several embryos which scored more highly than the mock 
group. The range of pathology scored across the groups however, lead to this 
difference not being significant. On the other hand, WF10 FS infected embryos 
were significantly more damaged. There was also a significant difference 
between the scores of WF10 WT and FS embryos, with the latter group showing 
more pathology (Figure 5.2F). This suggested that removal of PA-X expression via 
mutation of the frameshift site (FS) led to enhanced pathogenesis by WF10 virus. 
Embryo length was also measured using ImageJ analysis software (Figure 5.2G).  
There were no significant differences between the sizes of UDL-01 WT, UDL-01 
FS and WF10 WT infected embryos compared to mock infected animals.  
However, WF10 FS infected embryos were significantly smaller than mock and 
WF10 WT infected specimens. Therefore removal of PA-X expression from WF10 
enhanced embryo pathology by two measures. 
5.2.1.3: Infectious dose differentials between the viruses 
To further investigate the effect PA-X expression had on H9N2 AIVs in ovo, 
experiments to assess the amount of virus required to induce infection within 
eggs were conducted. As before (5.2.1.1.), 10-fold serial dilutions of each virus 
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(10,000 pfu to 0.001 pfu) were made and used to infect 5 eggs per virus per 
dilution. A mock group was included which were inoculated with sterile PBS. 
Embryos were candled twice daily up to 84 h.p.i. to check for embryo viability. At 
either the end of the study period or once an end point had been met (see chapter 
7 for details), embryos were chilled. Samples of allantoic fluid were taken and “in-
cell westerns” were performed to assay for infectious virus as previously 
described (section 5.2.1.1). None of the ‘mock-infected’ eggs had a positive signal 
for viral NP protein within the “in-cell western” assays (data not shown). To 
determine any effects of the PA-X mutations on viral infectivity the EID50 of each 
virus was then calculated via the Reed-Muench method. Only minor differences 
in EID50 were observed between the UDL-01 and WF10 pairs, with the UDL-01 
pair being slightly lower compared to the WF10 pair (0.024 vs. 0.032). However, 
PA-X expression did not alter the EID50 between the viral pairs.  
5.2.2: Effect of PA-X on H9N2 viral fitness in vivo 
Gao et al. (2015c), showed that H9N2 PA-X has a pro-virulence effect 
within mammalian systems of infection. However, little has been done to 
elucidate the effect PA-X expression has on pathogenicity of H9N2 AIVs within a 
natural model of infection, the chicken. When the effect of H5N1 PA-X on 
pathogenicity within avian models was investigated, the presence of PA-X was 
shown to reduce viral virulence. Therefore, within this study the effect of H9N2 
PA-X within a chicken model was investigated. The UDL-01 WT and FS virus pair 
were taken forward within this study as the WT virus has been well characterised 
within previous literature (James et al., 2016; Iqbal et al., 2013; Long et al., 2016) 
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and this virus displays active host cell shut off activity via PA-X and some survival 
differences were seen after mutation of PA-X in ovo. For this experiment, White 
Leghorn (VALO breed) chickens were used at three weeks of age. Groups of 10 
birds housed in self-contained isolators were inoculated with 100µl of a 105 
pfu/ml stock of either UDL-01 WT or FS virus or sterile PBS (to provide a mock-
infected group) via the intranasal route (Figure 5.3). These birds are hereafter 
termed ‘directly infected’. One day post-infection, 8 naïve ‘contact’ birds were 
introduced into the isolator alongside the directly infected birds in order to 
assess viral transmission. Before infection (day -1), and then throughout the 
experiment, birds were swabbed in both buccal and cloacal cavities from day 1 to 
day 8 and as well as day 10 and 14 post-infection to determine viral shedding 
(Figure 5.3). Additionally, environmental samples (taken from food and water) 
from each group were collected daily throughout the experimental duration. On 
experimental day 2 (day 2 post-infection for directly infected and day 1 post-
exposure for contacts), 3 birds per group (directly infected, contacts and mock) 
were culled and a panel of post-mortem tissues taken. Tissue sections were 
stored in both RNA later and snap frozen. Birds were observed twice daily by 
members of animal services and whilst procedures were carried out for the 
presence of clinical signs of infection. Mild clinical signs expected during the 
study included; ruffled feathers, pale comb/wattles, eye and nasal discharge, 
reddened eyes, snicking and depression. Additional moderate clinical signs that 
were expected included drooping wings, swollen heads and sporadic diarrhoea.  























Day 0: Infection 
Ten 3-week-old VALO 




UDL-01 WT or FS 
virus. Mock birds 




All birds swabbed in 
buccal and cloacal 
cavities 
Day 1: Contacts 
8 naïve contact 
birds introduced 
into each infected 
group 
Day 2: Scheduled cull 
3 birds per group 
(direct and contact) 
culled. Panel of tissues 
taken in RNA later and 
snap frozen. 
Day 14: Experiment 
end 
All remaining birds 
culled  
Day 1-14: Swabbing 
Birds were swabbed every day from day 1 to 
day 8 and then on day 10 and day 14 via both 
buccal and cloacal cavities.   
Day 1-14: Environmental samples  
Food and water samples from each group 
collected 
Figure 5.3: In vivo experimental design summary. Ten 3-week-old white leghorn (VALO) 
chickens housed within 2 isolators were infected with 105 pfu of either UDL-01 WT or UDL-01 
FS virus. A 3rd mock-infected group was kept in a pen and inoculated with sterile PBS. One day 
post-infection, 8 naïve contact birds were introduced into each infected group. Birds were 
swabbed in their buccal and cloacal cavities daily between day 1 and day 8 and then on days 
10 and 14 post-infection. 3 birds per group (directly infected, contacts and mock) were culled 
on day 2 post-infection and a panel of tissues collected in RNA later and snap frozen. 
Throughout the study duration environmental samples (food and water) were collected daily. 
All remaining birds were culled on day 14 post-infection.  
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sitting alone and showing no signs to evade capture and in the most extreme 
instances paralysis and unconsciousness were observed birds were euthanised 
via a schedule one method. The experiment was terminated on day 14 post initial 
inoculation, and all birds were humanely culled. 
5.2.2.1: Viral shedding analyses from directly infected and contact birds  
To study the effect of PA-X on viral pathogenicity throughout the study 
duration birds were monitored for clinical signs and anything of note was 
recorded. However, clinical signs throughout the study were minimal for the 
most part; too minimal to draw any conclusions. The majority of birds showed 
only minor signs such as mild diarrhoea and depression as expected from 
previous reports of H9N2 infection (Sun et al., 2010). This was in contrast to the 
previous study within this thesis (chapter 3), where some mortality was seen 
with the same UDL-01 WT virus. This difference was most likely linked to the 
difference in breed of chicken used for each study, with the RIR known to be more 
susceptible to infection than the White Leghorns (Sironi et al., 2008; Matsuu et 
al., 2016; Rasool et al., 2014).  
In order to assess the ability of the H9N2 viruses which differ in 
expression of PA-X to replicate within the natural host, birds infected with UDL-
01 WT or UDL-01 FS were swabbed via both the buccal and cloacal cavities 
throughout a two week period post-infection and virus titre determined by 
plaque assay. Mock-infected birds were also swabbed periodically during the 
infection period. Throughout the study duration, all mock infected samples were 
below the limit of detection via plaque assay (2.5 pfu/ml) in both buccal and 
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cloacal swabs (data not shown). Neither was any live virus detected in any of the 
cloacal swabs collected during the experiment. These latter data were consistent 
with Ruiz-Hernandez et al. (2016), who previously found that Line 0 (white 
leghorn) chickens showed a lack of detectable cloacal shedding. Similarly, 
although environmental samples were taken from food and water in each isolator 
daily throughout the experiment, no virus was detected via plaque assay. In 
contrast, directly infected birds showed readily detectable buccal shedding from 
days 1-6, peaking at titres of over 104 pfu/ml (Figure 5.4A). However, those birds 
infected with UDL-01 FS (lacking normal PA-X expression) showed a delayed 
shedding profile compared to birds infected with UDL-01 WT virus. On day 1 and 
2 post-infection (Figure 5.4B) UDL-01 FS infected birds shed a significantly less 
virus than WT-infected animals. By day 3 post infection, shedding levels had 
evened out between groups (Figure 5.4C). However at day 6, an increased 
number of animals infected with UDL-01 FS were shedding than infected with 
UDL-01 WT (Figure 5.4D). Within both groups viral shedding was cleared by day 
7 post-infection. To estimate the total amount of virus shed by each group, the 
area under the shedding curves (AUC) were calculated, giving values of 81,674 
for WT UDL-01 versus 241,229 for the FS mutant. This suggested that UDL-01 FS 
infected birds shed more virus overall than the UDL-01 WT infected birds. 
The same trend of delayed shedding kinetics of birds infected with the 
UDL-01 FS virus was observed within the buccal shedding of contact birds 
(Figure 5.4E). This difference in shedding with respect to the WT virus was 
significant on 2 post-infection (Figure 5.4F). Again by day 3 post introduction the 






























Figure 5.4: Buccal shedding profiles of White Leghorn birds infected with H9N2 AIVs. 
Birds were infected with either UDL-01 WT virus or a UDL-01 virus lacking expression of 
PA-X (UDL-01 FS) or introduced one day post inoculation. Swabs were taken from the 
buccal cavity throughout the study duration and virus titrated via plaque assay to calculate 
plaque forming units (PFU)/ml. The average +/- SD buccal shedding profile of at least 4 
birds per group are shown for (A) directly infected birds and (E) contact birds. (B-D) buccal 
shedding on separate days post infection for directly infected birds with each bird 
represented via a single point. (F-I) buccal shedding on separate days for contact birds with 
each bird represented via a single point.  Unpaired T test (Contact Day 2 (F), 3 (G) and 4) or 




infected birds also displayed increased shedding on day 5 post-introduction 
compared to UDL-01 WT infected birds, although this was not significant (Figure 
5.4H). Within both contact groups viral shedding was cleared from day 6 post-
introduction.  When AUC values were calculated for the contact bird populations, 
the UDL-01 WT AUC was 94,171 whereas the UDL-01 FS AUC was 104,655 
indicating only a marginal difference in shedding. All contact birds became 
infected within both groups; therefore removal of PA-X from UDL-01 did not alter 
the transmissibility of the virus in this model. Overall, the shedding profiles of the 
infected birds suggested that presence of PA-X (within the WT virus) accelerated 
the buccal shedding of virus compared to a virus which lacked PA-X expression. 
5.2.2.2: Stability of mutations to remove PA-X during replication in infected 
chickens  
 To determine if the effects on buccal shedding observed within these 
studies were the result of the removal of PA-X or due to other compensatory 
mutations within PA or other viral gene segments, RNA was extracted from swab 
supernatants and prepared for NGS to  allow for high quality sequencing reads to 
be prepared. Within the input virus, the PA-X slippage site mutation were the only 
differences seen between UDL-01 WT and FS viruses as expected.  The NGS data 
showed that the frameshift site mutations introduced to remove PA-X expression 
from the UDL-01 FS virus remained in the output viruses from samples isolated 
from buccal swabs. A further single Q193K amino acid change in the PA gene of a 
sample that was shed via the buccal cavity of an UDL-01 WT infected bird was 
seen at consensus sequence level. This lies with one of the PA NLSs and Llompart 
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et al. (2014), noted that a Q193H change in the PA gene of PR8 was present within 
a strain which did not have RNA polymerase II degradation ability. However, this 
phenotype was ascribed to other mutations within the PA and PB2 genes. No 
further mutations were seen in the consensus amino acid sequences of output 
viruses from UDL-01 WT or UDL-01 FS infected birds within either the PA gene, 
the accessory protein PA-X or the remainder of the viral gene sequences. 
Consistent with the genetic stability of the viruses, no differences were observed 
within the plaque phenotypes of the input viruses versus output viruses (data not 
shown).  
5.2.2.3: Viral dissemination in tissue and organs of directly inoculated and 
contact birds  
A panel of tissues were taken during post-mortem examination on 
experimental day 2 from the directly infected, contact, and mock birds and stored 
either in RNA later or snap frozen. This allowed for viral dissemination 
throughout the visceral organs to be investigated and compared between UDL-
01 WT viruses and those lacking PA-X.  
5.2.2.3.1: Presence of M segment RNA within tissues  
Tissue samples stored in RNA later were homogenised and RNA extracted, 
quantified and 100ng of RNA/ sample used in triplicate within qRT-PCR for the 
viral M gene as a marker for presence of virus within tissues. As before an M gene 
RNA standard allowed for the copies of segment 7 to be calculated. Tissues from 
mock infected birds were also processed but all fell below the limit of detection 





















Figure 5.5: Detection of viral M gene within tissues of infected birds. On day 2 post-
infection 3 birds per group were culled, a panel of tissues taken and following RNA extraction 
qRT-PCR for viral M gene carried out. CT values were compared to a M gene standard curve 
to determine copy number. Graphs show mean +/- SD viral RNA copy number detected within 
tissues from (A) directly infected birds and (B) contact birds.  Unpaired T-test (Direct; Lung, 
Duodenum, Colon, Kidney, Liver, Spleen, Contact; Lung, Duodenum, Colon, Kidney and Liver) 
or Mann Whitney test ( Direct; Nasal, Trachea and Thymus, Contact; Nasal and Trachea) P 





Within tissues isolated from directly infected birds, viral replication was 
primarily observed within the upper respiratory tract in both UDL-01 WT and 
UDL-01 FS infected birds (Figure 5.5A). There were no significant differences in 
M gene copy number within the nasal tissue and trachea. However, significantly 
more viral RNA was detected lower down the respiratory tract from lung tissues 
of UDL-01 WT infected birds. Within other visceral organs, little M gene RNA was 
amplified, particularly in tissues collected from UDL-01 FS infected birds. Both 
the liver and kidneys of UDL-01 WT infected birds had significantly more viral M 
gene compared to tissues from UDL-01 FS infected birds. Therefore, UDL-01 WT 
virus showed increased viral dissemination compared to UDL-01 FS at day 2 post-
inoculation. Tissues taken from the contact birds at day 2 of the experiment, and 
therefore day 1 post their introduction, again showed the highest level of M gene 
RNA detection from respiratory tissues, most notably the nasal tissue and trachea 
(Figure 5.5B). Viral loads were not significantly different between UDL-01 WT 
and FS infected birds at this point and little M gene was amplified within any 
other tissues tested. Overall, these data show that removal of PA-X from UDL-01 
AIV (FS) led to reduced viral dissemination at day 2 post-infection for directly 
inoculated birds. 
5.2.2.3.2: Detection of virus in the tissues from wildtype or mutant virus-
infected birds  
In order to determine whether the isolation of viral RNA from tissues 
corresponded to isolation of live virus, snap frozen tissues were processed. 30 mg 






















Figure 5.6: Detection of virus from tissues from infected birds. Snap frozen tissue 
samples were homogenised with serum free DMEM. Supernatants were clarified and titrated 
via plaque assay. (A) viral isolation from directly infected birds (B) viral isolation from 
contact birds. Data represents viral titres present in each birds tissues. Error bars +/- SD. 





used to titrate presence of virus via plaque assay. No infectivity was detected 
from any tissues collected from mock infected birds (data not shown). Tissues 
collected from birds directly infected with UDL-01 WT virus had variable but 
sometimes high titres of virus in tissues from the upper respiratory tract (Figure 
5.6A). However, not all birds gave positive results using this assay, in contrast to 
the qRT-PCR results seen previously. Only three samples from birds directly 
infected with the FS mutant were positive for infectious virus; two from the nasal 
tissue and one from the trachea, all at lower average titres than the WT 
counterparts. Some of the lung, spleen, colon, kidney and liver samples collected 
from UDL-01 WT infected birds were also positive by plaque assay, whereas none 
of the same tissues were positive from the UDL-01 FS infected birds at day 2 post-
infection.  
In contact birds, live virus was only isolated from the nasal tissue and 
trachea of birds infected with either UDL-01 WT or FS viruses, again with lower 
average titres of the mutant virus (Figure 5.6B). All other tissues were negative 
for virus by plaque assay (data not shown). Unfortunately, statistical analysis 
could not be carried out due to the only two of the three UDL-01 FS infected birds 
showing positive results via this assay. Nevertheless, overall, these data support 
that previously seen via detection of viral M gene RNA and indicate that UDL-01 
WT virus was better able to disseminate throughout the chicken visceral organs 
compared to UDL-01 FS virus. This suggested that the PA-X protein plays a role 




5.2.2.4: Cytokine expression in infected tissues 
 Next the immune responses of the chickens to infection with the viruses 
were assessed. PA-X is known to alter host responses by downregulating protein 
synthesis (Jagger et al., 2012). Within different host species, modulation of PA-X 
expression has been shown to alter host expression of cytokines and chemokines; 
for example an H9N2 AIV unable to express PA-X has been shown have decreased 
expression of IL-6, IL-1β, CCL3, IFN-γ and TNF-α within a mouse model compared 
to a virus with PA-X expression (Gao et al., 2015c). Therefore within the 
experiments reported here, the aim was to determine if alteration of PA-X 
expression in UDL-01 led to differential cytokine and chemokine responses 
within the chicken host. In the first instance the tissues of the respiratory tract 
(trachea and nasal tissue) were selected as the most viral RNA and live virus was 
isolated from these tissues. As before, RNA extracted from homogenised tissues 
was then used to complete qRT-PCR for a range of chicken cytokines and markers 
of the interferon response. Three reference host genes (RPLPO-1, RPL13 and 28S 
rRNA) were selected for normalisation and the most stable gene across the 
samples chosen for normalisation. 
Nasal tissue at day 2 post-infection from birds directly infected with UDL-
01 WT or UDL-01 FS viruses displayed little differences in immune response 
(Figure 5.7A). Some minor differences were seen with expression of IFN-β, IFN-γ 
and IL-18 with UDL-01 WT infected birds generally expressing higher levels of 























Figure 5.7: Cytokine expression compared to reference gene in directly infected birds. 
RNA was extracted from nasal tissue (A) or trachea (B) of WT UDL-01 and UDL-01 FS 
infected chickens. qRT-PCR was performed for a panel of cytokines and levels compared to 
RPLPO-1 reference gene were calculated. Cytokine expression for each bird is represented 
in a single dot, with error bars displaying mean +/- SD of tissues from n=3 chickens. Unpaired 
T-test (All Nasal tissue (A) Trachea- IFN-β, IFN-γ, IL-1β, IL-18, TGF-β4, CXCLi2 and Mx) or 





and Mx, with UDL-01 WT infected birds expressing higher levels of these immune 
markers.   
Immune responses in the tracheas of directly infected birds showed a 
similar trend to those in the nasal tissue (Figure 5.7B). Few differences in 
cytokine expression were seen between UDL-01 WT and UDL-01 FS infected 
animals. UDL-01 WT infected animals again tended to have an increased 
expression of IFN-β, IFN-γ and IL-1β although this only reached significantly 
different levels with CXCLi2. There was more variation in the responses within 
the trachea samples compared to the nasal tissue, particularly within the UDL-01 
WT infected birds.  
  Tissues taken from contact birds on day 1 post-exposure, were also 
assessed for their immune responses. Within the nasal tissues of these birds, 
there were no significant differences in expression of any of the tested cytokines 
between the UDL-01 WT and UDL-01 FS infected birds (Figure 5,8A). There were 
some minor fluctuations with UDL-01 FS infected birds tending to show a slightly 
increased expression for example, IL-6, IFN-β, IL-1β and Mx. This is the opposite 
trend to that seen on day 2 with the directly infected birds (Figure 5.7A).   
 Within the trachea samples taken from contact birds on day 1 post 
exposure, again no significant differences were seen in cytokine expression 
between UDL-01 WT and UDL-01 FS infected birds (Figure 5.8B). Although as 
with the nasal tissue samples UDL-01 FS infected animals tended to exhibit a 
slightly increased response particularly with IFN-α and CXCLi-2. However, the 






















Figure 5.8: Cytokine expression compared to reference gene in contact birds. RNA was 
extracted from nasal tissue (A) or trachea (B) of WT UDL-01 and UDL-01 FS infected 
chickens. qRT-PCR was performed for a panel of cytokines and levels compared to RPLPO-1 
reference gene were calculated. Cytokine expression for each bird is represented in a single 
dot, with error bars displaying mean +/- SD of tissues from n=3 chickens. Unpaired T-test 
(all contact Nasal, Contact Trachea- IFN-α, IFN-β, IL-1β, IL-18, CXCli2 and Mx) or Mann-





infected tracheas. Overall, there were few differences in cytokine expression 
between UDL-01 WT and UDL-01 FS infected birds and the differences seen 
appeared to be tissue dependant.  
5.3: Discussion  
 In this chapter, the role of the accessory protein PA-X within H9N2 AIV 
was investigated within avian in vivo models; first using fertilised hens’ eggs and 
then 3-week-old chickens. Within in ovo studies, UDL-01 infected embryos 
showed differences in their dose response to mortality, with UDL-01 WT having 
the expected effect, where higher viral dose leads to increased mortality, whereas 
UDL-01 FS had no dose response to mortality. This could suggest that removing 
PA-X from UDL-01 viruses does alter virus pathogenicity to some extent although 
repeat experiments would be required to confirm this. On the other hand, there 
was no difference between the WF10 virus pair in terms of dose response to 
mortality, this could be expected due to the lack of functionality previously seen 
with the WF10 PA-X protein. However, when the gross pathology of the embryos 
was assessed, embryos infected with UDL-01 viruses with or without PA-X 
expression did not differ in their gross pathology, whereas, removal of PA-X from 
WF10 viruses appeared to increase pathogenicity (Figures 5.3 and 5.4). This 
could suggest that although WF10 PA-X is not functional in terms of host cell shut 
off, it could have an additional, as yet unknown, function which is affected when 
the protein is removed from WF10. This in turn could affect gross pathology 
caused by the virus. Interestingly, the results seen here with non-functional 
WF10 PA-X differ to those seen by Hussain et al., (2019), where PR8 (H1N1) 
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lacking PA-X exhibits a reduced gross pathology of chicken embryos and reduced 
embryo size. PR8 has also been shown to have a non-functional PA-X in terms of 
host cell shut off. This difference is likely due to strain variations but could act via 
a common mechanism. This was not investigated any further during this thesis 
although repeat studies and additional research into the mechanism of action 
would be beneficial to increase the confidence in these findings.  
 The effect of PA-X expression in vivo was then assessed using chickens as 
an avian model for infection. In these studies, loss of PA-X from the UDL-01 
background led to delayed viral shedding, with virus being shed through the 
buccal cavity at later time points than with the WT virus with normal PA-X 
expression (Figure 5.6). This is understandable as, if PA-X functions to enable the 
virus to escape from the host immune response by dampening host production of 
cytokines, it is likely the virus is able to more rapidly replicate within the host. 
Whereas if the virus is unable to control the host antiviral response via PA-X, it 
might take longer to overcome this mechanism. It may be beneficial for viruses to 
contain PA-X as the enhanced shedding could be enhance transmission and 
environmental deposition. This would provide the virus an advantage within a 
chicken shed, as is this situation, birds are densely packed and viruses have little 
need to remain in the environment for long periods of time. The replicative 
advantage that expression of PA-X gives the H9N2 virus within the chicken host 
could be enough to ensure that this virus is first transmitted to the other birds 
within the flock. It would be interesting to complete some competition studies to 
confirm any transmission advantages over the UDL-01 FS virus which were not 
seen within these studies. Other studies have shown the influenza PA-X also 
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enhances the shedding window, with FS viruses being cleared more quickly in 
Cal09 (H1N1) infected mice (Lee et al., 2017). An enhanced shedding period has 
previously been shown to be beneficial for virus transmission within chickens 
(James et al., 2016), with the authors hypothesising that expression of full length 
PB1-F2 within AIV increases the period when transmission to naïve hosts can 
occur, giving benefit within backyard poultry production, when contact between 
animals less frequent than in large poultry houses. It appears that again the role 
of the accessory protein PA-X in shedding and transmission may be very much 
strain dependant and if this links to the virus host remains to be seen. In this 
instance it appears that UDL-01 PA-X enhances the initial shedding period to 
populate other animals and the environment rapidly. This would give advantages 
in initial transmission in a busy poultry shed compared to viruses lacking PA-X. 
The reduced shedding at early time points by UDL-01 FS could of course also be 
related to the lack of host shut off ability of the virus, whereby the host immune 
response is better able to control the virus within its initial replication period 
compared to UDL-01 WT. This restriction appears to subside by day 2 post 
infection, where other viral mechanisms such as the action of NS-1 could dampen 
the host response to allow the virus to replicate efficiently.  
Any correlation of this altered shedding with the pathogenicity of these 
viruses could not be determined as the clinical signs observed within the VALO 
chickens were minimal and no distinction could be seen between the groups. 
There was also a lack of cloacal shedding and environmental deposition in the 
VALO breed of birds, however this was expected from previous reports (Sironi et 
al., 2008; Matsuu et al., 2016; Rasool et al., 2014). This made it difficult to draw 
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firm conclusions on the impact of shedding by PA-X. As if the UDL-01 WT had for 
example, also had enhanced environmental deposition and cloacal shedding we 
could conclude that PA-X within H9N2 acts to enhance the shedding window to 
increase contact time between host and virus and therefore enhance shedding. 
Therefore, in future studies it would be more beneficial to use RIR birds to see if 
these conclusions can be drawn.  
Viral dissemination to the chicken visceral organs of the UDL-01 WT virus 
compared to the FS virus was enhanced at day 2 post-infection in the directly 
infected birds. This is expected as if the virus is unable to control the host 
response as efficiently, the innate immune system is able to more rapidly clear 
virus infection. Samples were only collected at one time point post-infection, so 
in future studies it would be interesting to collect samples at later time points to 
determine if the FS virus can still spread systemically, but more slowly as with 
the shedding where overall, amounts of virus shed were similar the response was 
just delayed within the UDL-01 FS virus.  
 Immune responses within birds infected with UDL-01 FS virus were 
largely similar to those responses within birds infected with the WT virus. 
However, subtle differences were observed, although perhaps not in an expected 
fashion. Within the upper respiratory tract of birds directly infected with UDL-01 
FS a reduction in expression of IL-1β, Mx and CXCLi-2 was seen. It would be 
expected that increases in expression of cytokines would be seen as with 
previous studies (Jagger et al., 2012; Gao et al., 2015a; Hu et al., 2015).However, 
our data does support that from Gao et al., (2015c), where H9N2 AIV within a 
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mouse model also showed a downregulation of cytokines compared to H9N2 
virus containing PA-X. This could suggest that H9N2 PA-X has an alternative 
mechanism of action compared to other strains although further work needs to 
be completed to support this. The reduction in immune response at day 2 post 
infection seen with the UDl-01 FS virus could be linked to the reduced virus 
present at this time point within the tissues selected. If the ratios of M gene: 
cytokine expression are calculated there is a generally increase within the UDL-
01 FS infected birds (data not shown). Therefore, if the same levels of replication 
were seen it is possible that the UDL-01 FS birds would have increased levels of 
cytokines as we would expected from the known functions of PA-X. To confirm 
this it would be useful to conduct some in vitro studies with equal amounts of 
virus to see how cytokine responses are altered. On the other hand, within 
contact birds at day 1 post infection, UDL-01 FS infected birds had slightly 
increased expression of cytokines such as the Type-1 IFNs, IL-6, IL-18, Mx and 
CXCLi2, however, none of these differences were significant. It appears that UDL-
01 PA-X can impact upon expression of pro-inflammatory cytokines and 
chemotaxis. This suggests that the dynamics of cytokine expression across the 
infection period may differ with PA-X expression. It would be interesting to take 
samples at later time points post infection to determine if the immune response 
dynamics are altered.   
The VALO breed of bird used for these studies was not the ideal choice, 
due to the limited clinical signs seen and the lack of cloacal shedding of the virus. 
This meant that viral pathogenicity was not able to be fully assessed. 
Unfortunately, circumstances (outside my control) with ordering of animals 
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meant that using White Leghorns was the only way the study could go ahead, but 
it would have been preferable to use RIR (as in chapter 3) to better assess 
pathogenicity. It would have also been interesting to assess the function of WF10 
PA-X on replication, pathogenicity and transmission within chicken models due 
to the differences seen in embryo gross pathology with these viruses. However, 
due to the space limitations of our animal facility and time scales for this project 
only one virus pair could be assessed.  
Overall, within this chapter, the effect of PA-X expression on H9N2 viral 
fitness, transmission, host dissemination and cytokine response was assessed. 
Expression of PA-X from an H9N2 AIV in a chicken model of infection enhanced 
viral shedding through the buccal cavity and increased the ability of the virus to 












Chapter 6: Final Discussion  
6.1: Conclusions  
The aim of this study was to elucidate the mechanisms by which H9N2 
AIVs have evolved increased fitness, transmission and pathogenicity within 
poultry populations by comparison of an early H9N2 isolate (A/guineafowl/Hong 
Kong/WF10/99-WF10) and a later reassortant H9N2 isolate containing PB2, 
PB1, PA and NS segments derived from HPAIV H7N3 (A/chicken/Pakistan/UDL-
01/08). By identifying the molecular basis of the enhanced fitness of these novel 
reassortant viruses, innovative control mechanisms could potentially be revealed 
or improvements could be made to vaccine design, as well as increasing our 
fundamental understanding of influenza virus biology. 
 The data represented within this thesis provide evidence that a single 
amino acid change within the PA gene is able to swap several phenotypes 
between the two viral strains. Introduction of PA E26K within UDL-01 reduced 
viral plaque size and viral replication in vitro as well as decreasing viral shedding 
and pathogenicity in vivo. It was found that this amino acid change exerts its 
function at least in part by its action within the accessory protein PA-X. UDL-01 
and WF10 PA-Xs exhibited differing effects on the virus’s ability to induce host 
cell shut off; UDL-01 PA-X had high shut off activity and WF10 PA-X had no 
measurable shut off activity. When the amino acid change at position 26 was 
introduced, this host cell shut off phenotype was switched between the two 
viruses. However, the exact mechanism of action remains undetermined. The 
polymorphism is in the endonuclease domain shared by PA and PA-X and 
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although its location on the surface adjacent to the enzyme active site plausibly 
suggests an effect on RNA substrate binding, this might also predict an effect on 
viral mRNA synthesis through decreased cap-snatching; something that was not 
seen. One possibility is that other substrate-binding activities within the 
polymerase trimer (e.g.  cap-binding by PB2) compensate for any defect. Detailed 
biochemical analyses using purified polymerase might permit this hypothesis to 
be tested. Another possible mechanism of action for the E26K mutation could be 
its ability to affect the stability of the polymerase. If having 26K within the PA 
protein makes the virus more unstable, it may be producing an increased number 
of DI particles or RNAs.  This could also link with the increased detection of UDL-
01 26E virus within water samples, although further work would need to be 
completed in vitro to confirm the effect on stability in the water in a more 
controlled manner.  
The small plaque morphology of the WF10 H9N2 AIV links with its 
inability to control host cell shut off. This is because if the virus is unable to 
control the host innate immune response, the host can prevent the spread of virus 
to neighbouring cells. This therefore restricts the virus spread so the ‘hole’ within 
the cell sheet caused by viral CPE is smaller. The opposite can be said for UDL-01 
where the virus can control the host immune response, thus can spread further 
between cells and cause larger areas of CPE and therefore a larger plaque. The 
mechanism of action of the difference in control of the host immune response 
between the two viruses was not fully determined within this thesis however, it 
was the result of an E26K change within PA. These two phenomenon were 
however, determined to be the result of two separate functions; the plaque 
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phenotype was the result of E26K’s position in the PA protein, whereas the effect 
on host cell shut off was the result of E26K’s position in the accessory protein PA-
X.  
Further studies also investigated the role of the PA-X protein within H9N2 
AIV using chickens as an in vivo model. Results from this were in support of those 
found by Gao et al. (2015c) in some part, who looked at the role of H9N2 PA-X in 
a mouse model and found that it was a pro-virulence factor, whose expression led 
to higher expression levels of cytokine and chemokines within the animals’ lungs. 
Within this thesis, it was demonstrated that a H9N2 virus able to express PA-X 
did induce higher cytokine production within the chicken respiratory tract than 
the mutant counterpart lacking PA-X but the role of PA-X in virulence could not 
be determined as no clinical signs were observed. The presence of PA-X did 
enhance viral replication and dissemination within chickens. These differences 
could be due to the different H9N2 strains used for the studies, or the limited 
pathogenicity seen in the precise model system used here. Plausibly, it could also 
be due to our using the virus’s natural host as a laboratory model. These findings 
increase our understanding of the effect of the PA gene within H9N2 AIV biology 
and also increase knowledge on the accessory protein PA-X. The ability of UDL-
01 WT virus to shed virus more rapidly than when PA-X was removed, shows that 
it is important for H9N2 AIVs to deposit in the environment quickly after 
infection. It may be beneficial for viruses to contain PA-X as the enhanced 
shedding could be beneficial for transmission and environmental deposition. This 
would provide the virus an advantage within a chicken shed as in this situation, 
birds are densely packed and viruses have little need to remain in the 
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environment for long periods of time. The replicative advantage that expression 
of PA-X gives the H9N2 virus within the chicken host could be enough to ensure 
that this virus is first transmitted to the other birds within the flock.  
6.2: Future work and directions  
There are still a number of key areas that would increase our 
understanding of the enhancement in viral fitness seen in H9N2 AIVs following 
internal gene reassortment as well as furthering the reach of these studies to look 
at more specific mechanisms of action. This thesis only characterised the effect of 
E26K on viral fitness whereas other polymorphisms are seen at this site in the 
natural influenza virus population, including 26G, 26D and 26Q. So to further 
characterise the significant amino acid variation at this position, the effect of 
these other polymorphisms could be investigated in a similar manner. Such 
studies would further our understanding of the minor variants at this position 
within the influenza virus population.  
Another area where further study would be advised would be to look 
further at understanding the molecular basis for the effects of the E26K amino 
acid change on PA-X activity, as little was done to elucidate the exact molecular 
mechanism of action. Potentially the subcellular localisation of GFP tagged PA-Xs 
could elucidate to this. Initial studies, were completed although no differences 
could be seen in localisation between the mutants. However, these studies were 
not taken further. It was planned to complete GFP-TRAP pulldown studies 
following transfection of cells with GFP-PA-X in order to determine any 
differences in host cell interacting proteins between UDL-01 and WF10 PA-Xs 
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with or without the E26K mutations. However, technical difficulties with the 
experimental technique did not allow for this to be completed within the time 
constraints of the study. This would have potentially further elucidated 
mechanisms of action of both influenza PA-X in general and the E26K mutation. 
One factor which was not investigated within this thesis, was the endonuclease 
activity of the PA-Xs and whether UDL-01 and WF10 PA-Xs have different 
endonuclease activities which could explain their differences in host cell shut off 
ability. This would build upon data from Bavagnoli et al. (2015), who show that 
the truncated form of PA-X has a reduced endonuclease activity compared to full 
length PA-X.  
Another potential mechanism of action of the PA 26 mutation could be 
examined by looking at the number of defective interfering (DI) RNAs produced 
by the viruses used in these studies. DI RNAs are incomplete RNAs with, usually, 
large internal deletions. They can be replicated and transcribed by the RNA 
polymerase and packaged into the virion. However, this allows for the production 
of defective viral particles (Nayak et al., 1985). The production of DIs has been 
suggested to be generated as the result of a “jumping” polymerase (Jennings et 
al., 1983). A single amino acid change within PA (R638A) has been shown to 
produce an increased number of DI RNAs and consequently the virus produced 
pin head plaques (Fodor et al., 2002). Work by Bean et al. (1985) may also 
support this hypothesis as they showed that viruses with increased DI production 
were avirulent while those without DI production had increased virulence.  DI 
formation was not examined in this thesis. However, these previous studies could 
suggest the hypothesis that the presence of 26K within the PA gene leads to a 
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destabilised polymerase which allows for the “jumping” of the viral polymerase 
to produce incomplete RNAs which are then packaged into the virions. This could 
then lead to the production of a virus with a smaller plaque phenotype (as seen 
with WF10) and a reduced virulence.   
The in vivo studies described in chapter 3 and 5 only used UDL-01 viruses 
due to the time and space limitations of the animal facilities at the Pirbright 
Institute. It would have been beneficial to investigate the effects of K26E and 
removal of PA-X (FS) within a WF10 viral background in order to investigate if 
the reciprocal effect is seen compared to UDL-01 viruses. This would further 
cement the importance of amino acid 26 within the phenotypes of UDL-01 and 
WF10 H9N2 AIVs. Investigation of WF10 viruses with altered PA-X expression 
could elucidate any additional mechanisms of action of PA-X, as WF10 PA-X was 
shown not to induce active host cell shut off in vitro (chapter 4). It was also 
planned to look at the histopathological effects of the viruses in a number of 
tissues and samples were collected within 10% NBF to do so. However, time 
constraints of the project did not allow for this to happen. Analysis and 
processing of these samples would allow for investigation into immune cell 
proliferation into different tissues to further cement the ideas that E26K and PA-
X play a role within the host immune response and to identify which tissues viral 
antigen is present within.  
One factor within the in vivo studies that would have been interesting to 
continue further was the increased detection of UDL-01 E26K virus within the 
isolator water samples than the UDL-01 K26E virus. This could suggest a 
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mechanism behind the innate immune activation differences seen between the 
two virus caused by viral stability differences. In order to test the stability of the 
two viruses in water, in vitro studies could be conducted whereby the two viruses 
were left in water samples for numerous time points and temperatures, at 
controlled conditions, and then after the required time had passed the quantity 
of virus within the sample determined via plaque assay. This would give an 
indication of the virus stability in the environment, which could have implications 
for transmission within different water systems. For example, an unstable virus 
would not last for long periods in water so would not have as much opportunity 
to successful transmit to other hosts. This would cause problems within systems 
where hosts are spread out and don’t come into contact as frequently as in 
commercial chicken sheds such as backyard production.  
Although the E26K amino acid change within the PA gene altered viral 
phenotypes between these two viral strains, it is unlikely that this polymorphism 
is the sole reason behind the increased replication and pathogenicity of H9N2 
AIVs within the field. Of particular note, is the lack of representation of 26K 
sequences within IAV genomes seen in chapter 2 and the prototype early G1-like 
H9N2 (A/quail/Hong Kong/ G1/97) possesses PA 26E. This suggests that another 
factor could be important for the enhanced viral fitness. Potentially it could be 
one of the other genes also donated to the reassortant H9N2 viruses: PB2, PB1, 
NS1 or NS2. Within initial screens the NS segment was also shown to alter the 
viral plaque phenotypes between WF10 and UDL-01 H9N2 AIVs (unpublished 
data from the Iqbal lab), so this could be a good place to start. It is possible that 
differences in the host cell shut off activity between WF10 and UDL-01 H9N2s 
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could act via NS1 as well as PA-X (as seen in chapter 4). NS1 acts by binding to 
and inhibiting CPSF30 to prevent nuclear export of host transcripts so they can 
be accessed via the viral polymerase for cap snatching (Nemeroff et al., 1998). If 
alterations occur in the interplay between NS1 and PA-X host cell shut off, the 
viruses’ ability to replicate within cells could be severely diminished. To first test 
this theory, the interaction of WF10 and UDL-01 NS1s with CPSF30 could be 
investigated. This could be completed via GFP-TRAP pulldown studies to assess 
protein-protein interactions. Plasmid-based reporter assays could also be used 
to look at the shut-off activities of the NS1 protein. Another function of NS1 is its 
blocking of PKR-mediated sensing of viral dsRNA therefore blocking the 
induction of the host innate immune response (Lu et al,. 1995; Tan et al., 1998). 
This could be investigated using transfection based reporter assays with the NS1 
proteins and an IFN-β reporter plasmid or by looking at the levels of type one IFN 
secreted during infection of cells in the first instance.  
Another limitation of the studies described within this thesis is that only 
one influenza virus strain was used to represent the early or reassortant H9N2 
AIVs. To gain a broader understanding of the sequence differences between G1-
like and novel reassortant H9N2s it would be beneficial to use a large scale 
bioinformatics screen with multiple sequences for each group. This would allow 
for trends and polymorphisms within each group to be more thoroughly 
investigated and would increase the impact of such studies within the future. This 
would require large scale bioinformatics analysis and could pose a challenging 
task particularly if taking into consideration the potential effect of the NS1 gene 
as well as PA.  
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Chapter 7: Materials and methods 
7.1: Materials 
7.1.1: General reagents 
Agarose for gel electrophoresis     Eurogentec (18037G) 
Agarose for plaque assay      Oxoid (LP0028) 
Avicel FMC Health and 
Nutrition (CL-611) 
 
DNA molecular markers     Bioline 
DNA plasmid miniprep kit     Qiagen 
DNA plasmid midiprep kit     Qiagen 
Lipofectamine 2000      Invitrogen 
Neutral buffered formalin     Sigma 
Nitrocellulose membranes      BioRad 
PCR purification kit       Qiagen 
Protein molecular weight markers    BioRad 
Tetramethylethylenediamine (TEMED)   BioRad (161-0800) 
Trizol reagent       Ambion 
Superscript III platinum One-step qRT-PCR kit        Life Technologies 
One-step RT-PCR kit      Invitrogen  
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QuikChange site directed mutagenesis kit     Agilent  
Vectashield       Vector Laboratories 
Polyester tip swab in tube Technical service 
consultant Ltd 
Puromycin       Sigma (P8833)  
Chloroform        Sigma 
RNA extraction kit       Qiagen  
X-ray film       Thermo Fisher  
Luciferase Assay kit       Promega 
B-galactosidase assay kit      Promega 
In Vitro Translation kit     Promega  
7.1.2: Enzymes 
The following enzymes were supplied by the provided suppliers and used 
according to the manufacturer’s instructions unless otherwise stated.  
DNA restriction enzymes     New England Biolabs 
Taq DNA polymerase     Invitrogen 
Pfu Ultra II fusion HS DNA Polymerase    Agilent 






Antibody Application  Source 
Rabbit polyclonal anti-PR8 
PA (V23) 
WB (1:500) Digard group  
Mouse monoclonal anti-
GFP (JL8) 





Iqbal group  
Rabbit monoclonal anti-
alpha- tubulin  
WB (1:1000) Abcam (ab15246) 
Monoclonal anti-
puromycin  
WB (1:1000) Millipore (MABE343) 
Monoclonal anti-G3BP IF (1:500) BD Biosciences (611126) 
 
Antibody  Application  Source 
IRDye 680RD Goat-anti-
mouse antibody  
WB (1:10000) Licor 
IRDye 800RD Goat anti-
rabbit antibody  
WB (1:10000) Licor  
Donkey anti-Mouse IgG 
(H+L) Secondary  
Antibody, Alexa Fluor® 
488 conjugate  
IF (1:1000) Thermo Fisher  
(A-21202). 
Goat anti-Mouse IgG (H+L) 
Secondary  
Antibody, Alexa Fluor® 
568 conjugate 
IF (1:1000) Life Technologies 
(A11004) 
 
Dye  Application Source 




Table 7.1: Primary antibodies  
Table 7.2: Secondary antibodies  
Table 7.3: Fluorescent dyes 
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7.1.4: Eukaryotic cell culture medium  
7.1.4.1: Cell lines 
Madin-Darby Canine Kidney Cells (MDCK)   Sigma/ECACC 
Human Embryonic Kidney 293T Cells (293T)  Sigma/ECACC 
Human Adenocarcinomic Alveolar Basal   ECACC 
Epithelial Cells (A549)   
 
Chicken Fibroblast Cells (DF-1s)    ATCC 
Japanese Quail Fibrosarcoma cell line (QT-35)  Houghton  
Primary Chicken Kidney Cells (CKC) Pirbright Institute cell 
culture services  
Primary chicken embryo fibroblasts (CEF) Mariya Goncheva, The 
Roslin Institute 
7.1.4.2: Cell culture reagents  
Dulbecco’s Modified Eagle Medium (DMEM)     Sigma (D6429) 
Eagles Dulbecco’s Modified Eagle medium (EMEM)  Sigma (M4655) 
Fetal bovine serum (FBS)       Sigma (F0926) 
L-Glutamine         Life Technologies 
(A29168-01)  
Penicillin/Streptomycin (Pen/Strep)   Gibco (15140-122) 
2.5% Trypsin-EDTA     Gibco (15090-046) 
Opti-MEM              Gibco (31985-047) 
Methionine- and Cysteine-free D-MEM      Gibco  
Medium 199       Gibco (21180-02) 
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10x MEM       Sigma (M02075) 
Bovine serum albumin (BSA)    Sigma (A7906) 
Polymyxin B       Sigma 
Gentamicin       Sigma 
Nystatin        Sigma 
Ofloxacin HCl       Sigma 
Sulfamthoxazole      Sigma 
Tryptose phosphate broth     Pirbright CSU 
N-tosyl-L-phenylalanyl chloromethyl    Sigma 
ketone (TPCK) treated trypsin   
 
Hepes        Sigma 
Sodium bicarbonate       Sigma 
Dextran hydrochloride     Sigma 
Versene        Gibco 
7.1.4.3: Cell culture media composition  
Plaque assay overlay media 10x Minimum Essential Medium, 0.2% w/v 
BSA, 2mM L-glutamine, 0.15% w/v sodium 
hydrocarbonate, 10mM Hepes, 0.0005% 
dextran hydrochloride, 100U/ml Pen/Strep, 
2µg/ml TPCK trypsin 
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Complete media   DMEM, 10% (v/v) FCS, 100U/ml Pen/Strep 
Virus growth media    DMEM, 2µg/ml TPCK trypsin  
Virus transport media Medium 199, 0.5% (v/v BSA), Penicillin G 
2x106U/L, Streptomycin 200mg/L, 
Polymyxin B 2x106 U/L, Gentamicin 
250mg/L, Nystatin 5x105 U/L, Ofloxacin HCl 
60mg/L, Sulfamthoxazole 0.2g/L. adjusted to 
pH 7.4. 
CKC media EMEM, 0.6% (w/v) BSA, 10% (v/v) tryptose 
phosphate broth, 300U/ml Pen/Strep  
CEF media     M199, 4% FCS, 100U/ml Pen/Strep 
Reverse genetics media  DMEM + 2mM glutamine, 100U/ml 
penicillin, 100U/ml streptomycin, 0.14% 
(w/v) BSA, 5µg/ml TPCK-treated trypsin 
7.1.5: Bacterial culture 
Luria Broth (LB), LB agar and SOC media were made and provided by the Roslin 
Institute or Pirbright Institute cell culture services.  
Luria Broth 1% (w/v) tryptone, 0.5% (v/v) yeast extract, 0.5% (w/v) 
sodium chloride (pH 7.0) 
LB agar 1.5% (w/v) agar, 1% (w/v) tryptone, 0.5% (v/v) yeast 
extract, 0.5% (w/v) sodium chloride (pH7.0) 
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Super optimal broth with catabolite repression (SOC)   
2% (w/v) tryptone, 0.5% (v/v) yeast extract, 10mM 
sodium chloride, 2.5mM potassium chloride, 10mM 
magnesium chloride, 10mM magnesium sulphate, 20mM 
glucose 
7.1.6: Protein buffers and solutions  
Protein loading buffer  8M urea, 2% (w/v) SDS, 10mM Tris HCl pH 6.8, 
0.01% (v/v) bromophenol blue, 2% (v/v) β-
mercaptoethanol 
SDS running buffer 0.025M Tris, 0.192M glycine, 0.1% (w/v) SDS, 
adjusted to pH 8.5 
4x resolving buffer (Protogel)  1.5M Tris-HCl, 0.4% (w/v) SDS, pH 8.8 
4x stacking buffer (Protogel)  0.5M Tris-HCl, 0.4% (w/v) SDS, pH 6.8 
10% resolving polyacrylamide gel  3.33ml 30% acrylamide: bisacrylamide 
(37.5:1) (Bio-Rad), 2.5ml 4x resolving buffer, 
4.06ml water, 100µl 10% (w/v) APS, 10µl 
TEMED. 
4% stacking polyacrylamide gel  1.3ml 30% acrylamide: bisacrylamide 
(37.5:1) (BioRad), 2.5ml 4x stacking buffer, 




Polyacrylamide gel fix solution 50% (v/v) methanol, 10% (v/v) acetic acid 
Protein transfer buffer 25mM Tris, 192mM glycine, 20% (v/v) 
methanol 
Blocking solution  PBS/0.1% (v/v) Tween20, 5% (w/v) 
skimmed milk 
Wash buffer     PBS/0.1% (v/v) Tween20 
7.1.7: Other buffers and solutions   
TBE buffer 89mM Tris-borate, 2mM EDTA, adjusted to 
pH 8.3.  













Name Description  Source 
pHW2000 Reverse genetics plasmid. Bidirectional pol 
I and pol II promoters either side of insert 
lead to mRNA and vRNA-like RNA 
synthesis. 
The Pirbright Institute 
pDUAL Reverse genetics plasmid. Bidirectional pol 
I and pol II promoters either side of insert 
lead to mRNA and vRNA-like RNA 
synthesis. 
Gift from Prof. Ron 
Fouchier a  
pCAGGs Pol II expression plasmid. Contains a CMV 
Immediate Early  promotor 
The Pirbright Institute  
pPol 1 Reverse genetics plasmid. Plasmid 
containing RNA polymerase I promoter 
and terminator, leading to the expression 
of vRNA  
The Pirbright Institute  
pEGFP-
N1 
Constitutively expresses eGFP under 
control of CMV promoter. MCS upstream 
allows opportunity to clone C-terminally 
tagged proteins 
Clontech 
pPol I Luc Reporter for RNP reconstitution assays. 
Contains firefly luciferase reporter gene in 
the reverse orientation and flanked by the 
UTRs of PR8 segment 8, under the control 
of a pol I promoter (human or avian) 
Gift from Prof. Laurence 
Tileyb 
β-gal  Β-galactosidase reporter plasmid, β-gal 
under constitutive expression of an RNA 
polymerase II promoter 
Jagger et al., 2012 
a Erasmus University Medical Centre, Rotterdam, Netherlands. 
b Department of Veterinary Medicine, The University of Cambridge, Cambridge, UK. 
7.1.8.1: Reverse genetics systems  
i) A/Puerto/Rico/8/1934 (H1N1) 
The PR8 eight-plasmid reverse genetic system was a kind gift from Prof. Ron 
Fouchier (Erasmus University Medical Centre, Rotterdam, Netherlands) (de Wit 
et al., 2004).  
 
Plasmid backbone Segment Accession number  Reference  
pDUAL PB2 EF467818  (de Wit et al., 
2004) PB1 EF467819  
PA EF467820 
HA EF467821 
Table 7.4: Plasmids  





M  EF467824  
NS EF467817 
 
ii) A/Chicken/Pakistan/UDL-01/08 (H9N2) 
The UDL-01 reverse genetics systems was produced in house by Dr Joe James 
(The Pirbright Institute, UK). A helper expression plasmid encoding 
A/Victoria/3/75 PB1 was co-transfected with the 8 UDL-01 plasmids to provide 
an initial boost of a high activity PB1 protein (Neumann et al., 1999; Elleman 






pHW2000 PB2 CY038455 Long et al., 2016; 
Iqbal et al., 2013 polI PB1 CY038456 




M  CY038461 
NS CY038462 
 
iii) A/GuineaFowl/Hong Kong/WF10/99 (H9N2) 
The eight-plasmid reverse genetics system for WF10 was kindly provided to the 












M  AOT22377 
Table 7.6: UDL-01 reverse genetics system 






Name  Sequence  Description  
pDUAL FP ATGTCGTAACAACTCCGCCC  For sequencing from 
the 5’ end of insert in 
pDUAL plasmid  
pDUAL RP TTTTTGGGGACAGGTGTCCG  For sequencing from 
the 3’ end of insert in 
pDUAL plasmid  
Uni12 AGCAAAAGCAGG  Complementary to 
the 3’ end of all IAV 
vRNA segments.  
T7F TAA TAC GAC TCA CTA TAG GG Sequencing 
PHW2000 from T7F 
site 
pHW2000 RP CAGGTGTCCGTGTCGCGCGTC Sequencing 
PHW2000, reverse 
primer 
eGFPN1 FP GGCGGTAGGCGTGTA  For sequencing insert 
from 5’ end in 
pEGFPN1.  
PA seq FP 755-775 GGCAAGCTTTCTCAAATGTCG For forward 
sequencing from bp 
755-775 of H9 PA 
PA seq RP 2200 TAGCAAATAGTAGCATTGCCACA For reverse 
sequencing from by 
2200 of H9 PA 
PA seq FP 9-31 CAGGTACTGATCCAAAATGGAAG For forward 
sequencing from bp 
9-31 of H9 PA  
PA seg RP 798-778 CTCAATTCTGGCGTTCACTTC For reverse 
sequencing from bp 
798-778 of H9 PA 
Uni-12FA primer, ACGCGTGATCAGCAAAAGCAGG 
 
Primers for isolation 
of all influenza 
segments for next 
generation 
sequencing  
Uni-12FG primer ACGCGTGATCAGCGAAAGCAGG 
 
Uni-13R primer ACGCGTGATCAGTAGAAACAAGG 
 






UDL-01 PA gene start codon 
with an NotI enzyme site 
forward primer 
Table 7.8: Sequencing primers  








UDL-01 PA gene stop codon 
with a SalI enzyme site 






UDL-01 PA gene start codon 







WF10 PA gene stop codon 
with a XhoI enzyme site 
reverse primer 
 
Name  Sequence  Description  
Uni12 AGCAAAAGCAGG  Complementary to the 5’ end 
of vRNA of all IAV segments  
FluG TATTCGTCTCACCCAGCGAAAGCA
GG 
Complementary to the 5’ end 




Name  Sequence Description  
Influenza M FP AGATGAGTCTTCTAACCGAGGTCG Designed to amplify 




IFNα FP GACAGCCAACGCCAAAGC Designed to amplify 
chicken IFNα IFNα RP GTCGCTGCTGTCCAAGCATT 
IFNα probe  FAM-CTCAACCGGATCCACCGCTACACC-
TAMRA 
IFNβ FP CCTCCAACACCTCTTCAACATG Designed to amplify 
chicken IFNβ IFNβ RP TGGCGTGTGCGGTCAAT 
IFNβ Probe  FAM-
TTAGCAGCCCACACACTCCAAAACACTG-
TAMRA 
IFNγ FP GTGAAGAAGGTGAAAGATATCATGGA Designed to amplify 
chicken IFNγ IFNγ RP GCTTTGCGCTGGATTCTCA 
IFNγ probe FAM-TGGCCAAGCTCCCGATGAACGA-
TAMRA 
IL-1β FP GCTCTACATGTCGTGTGTGATGAG Designed to amplify 
chicken IL-1β IL-1β RP TGTCGATGTCCCGCATGA 
IL-1β probe FAM-CCACACTGCAGCTGGAGGAAGCC-
TAMRA 
IL-4 FP AACATGCGTCAGCTCCTGAAT Designed to amplify 
chicken IL-4 IL-4 RP TCTGCTAGGAACTTCTCCATTGAA 
IL-4 probe FAM-AGCAGCACCTCCCTCAAGGCACC-
TAMRA 
IL-6 FP GCTCGCCGGCTTCGA Designed to amplify 
chicken IL-6  IL-6 RP GGTAGGTCTGAAAGGCGAACAG 
Table 7.10: reverse transcription primers  






IL-18 FP AGGTGAAATCTGGCAGTGGAAT Designed to amplify 
chicken IL-18 IL-18 RP ACCTGGACGCTGAATGCAA 
IL-18 probe FAM-CCGCGCCTTCAGCACGGATG-TAMRA 
TGF-β4 FP AGGATCTGCAGTGGAAGTGGAT Designed to amplify 




CXCLi2 FP GCCCTCCTCCTGGTTTCAG Designed to amplify 




Mx FP CACTGCAACAAGCAAAGAAGGA Designed to amplify 
chicken Mx Mx RP TGATCAACCCCACAAGGAAAA 
Mx probe FAM-ACAAAGCACACACCCAACTGTCAGCG-
TAMRA 
28S FP GGCGAAGCCAGAGGAAACT Designed to amplify 
chicken ribosomal 
protein 28S 
28S RP GACGACCGATTTGCACGTC 
28S probe FAM-AGGACCGCTACGGACCTCCACCA-
TAMRA 
RPLPO-1 FP TTGGGCATCACCACAAAGATT Designed to amplify 
chicken Ribosomal 
phosphoprotein PO 




RPL13 FP TCGTGCTGGCAGGATTC Designed to amplify 
chicken Ribosomal 
protein L13 





Name  Sequence  Description  
A20T FP GTCGAGCTTGCGGAAAAGACAATGAAAGAATAT
GGGG 
Introduction of A20T 





Introduction of T20A 





Introduction of E26K 
change in UDL-01 PA 
E26K RP AAAAGGCAATGAAAGAATATGGGAAAGATCCGA
AAATCGAAACAAAC 





Introduction of K26E 
change in WF10 PA 
K26E RP AAAAGACAATGAAGGAGTATGGGGAAGATCCGA
AAATTGAAACAAAT 
T85I FP CCAGGCCATCGCTCGGTCTCTCCCTTCAATT Introduction of 85I 
change in UDL-01 PA T85I RP AATTGAAGGGAGAGACCGAGCGATGGCCTGG 
I85T FP CTGTCCAGGCCATTGTTCGGTCTCTTCCTTC Introduction of I85T 























Introduction of I118T 





Introduction of T118I 





Introduction of E237K 





Introduction of K237E 





Introduction of G316D 





Introduction of D316G 





Introduction of K327E 





Introduction of E327K 





Introduction of K367M 







Introduction of M367K 





Introduction of S400L 





Introduction of L400S 





Introduction of G684E 





Introduction of E684G 





Introduction of E688G 





Introduction of G688E 





Introduction of R221L 
change in UDL-01 PA-
X R221L RP GACCAAAGTCTACCACCTAACTTCTCCAGCCTTG
A 
L221R FP CAAGGCTGGAGAAGTTCGGTGGGAGACTTTGGT Introduction of L221R 
change in WF10 PA-X L221R RP ACCAAAGTCTCCCACCGAACTTCTCCAGCCTTG 
Q250R FP GCAAGCTTTCTCAAATGTCGAAAGAAGTGAACGC
CAGAA 
Introduction of Q250R 
change in UDL-01 PA-




Introduction of R250Q 









termination codon 1 

















termination codon 1 







termination codon 2 











termination codon 2 











termination codon 3 











termination codon 3 











termination codon 4 











termination codon 4 










mutation to frameshift 
site to remove PA-X 










mutation to frameshift 
site to remove PA-X 









Removal of C in 
frameshift site to drive 
expression towards +1 







GTCTATGGGATTCCTTTGTCAGTCCGAGAGAGG Removal of C in 
frameshift site to drive 
expression towards +1 








Introduce d108a into 
UDL-01 PA to 
inactivate 







CCTTGTAGTCGTATAGGGCCGGAAGAATTTGGGT Introduce d108a into 
WF10 PA to inactivate 







[35S]-L-methionine and [35S]-L-cysteine protein labelling mix           Perkin-Elmer.  
[14C] Protein Molecular Weight Marker             Perkin-Elmer. 
7.2: Methods 
7.2.1: DNA preparation, cloning and analysis 
7.2.1.1: Site directed mutagenesis  
Primers for site directed mutagenesis were designed using Agilent 
QuikChange primer design programme 
(www.genomics.agilent.com/primerDesignProgram.jsp). This allowed for the 
generation of primers where the intended mutation was positioned in the middle 
of the sequence and had a Tm of 65-70°C. The primers had a GC content of 
approximately 40% and terminated on one or more C or G bases.  
Site directed mutagenesis was performed on the H9 PA gene containing 
pHW2000 plasmids using the QuikChange Lightning Site-Directed Mutagenesis 
system (Agilent - #210519), as per the manufacturer’s instruction except using 
half volumes of each reagent. Briefly, within a 25 µl reaction mix: 5µl 10x reaction 
buffer, 50ng of dsDNA template, 125ng forward primer, 125ng reverse primer, 
1µl dNTP mix, 1.5µl QuikSolution reagent, 1µl QuikChange Lightning Enzyme, 
made up to 25µl with ddH20. Thermocycling conditions as follows: i) 2 min 
denaturing step at 95°C, ii) 2 sec denaturing step at 95°C, iii) 10 sec primer 
annealing step at 60°C, iv) 2 min 30 sec elongation step at 68°C, with steps ii) to 
iv) performed for 18 cycles, and v) final 5 min elongation step at 68°C. PCR 
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products were digested using Dpn 1 enzyme to remove parental methylated and 
hemimethylated DNA, 1µl of enzyme added per reaction and incubated for 30 min 
at 37°C. Dpn 1 digested product was visualised via gel electrophoresis (section 
7.2.1.5) before transformation into competent E.coli (section 7.2.1.2).  
7.2.1.2: Transformation of competent bacteria with plasmid DNA 
Commercial competent cells (DH5α, XL10-Gold ultracompetent cells) or 
home-made cells derived from One Shot® TOP10 Chemically Competent E.coli 
(Life Tech) were used for transformation with plasmid DNA. Briefly, 250ng of 
plasmid DNA (or 2µl of site-directed mutagenesis product) was added to 25µl of 
competent cells (thawed on ice), mixed gently and incubated for 30 min on ice. 
Cells were transformed by a 45 sec heat shock at 42°C followed by immediate 
placement on ice for a further 2 min. 250µl of pre-warmed SOC medium was 
added to the cells, which were allowed to recover for 1h at 37°C, shaking. Cells 
were spread onto appropriate antibiotic selection plates using a sterile spreader 
and Bunsen burner to reduce contamination. Plates were incubated at 37°C 
overnight. Single colonies were selected and grown in LB broth (5ml for mini-
prep, 100ml for midi-prep) containing the appropriate antibiotic (37°C, 16h, 
shaking). Bacterial cells were pelleted via centrifugation (1,600xg, 20 min, 4°C), 
and supernatants removed. Cells were used immediately or stored at -20°C for 
processing at a later date via plasmid DNA purification (section 7.2.1.3).  
7.2.1.3: Plasmid DNA purification  
Plasmid DNA mini-preps were performed using QIAGEN’s Plasmid DNA 
Mini Prep kit according to the manufacturer’s instructions. Plasmid DNA midi-
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preps were performed using QIAGEN’s Plasmid Plus DNA Midi Prep kit according 
to manufacturer’s instructions. DNA was eluted in water and the quality and 
concentration of purified plasmid DNA assessed via a NanoDrop ND-1000 
spectrophotometer (Thermo Scientific). 
7.2.1.4: Plasmid sequencing  
After cloning or site-directed mutagenesis, sequencing of the DNA plasmid 
was completed to ensure presence of the correct insert or mutation. Sanger 
sequencing was performed by GATC or Source Biosciences. Each plasmid was 
sequenced with primers designed for the vector backbone (see Table 7.8 for 
details).  
7.2.1.5: DNA gel electrophoresis   
Gel electrophoresis was used to separate DNA. Agarose was boiled in 1x 
TBE buffer at typically 1.0% (w/v) and 1x GelRed nucleic acid stain (Biotium) was 
added to cooled molten agarose and mixed. DNA samples were mixed with 1x 
DNA loading dye (final concentration) and loaded onto the set agarose gel 
alongside a Promega 1kb DNA ladder marker or Hyperladder™ 1kb (Bioline) to 
estimate DNA band sizes. Gels were run at between 50-100V for the desired 
length of time. DNA was visualised using a Gel Doc™ EZ Imager (BioRad) using 
the ‘GelRed’ setting.  
7.2.1.6: Cloning PA segments in pCAGGs 
The ORFs of both UDL-01 and WF10 PAs were cloned out of the pHW2000 
plasmids using primers designed to insert a 5’ NotI site and a 3’ SalI site (UDL-01 
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PA) or a 5’ NotI site and a 3’ XhoI site (WF10 PA). 10ng of DNA template was 
amplified in a 50µl PCR reaction using Pfu Ultra II fusion HS DNA Polymerase 
(Agilent) using the reaction set up as per manufacturers’ instructions.  
Thermocycling conditions were as follows: i) a 2 min denaturation step at 95°C, 
ii) a 20 sec denaturation step at 95°C, iii) a 20 sec primer annealing step at 60°C, 
iv) a 15 sec elongation step at 72°C, with steps ii) – iv) performed for 30 cycles, 
and v) a final 3 min elongation step at 72°C.  PCR product was analysed via gel 
electrophoresis and purified using Qiagen’s QIAquick PCR purification kit as per 
manufacturers instruction eluting in 30µl of water. The whole reaction plus 5µg 
of pCAGGs vector was digested with NotI, SalI or XhoI- HF DNA endonuclease 
(New England Biolabs) using conditions recommended by manufacturer and 
again purified as above. 50ng of cut pCAGGs vector was used in a ligation reaction 
at a molecular ratio of 5:1 (vector: insert) using T4 DNA ligase (New England 
Biolabs), following recommendations from manufacturer. 2µl of ligation product 
was transformed into competent E.coli as described in section 7.2.1.2. Plasmid 
DNA was extracted from individual colony suspensions by mini-prep purification 
(section 7.2.1.3).  
7.2.2: Cell culture  
7.2.2.1: Passaging of continuous cell lines 
MDCK cells, 293T cells, DF-1 cells and QT-35 cells were maintained in 
DMEM supplemented with 10% (v/v) FBS and 100U/ml Penicillin-Streptomycin 
(complete DMEM). All cells were grown at 37°C, 5% CO2. Cells were typically 
passaged every 3-4 days: cells were washed twice (once for 293T cells) with PBS 
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and removed using 0.25% (v/v) trypsin/versene. Cells were resuspended in a 1 
in10 dilution in complete DMEM.  
7.2.2.2: Preparation of primary chicken cells  
Primary chicken kidney cells (CKCs) were generated as previously 
described by the cell culture team at the Pirbright Institute (Hennion et al., 2015). 
Briefly, kidneys from 3 week old SPF Rhode Island Red birds were removed, 
shredded, washed in PBS and then trypsinised and filtered. Cells were 
resuspended in CKC growth media (EMEM + 0.6% w/v BSA, 10% v/v tryptose 
phosphate broth, 300U/ml penicillin/streptomycin), plated and grown at 37°C, 
5% CO2. 
Primary chicken embryo fibroblast cells (CEF) were generated by Mariya 
Goncheva at the Roslin Institute. Briefly, 9-11-day old chicken embryos were 
removed from their egg, the head and viscera removed and the embryos washed 
three times in PBS. Embryos were chopped up and passed through a 20ml syringe 
and added to a 50ml falcon topped up with PBS. Chopped embryos were 
centrifuged (500xg, 5 min), supernatants discarded and then  passed through 
10ml syringe into a 50ml falcon topped up with PBS. This was repeated 5 times. 
To each mashed embryo 5ml of trypsin/EDTA was added and stirred for 30min 
at 37°C, 5% CO2. Supernatant was passed through a metal mesh filter, a further 
5ml of trypsin/EDTA was added to the solid phase and the process repeated. 
Supernatants were centrifuged (500xg, 10 min) and the resulting supernatant 
passed through a 100µm nylon filter unit and centrifuged once more. Cell pellet 
282 
 
resuspended in CEF media (M199, 4% (v/v) FBS and 100U/ml Pen/Strep), plated 
and grown at 37°C, 5% CO2. 
7.2.3: Virus rescue, growth and titration 
7.2.3.1: Virus rescue via reverse genetics  
7.2.3.1.1: PR8 7:1 H9N2 reassortant viruses  
Reverse genetics plasmid sets (7 segments derived from PR8 and the UDL-
01 or WF10 segment 3) were transfected into 293T cells in 6 well plates using 
Lipofectamine2000 transfection reagent. 250ng of each reverse genetics plasmid 
was diluted into 100µl of Opti-MEM. 4µl (4µg) of Lipofectamine2000 was mixed 
with 100µl of Opti-MEM for 5 min at room temperature. The Lipofectamine2000 
and diluted DNA were then mixed and left for a further 30 min at room 
temperature. Meanwhile, 293T cells were washed once with PBS and overlaid 
with Opti-MEM. After the 30 min incubation, the transfection mix was added 
dropwise over the 293T cells. 16h post transfection, media was changed to 
reverse genetics media (DMEM + 2mM glutamine, 100U/ml penicillin, 100U/ml 
streptomycin, 0.14% (w/v) BSA, 5µg/ml TPCK-treated trypsin). Following a 48h 
incubation at 37°C, 5%CO2 supernatants were collected and stored at -80°C. 
These were termed P0 stocks.  
7.2.3.1.2: H9N2 avian influenza viruses  
Reverse genetics plasmid sets for UDL-01 (9-plasmids) and WF10 (8 
plasmids) were transfected into 293T cells using Lipofectamine2000 transfection 
reagent. The transfection protocol was as described above except 1µg of each 
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reverse genetics plasmid was included in the DNA mix along with 10µl (10µg) of 
Lipofectamine2000. 24h post transfection, 293T cells were co-cultured with 
MDCK cells in a T25 flask, once cells had adhered (8-16h post transfection), media 
was changed to DMEM + 2µg/ml TPCK trypsin. Cells were assessed for presence 
of cytopathic effect (CPE) and 2-7 days post co-culture, once CPE was visible, 
supernatants were harvested, clarified (1000xg, 5 min) and stored at -80°C in 
0.5ml or 1ml aliquots. These were termed P0 stocks.  
7.2.3.2: Virus propagation  
7.2.3.2.1: PR8 7:1 H9N2 reassortant viruses  
P1 virus stocks were generated on MDCK cells seeded in T150 flasks or within 
embryonated hens’ eggs. MDCK stocks were produced as follows; 100µl of P0 
stock was diluted in 1ml of reverse genetics media. A confluent T150 flask of 
MDCK cells was washed twice with PBS before the P0 stock dilution added. Cells 
were incubated for 1h at 37°C before 20ml of reverse genetics medium added. 
Supernatants were clarified via centrifugation (1000xg, 5 min) and stored at -
80°C in 0.5ml or 1ml aliquots. Virus titration was performed after one round of 
freeze-thaw to account for any losses in infectivity. 
 Egg grown P1 virus stocks were produced as follows; 100µl of P0 stock was 
diluted in 1ml of serum-free DMEM. Embryonated hens’ eggs (Henry Stewart & 
Co.) were incubated at 37°C, 40-50% humidity, for 10 days and candled to ensure 
viability prior to inoculation. A small hole was introduced into the egg shell just 
below the line of the air sac. The shell was sterilised with 70% (v/v) ethanol. 
100µl of the P0 stock was introduced into the allantoic cavity using a 1ml syringe 
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and 25G needle. The hole was sealed with Scotch tape and eggs were incubated 
for 48-72h. Eggs were culled via refrigeration at 4°C for a minimum of 6h. The top 
of the shell removed using forceps and the air sac punctured using a P1000 Gilson 
pipette tip. Allantoic fluid was collected using a P1000 Gilson pipette, pooled and 
clarified (1400xg, 10 min), then stored in 0.5 or 1ml aliquots at -80°C. Virus 
titration was performed after one round of freeze-thaw to account for any losses 
in infectivity arising from the freeze thaw step.  
7.2.3.2.2: H9N2 avian influenza viruses 
To produce P1 stocks of H9N2 AIVs, embryonated hens’ eggs were utilised. 
The protocol was as described above, except the embryonated hens’ eggs were 
supplied by VALO.  
7.2.3.3: Virus titration  
7.2.3.3.1: PR8 7:1 H9N2 reassortant viruses  
Plaque assays within MDCK cells were used to titrate viral stocks or 
supernatants (Huprikar, 1980). Briefly, the day prior to assay, MDCK cells were 
seeded in 6-well plates to achieve 100% confluency (typically seeding 0.3 x106 
cells per well). Virus samples were serially diluted 10-fold in serum-free DMEM. 
Cells were washed once in PBS before 400µl of virus dilution applied to each well. 
Cells were incubated for 1h at 37°C, after which virus was removed and 2ml of 
overlay added per well. Avicel overlay: virus growth media supplemented with 
1.2% (w/v) Avicel. Plates were incubated at 37°C for 48h. Cells were fixed with 
2ml/well of 10% neutral buffered formalin (NBF) for 20 min-24h. Formalin was 
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removed and cells were stained with 0.1% (w/v) toluidine blue for 20 min-6h. 
Stain was removed and plates washed with water prior to plaque counting and 
titre calculations or plaque imaging.  
7.2.3.3.2: H9N2 AIVs 
Plaque assays within MDCK cells were also used to titrate H9N2 viral 
stocks or supernatants though the protocol differed slightly. The day prior to 
plaque assay, MDCK cells were seeded in 12-well plates to achieve 100% 
confluency (typically seeding 0.1 x 106 cells per well). Virus samples were serially 
diluted 10-fold in serum-free DMEM. Cells were washed once with PBS before 
200µl of virus dilution applied to each well. Cells were incubated for 1h at 37°C, 
after which virus was removed and 1ml of 0.6% agarose overlay was added to 
each well. For the agarose overlay, 2% (w/v) agar was boiled and incubated at 
55°C, 15ml was mixed with 35ml of plaque assay overlay media incubated at 
37°C. After agarose had set, plates were inverted and incubated at 37°C for 72h. 
Plaque assays were fixed and stained via one of two methods. First, the agarose 
plugs were removed and cells fixed and stained with 1ml of 0.1% (v/v) crystal 
violet solution (+20% methanol). Second, agarose plugs were removed and cells 
were fixed with 1ml of 10% NBF per well for 30 min. NBF was removed and cells 
washed twice with PBS. Cells were permeabilised with 1ml PBS/0.2 %( v/v) 
Triton X-100 per well. Cells were washed twice with PBS and incubated with 
250µl/well of mouse monoclonal α-NP (in house) which was diluted 1:2000 in 
PBS/2 %( w/v) BSA for 1h at room temperature on a rocker. Cells were washed 
twice in PBS and then incubated with 250µl/ well of goat anti-mouse IgG 568 
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conjugated secondary antibody (LICOR) diluted 1:10000 in PBS/2% (w/v) BSA 
for 1h at room temperature on a rocker. Cells were washed with water and plates 
imaged on the Odyssey to visualise immunofluorescence.  
7.2.3.4: Measurement of plaque diameter 
Post plaque assay the diameter of 20 plaques per virus was measured 
(unless otherwise stated) to calculate average plaque diameters within MDCK 
cells. Stained plates were photographed/scanned and ImageJ analysis software 
(Abramoff et al., 2004) was used to estimate plaque diameter based on the known 
diameter of the well using the ‘set scale’ function.  
7.2.3.5:  Virus infections of cells  
Cells were plated the day prior to infection to achieve around 90% 
confluency. Cells were washed in serum-free DMEM to remove residual FCS. 
Virus stocks were diluted in serum-free DMEM to achieve the desired multiplicity 
of infection (MOI) and applied to cells in a low volume (e.g. 100µl in a 24 well 
plate format) for 1h at 37°C. Cells were then overlaid with virus growth media 
(CKC growth media for CK cells) to achieve multicycle replication. Supernatants 
were collected at the desired time points post infection, clarified (1000xg, 5 min) 
and stored at -80°C for downstream analysis.  
7.2.3.6: Virus detection via immunofluorescence “in-cell westerns” 
Cells infected with virus were stained for presence of viral NP to assess 
infection rates. At 8h post infection, cells in 24 well plates were washed twice 
with PBS and fixed using 250µl PBS/4% (v/v) formaldehyde for 20 min. Fixed 
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cells were again washed with PBS before permeablisation with 250µl PBS/0.2% 
(v/v) Triton X-100 for 5 min. Cells were washed with 1ml PBS/1% (v/v) FCS and 
stained with α-NP (1:2000) for 1h at room temperature. Cells were washed with 
1ml PBS/1% (v/v) FCS and incubated with the appropriate secondary antibody 
diluted 1:10000 in PBS/1% (v/v) FCS for 1h at room temperature protected from 
light by foil. The presence of NP was detected via imaging on the Odyssey imager 
or via an epi-fluorescence microscope.  
7.2.3.7: Extraction of RNA from cell supernatants/allantoic fluid 
Viral RNA extraction from cell culture media or egg allantoic fluid was 
completed using the QIAamp Viral RNA mini kit (Qiagen) following the 
manufacturer’s instructions. Briefly, 140µl of sample was added to 560µl of 
prepared AVL buffer containing carrier RNA and was incubated at room 
temperature for 10 min to ensure sufficient lysis. 560µl (96-100%) ethanol was 
added to precipitate RNA and the mix added to the QIAamp Mini column. Columns 
were centrifuged (5800xg, 1 min) and flow through removed. The columns were 
then washed twice with the provided buffers and RNA eluted into a final volume 
of 60µl of Buffer AVE. 
7.2.3.8: Virus sequencing    
Viral RNA was extracted from P1 stocks as described above. cDNA 
synthesis from the viral RNA was completed using the Verso cDNA synthesis kit 
(Thermo Scientific; #AB-1453) as per the manufacturer’s instructions using the 
FluG (H9N2) or Uni12 (PR8 7:1) primers. Briefly, reverse transcription reactions 
were set up as follows: RT mix; vRNA- 200ng, Primer- 120ng (each), H2O- made 
288 
 
up to 10µl, then heated at 65°C for 10 min. Afterwards, RT mix (10µl-from above), 
dNTPs- 5mM each, RT enzyme- 1µl, 5x cDNA synthesis buffer- 4µl and H2O- made 
up to 20µl were added and the mix proceeded to RT programme (42°C for 60 
min) followed by an inactivation step of 95°C for 2 min.  
The cDNA product was amplified using PCR prior to sequencing. 2.5U Taq 
DNA polymerase was used within a 25µl reaction volume containing 1.5mM 
magnesium chloride, 1x Taq PCR buffer (Invitrogen), 200nM forward primer, 
200nM reverse primer and 250µM (each) dNTPs. Thermocycling conditions 
depended on the amplicon targeted. Typically an annealing temperature of Tm-
5°C (primer with lowest Tm) was adopted. For example, the following conditions 
were used for amplification of UDL-01 PA segment cDNA: i) a 2 min denaturation 
step at 94°C, ii) a 1 min denaturation step at 94°C, iii) a 1 min primer annealing 
step at 55°C, iv) a 3 min elongation step at 72°C, with steps ii) – iv) performed for 
30 cycles, and v) a final 10 min elongation step at 72°C.   
Prior to sequencing, PCR product was purified using QIAGEN’s QIAquick 
PCR purification kit as per the manufacturer’s protocol. The PCR product was 
eluted in 30µl of water and run on a 1% agarose gel (section 7.2.1.5). Sanger 
sequencing of cDNA was performed by GATC (PR8 7:1 viruses) or Source 






7.2.4: Transfection based assays  
7.2.4.1: Minireplicon assays   
293T cells were seeded into 24 well plates to achieve 70-80% confluency 
for transfection the following day (0.05 x 106 cells per well seeded). Protein 
expression plasmids for each of the components of a vRNP (PB2, PB1, PA and NP) 
along with a firefly luciferase reporter construct (pPol I Luc) at the following 
concentrations: PB2- 80ng, PB1- 80ng, PA- 20ng, NP- 160ng, pPol I Luc- 80ng, 
were added to 50µl of Opti-MEM. 2.5µl (2.5µg) of Lipofectamine2000 transfection 
reagent was mixed with another 50µl of Opti-MEM and incubated for 5 min at 
room temperature. The DNA and Lipofectamine2000 samples were mixed and 
incubated at room temperature for a further 30 min. 293T cell media was 
removed and replaced with 0.5ml of Opti-MEM per well. 100µl of transfection 
mixes was added dropwise to each well, with each sample repeated in triplicate. 
Cells were incubated at 37°C for 48h, after 8h media was removed and complete 
DMEM added for the remaining time. After 48h, media was gently removed and 
cells lysed in 100µl of 1x Passive Lysis Buffer (Promega). Plates were freeze-
thawed once to ensure efficient cell lysis. Cells were scraped and mixed with a 
P200 Gilson pipette tip. 10µl of cell lysate was added to a white bottomed 96-well 
plate. A Promega GloMax Multi Detection unit was employed to inject 25µl of 
Luciferase Assay Reagent II (Promega) per well and to measure the luciferase 
activity (injection speed 200µl/sec, 0.5 sec gap, 5 sec integration time) following 
the manufacturer’s instructions.  
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For RNP reconstitution assays within DF-1 cells, the protocol was as 
described above except twice the concentration of DNA was included within each 
reaction and the firefly luciferase reporter construct was driven by a chicken 
promotor (CKpPol I Luc).  
7.2.4.2: Plasmid based host cell shut off assays 
293T cells were seeded as above into 24 well plates to achieve 70-80% 
confluency for transfection the following day (0.05 x 106 cells per well seeded). 
5ng/µl of protein expression plasmids of the influenza segment 3 (PA) and 1ng/µl 
of a β-galactosidase (β-gal) reporter construct were added to 50µl of Opti-MEM. 
In a separate tube 50µl of Opti-MEM, 2.5µl (0.05µg/µl) of Lipofectamine2000 
were added. Mixes were incubated for 5 min at room temperature after which 
they were mixed and incubated for a further 30 min.  Meanwhile, 293T cell media 
was removed and replaced with 0.5ml of Opti-MEM per well. 100µl of 
transfection mixes were added dropwise to each well, with each sample repeated 
in triplicate. Cells were incubated at 37°C for 48h, after 8h media was removed 
and complete DMEM added for the remaining time. After 48h, cells were lysed 
with 100µl of 1x Reporter lysis buffer (RLB; Promega). β-gal expression was 
measured using the β-galactosidase enzyme assay system (Promega). Briefly, 
20µl of cell lysate was diluted in 30µl of 1xRLB in a clear bottomed 96-well plate. 
50µl of 2x Assay buffer was added to each well and the samples mixed by 
pipetting. The plate was incubated at 37°C for 30 min until the development of a 
yellow colour within the wells. Reaction progression was stopped via the addition 
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of 150µl of 1M sodium carbonate. A Promega GloMax Multi Detection unit was 
employed to read absorbance at 420nm.  
For β-gal assays within DF-1 cells, the protocol was as described above, 
except the concentrations of DNA were doubled within the transfection mix and 
the cell lysates were read neat and not diluted further in 1xRLB.  
7.2.5: Protein Analyses 
7.2.5.1: Protein Electrophoresis  
Proteins were separated by molecular weight by sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE) using a discontinuous 
polyacrylamide gel system. SDS-PAGE equipment was supplied by Bio-Rad (Mini-
PROTEAN tetra system). Polyacrylamide gels were cast using buffers and 
solutions supplied by Protogel according to manufacturers’ instructions, altering 
the concentration of acrylamide: bisacrylamide (37.5:1) solution to produce the 
required resolving gel percentage. Stacking gels were cast at 4%. Examples of 
resolving and stacking gel recipes are seen within section 7.1.6. 0.75mm spacer 
plates were used with appropriate short plates. In Vitro Translations (IVTs) were 
run on large gels with equipment supplied by BioRad.  
To generate cell lysates, typically cells seeded in 24-well plates were lysed 
in 200µl of protein loading buffer. Samples were boiled for 5 min at 95°C, 
vortexed and the briefly centrifuged. 10-20µl (25µl for IVTs) were loaded per lane 
of each gel. Gels were run vertically at a constant voltage of 100-120V for the 
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desired length of time, using a pre-stained molecular weight marker (Promega) 
as a guide for protein migration.  
7.2.5.2: Western Blotting  
Proteins separated via SDS-PAGE were blotted onto nitrocellulose 
membranes (BioRad) using a semi-dry blotting system (Trans-Blot Turbo 
Transfer System (Bio-Rad). The nitrocellulose membrane was placed onto the 
polyacrylamide gel supported by stacks of filter paper, this was then placed into 
the Trans-Blot system with the membrane on the negative cathode side. Protein 
transfers were run for 10min at 25V, 2.5A. Nitrocellulose membranes were 
blocked in PBS/0.1% (v/v) Tween20 with 5% (w/v) skimmed milk (Marvel) for 
at least 1h at room temperature on a rocker. Blocked membranes were probed 
with primary antibody, diluted in PBS/0.1% (v/v) Tween20 with 2% (w/v) 
skimmed milk (Marvel), typically, overnight at 4°C with rocking. Membranes were 
washed 3x 5 min in PBS/0.1% (v/v) Tween20, and then incubated with secondary 
antibody, diluted in PBS/0.1% (v/v) Tween20, for 1h at room temperature, 
rocking and covered from light by foil. Membranes were washed 3x 5 min in 
PBS/0.1% (v/v) Tween20 before imaging on the Odyssey CLX (LI-COR 
Biosciences).  
7.2.5.3: 35S-methionine/cysteine-labelling protein studies  
CEF cells were seeded in 24-well plates and infected with virus at an MOI 
of 3 using standard protocols (section 7.2.3.5). Cells were seeded in duplicate to 
allow for generation of cell lysates and assessment of successful infection via IF.  
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At 6h post-infection, cells were washed twice in warmed PBS before 
overlay with 1ml of methionine-and cysteine- free DMEM supplemented with 5% 
(v/v) dialysed FCS and 2mM L-Glutamine to starve the cells of methionine and 
cysteine. At 8h post infection, cells were washed twice with warm PBS and 
overlaid with 0.5ml of methionine- and cysteine- free DMEM (supplemented as 
above) including 35-S-methionine/cysteine protein labelling mix (Perkin/Elmer) 
at 0.8mBq/ml. Cells were incubated at 37°C in a vented box containing activated 
charcoal (Fisher) for 1h. Cells were washed once with ice-cold PBS and then cells 
lysed in protein loading buffer for SDS-PAGE as above and processed via 
autoradiography (section 7.2.5.1 + 7.2.5.6).  
7.2.5.4: Puromycin labelling protein studies  
MDCK cells were seeded into 12 well plates and infected with virus at an 
MOI of 5 using the standard protocol (section 7.2.3.5). At 7.5h post infection cells 
were washed with PBS and the medium changed to 1ml of complete DMEM 
containing 10µg/ml of Puromycin dihydrochloride from Streptomyces alboniger 
for 30 min. Cells were washed with ice cold PBS and lysed in 100µl of protein 
loading buffer for SDS-PAGE and western blotting for puromycin as above. 
Puromycylated protein synthesis was quantified in the region of the gel between 
45kDa and 80kDa.  
7.2.5.5: In Vitro translations  
To perform in vitro translations to visualise radiolabelled proteins the 
TnT® Coupled Reticulocyte Lysate system (Promega; #L4610) was adopted. 
Briefly, TnT reaction were set up as follows: 8µl TnT mix, 4µCi 35S-Methinone, 
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made up to 15µl with H2O, 200ng plasmid DNA. Mixes were prepared on ice using 
sawn off pipette tips to aliquot the TnT mix before reactions were incubated at 
37°C for 90 min. The reactions were denatured in 50µl protein loading buffer and 
analysed via SDS-PAGE and autoradiography (section 7.2.5.1 and 7.2.5.6) 
7.2.5.6: Autoradiography of dried polyacrylamide gels  
SDS-PAGE was run as described previously. Gels were fixed by rocking in 
gel fix solution (50% methanol (v/v), 10% acetic acid (v/v)) for 5-15 min 
depending on the size of the gel. The fix solution was replaced for 2 more rounds 
of fixing. Gels were laid on 3MM Whatman filter paper and covered with Clingfilm 
then dried in a gel dryer (Bio-Rad) by heating up to 80°C for 2-4h under vacuum 
pressure. Dried gels were placed in a sealed cassette with an X-ray film (Thermo 
Fisher) overnight, at a minimum or until the desired signal strength was achieved. 
X-ray films were developed using a Konica SRX-101A X-ograph film processor 
using manufacturers’ instructions.  
7.2.5.7: Densitometry  
Protein quantification following autoradiography was determined by 
densitometry using ImageJ analysis software. The gel analyser tool was used on 
scans of exposed films to measure the area under the peak generated by each 
‘band’ on the autoradiograph. The larger the peak, the brighter the band, the 





7.2.6: Modelling, sequence analysis and bioinformatics  
7.2.6.1: Modelling and mapping of PA structures  
Structural prediction of UDL-01 and WF10 endonuclease domains after 
mutation were completed using the I-TASSER server for protein structure 
prediction accessed online at https://zhanglab.ccmb.med.umich.edu/I-TASSER/. 
This platform has been developed as an integrated system for automated protein 
structure analysis. The amino acid sequence of the protein is used to generate 3-
D atomic models from multiple threading alignments and iterative structural 
assembly situations (Roy et al., 2010). Known PA structures were downloaded 
from the Protein Data Bank (PDB) for annotation with mutations identified 
during the study. All structural images were generated and annotated using 
PyMol v1.5.0 (www.pymol.org; Schrodinger, 2010).  
7.2.6.2: Analysis of sequencing data  
Sanger sequencing was outsourced to GATC and Source Biosciences 
(Lifesciences). Alignment of sequencing reads to plasmids or influenza gene 
segments were performed using CLUSTAL multiple alignment or optimal 
GLOBAL alignment functions (BioEdit).  
7.2.6.3: Bioinformatics of PA sequences  
To perform analysis of the diversity and distribution of amino acids across 
the PA gene bioinformatics analysis was carried out by Dr Samantha Lycett at the 
Roslin Institute. Full length sequences, with coding regions marked as complete 
or nearly complete, were downloaded from the NCBI influenza virus resource 
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(23th June 2015). Files were split into 1000 base pair regions and aligned using 
MUSCLE (MEGA6) and then re-joined.  Incomplete sequences or sequences with 
runs of non-identified amino acids were excluded from the analysis (totalling 88 
avian, 14 swine, 55 human and 1 canine-derived virus sequences).  This left 
12,248 avian, 3082 swine, 12,148 human, 77 canine and 177 equine virus 
sequences for further analysis. The data sets were analysed by host and the 
consensus amino acid as well as the further 3 most common amino acids 
identified for each position. The fraction of sequences with each of the amino 
acids was also calculated.  
7.2.7: In ovo characterisation of H9N2 AIVs 
7.2.7.1: Inoculation of embryonated eggs  
To characterise H9N2 AIVs in ovo, embryonated hens’ eggs (VALO breed) 
were used. The eggs were incubated at 37°C, 40-50% humidity, for 10 days and 
candled to ensure viability prior to inoculation. Virus stocks were diluted to the 
required pfu in 1ml of PBS. A small hole was introduced into the egg shell just 
below the line of the air sac. The shell was sterilised with 70% (v/v) ethanol. 
100µl of the diluted virus was introduced into the allantoic cavity using a 1ml 
syringe and 25 gauge needle. The hole was sealed with Scotch tape and eggs were 
incubated for 4-72h. Eggs were culled via refrigeration at 4°C for a minimum of 
6h. The top of the shell was removed using forceps and the air sac punctured 
using a P1000 Gilson pipette tip. Allantoic fluid from each egg was collected using 
a P1000 Gilson pipette and clarified by centrifugation (1400xg, 10 min). Viral 
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replication within the eggs was assessed via plaque assay or via immunostaining 
for NP (Sections 7.2.3.3.2 and 7.2.3.6).  
Viral passage in eggs was completed as above, except the allantoic fluid 
samples were titrated via plaque assay (section 7.2.3.3.2) after each passage and 
100 pfu inoculated into one egg per passage.  
7.2.7.2: Assessment of embryo gross pathology  
 Six eggs per group were inoculated with 100 pfu of each virus, or sterile 
PBS as described above (section 7.2.7.1). Embryos were candled twice daily to 
check for embryo viability. Eggs were assessed for experimental end points 
including lack of movement of the embryo, disruption of blood vessels and/or 
signs of haemorrhage. If any end point signs were observed, embryos were 
chilled immediately. At 48h post infection, all remaining embryos were 
refrigerated for a minimum of 6h. Each embryo was removed from the shell, 
washed twice with PBS and photographed to document the gross pathology. 
Samples of allantoic fluid were collected and viral titres within each egg assessed 
via plaque assay (section 7.2.3.3.2). Images of embryos which were positive for 
detection of virus and had not died early within the experiment (prior to the final 
candling) were selected for further analysis. 
The gross pathology of the embryos was then blindly scored by three 
group members. The scoring criteria were as follows: 0- no obvious bleeding, 1- 
subtle bleeding, 2- considerable bleeding, 3- very obvious bleeding and/or 
embryo not intact. Each scorer independently examined the embryo images and 
assigned a score between 0 and 3 with no half scores being given. This enabled a 
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quantifiable measure to be allocated to each infected group.  Embryo size was 
assessed using ImageJ analysis software. Estimates of embryo length were 
calculated from the images using the known diameter of the petri dishes the 
embryos were imaged in. The ‘set scale’ analysis tool was used to estimate length.  
7.2.7.3: Calculation of Egg infectious Dose 50 (EID50) 
A 10-fold serial dilution of the relevant virus (10000 pfu to 0.001 pfu) was 
made as used to infect 5 embryonated eggs per virus per dilution (as described 
in section 7.2.7.1). Samples of allantoic fluid were collected and presence of virus 
detected via immunofluorescence for viral NP protein (Section 7.2.3.6). To 
calculate the Egg Infectious Dose 50 (EID50), the Reed-Muench method was 
adopted (Reed and Muench, 1938): 
 𝑃𝑟𝑜𝑝𝑜𝑟𝑡𝑖𝑜𝑛𝑎𝑡𝑒 𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒
=  
50% − (%𝑖𝑛𝑓𝑒𝑐𝑡𝑖𝑜𝑛 𝑎𝑡 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑏𝑒𝑙𝑜𝑤)
(%𝑖𝑛𝑓𝑒𝑐𝑡𝑖𝑜𝑛 𝑎𝑡 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑎𝑏𝑜𝑣𝑒) − (%𝑖𝑛𝑓𝑒𝑐𝑡𝑖𝑜𝑛 𝑎𝑡 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑏𝑒𝑙𝑜𝑤)
 
 
𝐿𝑜𝑔10 𝐸𝐼𝐷50 = 𝑙𝑜𝑔10 𝑜𝑓 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑠ℎ𝑜𝑤𝑖𝑛𝑔 𝑖𝑛𝑓𝑒𝑐𝑡𝑖𝑜𝑛 𝑎𝑏𝑜𝑣𝑒 50% − 𝑃𝐷
∗ 𝑙𝑜𝑔𝑎𝑟𝑖𝑡ℎ𝑚 𝑜𝑓 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟  
This allowed for the dilution of virus in which 50% of the inoculated eggs showed 
viable infection to be calculated.  
7.2.7.4: Assessment of embryo survival  
A 10-fold serial dilution of the relevant virus (10000 pfu to 0.001 pfu) was 
made as used to infect 5 embryonated eggs per virus per dilution (as described 
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in section 7.2.7.1). Embryos were candled twice daily throughout the study 
period to check for embryo viability (up to 84 hours post infection). If eggs 
reached a predetermined end point at candling they were deemed to be dead and 
the eggs chilled to ensure death before disposal. The markers of the end point 
included; lack of movement of the embryo, disruption of blood vessels within the 
egg and/or signs of haemorrhage. If the embryos survived until the experiment 
end (84 hours post infection) they were culled via a schedule one method 
(chilling). Samples of allantoic fluid were collected and presence of virus detected 
via immunostaining for viral NP protein (section 7.2.3.6). Any eggs without 
positive detection of viral NP were removed from the study. 
7.2.8: In vivo characterisation of H9N2 AIVs 
7.2.8.1: Ethics statement 
All animal experiments were carried out in strict accordance with the 
European and United Kingdom Home Office Regulations and the Animal 
(Scientific Procedures) Act 1986 Amendment regulation 2012, under the 
authority of a United Kingdom Home Office Licence (Project Licence Numbers: 
P68D44CF4 X and PPL3002952).  
7.2.8.2: Influenza infectivity, transmission and pathogenicity experiment 
set up 
Rhode Island Red (RIR) or White Leghorn fertilised embryos were 
purchased from the National Avian Research Facility (NARF) or VALO 
respectively and housed within the Pirbright Institute BSU. Embryonated eggs 
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were incubated for 21 days and hatched at the Pirbright Institute by members of 
the animal services team after which point they were housed in floor pens within 
the Pirbright Institute BSU until 3 weeks old. Prior to the commencement of the 
study, all birds were swabbed (in both oropharyngeal and cloacal cavities) and 
bled via wing prick to determine any pre-study infection. The relevant number of 
birds were transferred into self-contained BioFlex B50 Rigid Body Poultry 
isolators (Bell Isolation Systems) so that they could remain at negative pressure. 
The remaining birds were kept housed in floor pens within the same room. 
Infection of RIR or VALO chickens was conducted by Prof. Munir Iqbal, Dr Holly 
Shelton and Dr Jean-Remy Sadeyen (The Pirbright Institute, UK). 10-20 birds per 
group were directly inoculated with 100µl of a 105 pfu/ml virus stock diluted in 
PBS via the nares (50µl in each nostril). Mock infected birds were inoculated with 
sterile PBS as an alternative. One day post infection 8 naïve contact birds were 
introduced into each isolator to determine viral transmissibility.  
Throughout the experiment, birds were swabbed in the buccal and cloacal 
cavities (on day 1-8, 10 and 14 post infection) by a trained member of staff who 
held a personal licence (Prof. Munir Iqbal, Dr. Holly Shelton, Dr. Jean-Remy 
Sadeyen, Dr. Pengxiang Chang, Dr. Sushant Bhat, Joshua Sealy, Anabel Clements). 
Swabs were collected into 1ml of virus transport media (WHO standard). Swabs 
were soaked in media and vortexed for 10 sec before centrifuging (2300xg, 10 
min) and aliquoting supernatant. Viral titres in swabs were determined via 
plaque assay (described in section 7.2.3.3.2). Environmental samples (at least 1g 
of food and 1ml of water) were collected on a daily basis from each isolator and 
the pen. 1g of food sample was weighed, mixed with 1ml of serum-free DMEM, 
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vortexed until homogenised and the clarified (5800xg, 15 min). Food and water 
samples were stored at -80°C before virus titrated via plaque assay.  
At various time points post infection; day 2 in both studies and day 1 and 
3 within the RIR study, birds housed within isolators were euthanised via 
overdose of pentobarbital (at least 1ml) injected into the wing vein or jugular 
(Prof. Munir Iqbal or Dr. Holly Shelton). Mock infected birds were culled via 
cervical dislocation (Rachel New, Billy Matthews). A panel of tissues were 
collected with the help of Dr. Jean-Remy Sadeyen during post-mortem 
examination. Tissues were split into 2 sections and stored in RNA later or snap 
frozen in dry ice. The RNA later and snap frozen tissues were stored at -80°C until 
further processing. On day 14 post infection, all remaining birds were culled via 
overdose of pentobarbital or cervical dislocation.  
7.2.8.3: Clinical scoring system 
Birds were observed twice daily by members of animal services and whilst 
procedures were carried out. Birds were monitored for the presence of clinical 
signs of infection. Mild clinical signs expected during the study included, ruffled 
feathers, pale comb/wattles, eye and nasal discharge, reddened eyes, snicking 
and depression. Additional moderate clinical signs that may be expected included 
drooping wings, swollen heads and sporadic diarrhoea.  If any signs of severe 
disease including laboured breathing, persistent diarrhoea, sitting alone and 
showing no signs to evade capture and in the most extreme instances paralysis 
and unconsciousness were observed birds were euthanised via a schedule one 
method and post mortem examination carried out.  
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7.2.8.4: Isolation of virus from tissues  
50mg of snap frozen tissues (collected during post mortem examination) 
were weighed and added to 250µl of sterile PBS + 100U/ml 
penicillin/streptomycin to make 20% (w/v) in a safe-lock Eppendorf tube. One 
sterile 5mm stainless steel bead was added per tube and tissues homogenised 
using the Retsch MM 300 Bead Mill system (20Hz, 4min). After one round of 
homogenisation, tissue disruption was checked and repeated if necessary until 
tissue was fully homogenised. Samples were centrifuged (16,000xg, 5 min, 4°C) 
and kept on ice. Supernatants were titrated via plaque assay (section 7.2.3.3.2) to 
determine presence of infectious virus.  
7.2.8.5: Trizol extraction of RNA from tissues 
30mg of tissue collected in RNA later were weighed and placed in a safe-
lock Eppendorf tube with 750µl of Trizol. One sterile 5mm stainless steel bead 
was added per tube and tissues homogenised using the Retsch MM 300 Bead Mill 
system (20Hz, 4 min). After one round of homogenisation, tissue disruption was 
checked and repeated if necessary until tissue fully homogenised. 200µl of 
chloroform was added per tube. Tubes were shaken vigorously and incubated for 
5 min at room temperature. Samples were centrifuged (9,200xg, 30 min, 4°C). 
The top aqueous phase containing total RNA was added to a new microcentrifuge 
tube and the remaining fluid discarded. RNA extraction was then carried out 





100ng of RNA extracted from tissue samples (section 7.2.8.5) was used for 
qRT-PCR. All qRT-PCR was completed using the Superscript III platinum One step 
qRT-PCR kit (Life Technologies) following manufacturer’s instructions for 
reaction set up. Primer probe sets outlined in Table 7.11. qRT-PCR was run in a 
7500 FAST ABI RT-PCR thermocycler (Applied Biosystems). Cycling conditions 
as follows: i) 5 min hold step at 50°C, ii) a 2 min hold step at 95°C, and 40 cycles 
of iii) 3 sec at 95 °C and iv) 30 sec annealing and extension at 60 °C. Cycle 
threshold (CT) values were obtained using 7500 softwarev2.3 and exported to 
Microsoft excel for further analysis. Mean CT values were calculated from 
triplicate data. Negative controls were included within each plate to determine 
any unspecific amplification or contamination.  
Within viral M segment qRT-PCR an M segment RNA standard curve was 
completed alongside the samples to quantify the amount of M gene RNA within 
the sample from the CT value. T7 RNA polymerase-derived transcripts from UDL-
01 segment 7 were used for the preparation of the standard curve (provided by 
Dr. Joe James).  
Within the cytokine qRT-PCRs, three housekeeping genes were included 
per sample (RPLPO-1, RPL13 and 28S rRNA). These had previously determined 
to be the most stable housekeeping genes within the broadest range of tissues 
(Tom Whitehead, personal communication). Briefly, the geNorm algorithm 
(Vandesompele et al., 2002) was adopted to calculate the stability for each 
reference gene and the optimal reference gene number from raw Cq values of 
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candidate reference genes using qbase+ real-time qPCR software version 3.0 
(Biogazelle).  
7.2.8.7: Next Generation Sequencing  
RNA was extracted from swab supernatants (Section 7.2.3.7) and RT-PCR 
for next generation sequencing was conducted using the Invitrogen one-step RT-
PCR kit (CAT#12574-035) and universal influenza primers (see table 7.10 for 
details). 30µl RT-PCR mixes were set up as follows: 15.0µl 2x RTPCR buffer, 2µM 
Uni-12FA primer, 6µM Uni-12FG primer, 6µM Uni-13R primer, 0.5µl enzyme mix, 
5µl of required RNA, made up to 30µl with H20. Reaction mixes were placed in a 
pre-warmed thermocycler paused at 42°C. Cycling conditions were as follows: i) 
42°C for 50 min, ii) 50°C for 10 min, iii) 94°C for 2 min, 5 cycles of iv) 94°C for 2 
min, v) 43°C for 30 sec,  vi) 68°C for 4 min, followed by a further 31 cycles of vii) 
94°C for 30 sec viii) 57°C for 30 sec ix)68°C for 4 min, then 68°C for 10 min. PCR 
products were analysed via gel electrophoresis to visualise the banding pattern 
spanning the influenza gene sizes (section 7.2.1.5). Products were then purified 
using the Qiagen PCR purification kit following manufacturers’ instruction. 
Samples were sent to the Francis Crick Institute (London) for NGS on the Illumina 
MiSeq using Illumina Nextera XT for library preparation. NGS reads were 
analysed for consensus sequences by Joshua Sealy. Consensus sequences were 
aligned as described in section 7.2.6.2. 
7.2.9: Statistical analyses 
All statistical analysis was carried out using GraphPad Prism 6/7 software. 
Distribution of data was assessed prior to deciding on the statistical test to use.  
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